id	sid	tid	token	lemma	pos
fnp-5813	1	1	regression	regression	NOUN
fnp-5813	1	2	of	of	ADP
fnp-5813	1	3	multiple	multiple	ADJ
fnp-5813	1	4	intracranial	intracranial	ADJ
fnp-5813	1	5	meningiomas	meningioma	NOUN
fnp-5813	1	6	after	after	ADP
fnp-5813	1	7	cessation	cessation	NOUN
fnp-5813	1	8	of	of	ADP
fnp-5813	1	9	long	long	ADJ
fnp-5813	1	10	-	-	PUNCT
fnp-5813	1	11	term	term	NOUN
fnp-5813	1	12	synthetic	synthetic	ADJ
fnp-5813	1	13	progesterone	progesterone	NOUN
fnp-5813	1	14	(	(	PUNCT
fnp-5813	1	15	megestrol	megestrol	NOUN
fnp-5813	1	16	)	)	PUNCT
fnp-5813	1	17	medication	medication	NOUN
fnp-5813	1	18	:	:	PUNCT
fnp-5813	1	19	case	case	NOUN
fnp-5813	1	20	report	report	NOUN
fnp-5813	1	21	and	and	CCONJ
fnp-5813	1	22	autopsy	autopsy	ADJ
fnp-5813	1	23	feel	feel	VERB
fnp-5813	1	24	free	free	ADJ
fnp-5813	1	25	to	to	PART
fnp-5813	1	26	add	add	VERB
fnp-5813	1	27	comments	comment	NOUN
fnp-5813	1	28	by	by	ADP
fnp-5813	1	29	clicking	click	VERB
fnp-5813	1	30	these	these	DET
fnp-5813	1	31	icons	icon	NOUN
fnp-5813	1	32	on	on	ADP
fnp-5813	1	33	the	the	DET
fnp-5813	1	34	sidebar	sidebar	NOUN
fnp-5813	1	35	free	free	ADJ
fnp-5813	1	36	neuropathology	neuropathology	NOUN
fnp-5813	1	37	5:27	5:27	NUM
fnp-5813	1	38	(	(	PUNCT
fnp-5813	1	39	2024	2024	NUM
fnp-5813	1	40	)	)	PUNCT
fnp-5813	1	41	case	case	NOUN
fnp-5813	1	42	report	report	NOUN
fnp-5813	1	43	regression	regression	NOUN
fnp-5813	1	44	of	of	ADP
fnp-5813	1	45	multiple	multiple	ADJ
fnp-5813	1	46	intracranial	intracranial	ADJ
fnp-5813	1	47	meningiomas	meningioma	NOUN
fnp-5813	1	48	after	after	ADP
fnp-5813	1	49	cessation	cessation	NOUN
fnp-5813	1	50	of	of	ADP
fnp-5813	1	51	long	long	ADJ
fnp-5813	1	52	-	-	PUNCT
fnp-5813	1	53	term	term	NOUN
fnp-5813	1	54	synthetic	synthetic	ADJ
fnp-5813	1	55	progesterone	progesterone	NOUN
fnp-5813	1	56	(	(	PUNCT
fnp-5813	1	57	megestrol	megestrol	NOUN
fnp-5813	1	58	)	)	PUNCT
fnp-5813	1	59	medication	medication	NOUN
fnp-5813	1	60	:	:	PUNCT
fnp-5813	1	61	case	case	NOUN
fnp-5813	1	62	report	report	NOUN
fnp-5813	1	63	and	and	CCONJ
fnp-5813	1	64	autopsy	autopsy	ADJ
fnp-5813	1	65	tamadar	tamadar	NOUN
fnp-5813	1	66	a.	a.	PROPN
fnp-5813	1	67	aldoheyan1,2	aldoheyan1,2	PROPN
fnp-5813	1	68	,	,	PUNCT
fnp-5813	1	69	marc	marc	PROPN
fnp-5813	1	70	r.	r.	PROPN
fnp-5813	1	71	del	del	PROPN
fnp-5813	1	72	bigio1,3	bigio1,3	PROPN
fnp-5813	1	73	department	department	PROPN
fnp-5813	1	74	of	of	ADP
fnp-5813	1	75	pathology	pathology	PROPN
fnp-5813	1	76	,	,	PUNCT
fnp-5813	1	77	max	max	PROPN
fnp-5813	1	78	rady	rady	PROPN
fnp-5813	1	79	college	college	PROPN
fnp-5813	1	80	of	of	ADP
fnp-5813	1	81	medicine	medicine	NOUN
fnp-5813	1	82	,	,	PUNCT
fnp-5813	1	83	university	university	PROPN
fnp-5813	1	84	of	of	ADP
fnp-5813	1	85	manitoba	manitoba	PROPN
fnp-5813	1	86	,	,	PUNCT
fnp-5813	1	87	winnipeg	winnipeg	PROPN
fnp-5813	1	88	,	,	PUNCT
fnp-5813	1	89	manitoba	manitoba	PROPN
fnp-5813	1	90	,	,	PUNCT
fnp-5813	1	91	canada	canada	PROPN
fnp-5813	1	92	current	current	ADJ
fnp-5813	1	93	appointment	appointment	NOUN
fnp-5813	1	94	:	:	PUNCT
fnp-5813	1	95	department	department	NOUN
fnp-5813	1	96	of	of	ADP
fnp-5813	1	97	pathology	pathology	PROPN
fnp-5813	1	98	,	,	PUNCT
fnp-5813	1	99	king	king	PROPN
fnp-5813	1	100	saud	saud	PROPN
fnp-5813	1	101	university	university	PROPN
fnp-5813	1	102	,	,	PUNCT
fnp-5813	1	103	riyadh	riyadh	PROPN
fnp-5813	1	104	,	,	PUNCT
fnp-5813	1	105	saudi	saudi	PROPN
fnp-5813	1	106	arabia	arabia	PROPN
fnp-5813	1	107	pathology	pathology	PROPN
fnp-5813	1	108	,	,	PUNCT
fnp-5813	1	109	shared	share	VERB
fnp-5813	1	110	health	health	NOUN
fnp-5813	1	111	manitoba	manitoba	PROPN
fnp-5813	1	112	,	,	PUNCT
fnp-5813	1	113	winnipeg	winnipeg	PROPN
fnp-5813	1	114	,	,	PUNCT
fnp-5813	1	115	manitoba	manitoba	PROPN
fnp-5813	1	116	,	,	PUNCT
fnp-5813	1	117	canada	canada	PROPN
fnp-5813	1	118	corresponding	corresponding	PROPN
fnp-5813	1	119	author	author	PROPN
fnp-5813	1	120	:	:	PUNCT
fnp-5813	1	121	marc	marc	PROPN
fnp-5813	1	122	del	del	PROPN
fnp-5813	1	123	bigio	bigio	PROPN
fnp-5813	1	124	·	·	PUNCT
fnp-5813	1	125	health	health	PROPN
fnp-5813	1	126	sciences	sciences	PROPN
fnp-5813	1	127	centre	centre	PROPN
fnp-5813	1	128	winnipeg	winnipeg	PROPN
fnp-5813	1	129	·	·	PUNCT
fnp-5813	1	130	department	department	NOUN
fnp-5813	1	131	of	of	ADP
fnp-5813	1	132	pathology	pathology	PROPN
fnp-5813	1	133	(	(	PUNCT
fnp-5813	1	134	ms4	ms4	PROPN
fnp-5813	1	135	)	)	PUNCT
fnp-5813	1	136	·	·	PUNCT
fnp-5813	2	1	820	820	NUM
fnp-5813	2	2	sherbrook	sherbrook	VERB
fnp-5813	2	3	street	street	NOUN
fnp-5813	2	4	·	·	PUNCT
fnp-5813	2	5	winnipeg	winnipeg	NOUN
fnp-5813	2	6	,	,	PUNCT
fnp-5813	2	7	mb	mb	ADP
fnp-5813	2	8	r3a	r3a	ADV
fnp-5813	2	9	1r9	1r9	NUM
fnp-5813	2	10	·	·	PUNCT
fnp-5813	2	11	canada	canada	PROPN
fnp-5813	2	12	marc.delbigio@umanitoba.ca	marc.delbigio@umanitoba.ca	PROPN
fnp-5813	2	13	submitted	submit	VERB
fnp-5813	2	14	:	:	PUNCT
fnp-5813	2	15	16	16	NUM
fnp-5813	2	16	august	august	PROPN
fnp-5813	2	17	2024	2024	NUM
fnp-5813	2	18	accepted	accept	VERB
fnp-5813	2	19	:	:	PUNCT
fnp-5813	2	20	03	03	NUM
fnp-5813	2	21	october	october	PROPN
fnp-5813	2	22	2024	2024	NUM
fnp-5813	2	23	copyedited	copyedit	VERB
fnp-5813	2	24	by	by	ADP
fnp-5813	2	25	:	:	PUNCT
fnp-5813	2	26	georg	georg	NOUN
fnp-5813	2	27	haase	haase	NOUN
fnp-5813	2	28	published	publish	VERB
fnp-5813	2	29	:	:	PUNCT
fnp-5813	2	30	29	29	NUM
fnp-5813	2	31	october	october	NOUN
fnp-5813	2	32	2024	2024	NUM
fnp-5813	2	33	https://doi.org/10.17879/freeneuropathology-2024-5813	https://doi.org/10.17879/freeneuropathology-2024-5813	PROPN
fnp-5813	2	34	keywords	keyword	NOUN
fnp-5813	2	35	:	:	PUNCT
fnp-5813	2	36	autopsy	autopsy	ADJ
fnp-5813	2	37	,	,	PUNCT
fnp-5813	2	38	meningioma	meningioma	NOUN
fnp-5813	2	39	,	,	PUNCT
fnp-5813	2	40	megestrol	megestrol	NOUN
fnp-5813	2	41	,	,	PUNCT
fnp-5813	2	42	progesterone	progesterone	NOUN
fnp-5813	2	43	receptor	receptor	NOUN
fnp-5813	2	44	,	,	PUNCT
fnp-5813	2	45	tumor	tumor	NOUN
fnp-5813	2	46	involution	involution	NOUN
fnp-5813	2	47	abstract	abstract	NOUN
fnp-5813	2	48	we	we	PRON
fnp-5813	2	49	report	report	VERB
fnp-5813	2	50	the	the	DET
fnp-5813	2	51	history	history	NOUN
fnp-5813	2	52	of	of	ADP
fnp-5813	2	53	a	a	DET
fnp-5813	2	54	woman	woman	NOUN
fnp-5813	2	55	who	who	PRON
fnp-5813	2	56	developed	develop	VERB
fnp-5813	2	57	four	four	NUM
fnp-5813	2	58	intracranial	intracranial	ADJ
fnp-5813	2	59	meningiomas	meningioma	NOUN
fnp-5813	2	60	during	during	ADP
fnp-5813	2	61	11	11	NUM
fnp-5813	2	62	years	year	NOUN
fnp-5813	2	63	of	of	ADP
fnp-5813	2	64	therapy	therapy	NOUN
fnp-5813	2	65	with	with	ADP
fnp-5813	2	66	the	the	DET
fnp-5813	2	67	synthetic	synthetic	ADJ
fnp-5813	2	68	progesterone	progesterone	NOUN
fnp-5813	2	69	agonist	agonist	NOUN
fnp-5813	2	70	megestrol	megestrol	NOUN
fnp-5813	2	71	.	.	PUNCT
fnp-5813	3	1	after	after	ADP
fnp-5813	3	2	discontinuation	discontinuation	NOUN
fnp-5813	3	3	of	of	ADP
fnp-5813	3	4	the	the	DET
fnp-5813	3	5	drug	drug	NOUN
fnp-5813	3	6	at	at	ADP
fnp-5813	3	7	age	age	NOUN
fnp-5813	3	8	75	75	NUM
fnp-5813	3	9	years	year	NOUN
fnp-5813	3	10	,	,	PUNCT
fnp-5813	3	11	she	she	PRON
fnp-5813	3	12	improved	improve	VERB
fnp-5813	3	13	clinically	clinically	ADV
fnp-5813	3	14	and	and	CCONJ
fnp-5813	3	15	a	a	DET
fnp-5813	3	16	ct	ct	NOUN
fnp-5813	3	17	scan	scan	NOUN
fnp-5813	3	18	showed	show	VERB
fnp-5813	3	19	near	near	ADP
fnp-5813	3	20	complete	complete	ADJ
fnp-5813	3	21	regression	regression	NOUN
fnp-5813	3	22	of	of	ADP
fnp-5813	3	23	the	the	DET
fnp-5813	3	24	meningiomas	meningioma	NOUN
fnp-5813	3	25	by	by	ADP
fnp-5813	3	26	78	78	NUM
fnp-5813	3	27	years	year	NOUN
fnp-5813	3	28	.	.	PUNCT
fnp-5813	4	1	autopsy	autopsy	ADJ
fnp-5813	4	2	was	be	AUX
fnp-5813	4	3	performed	perform	VERB
fnp-5813	4	4	at	at	ADP
fnp-5813	4	5	83	83	NUM
fnp-5813	4	6	years	year	NOUN
fnp-5813	4	7	of	of	ADP
fnp-5813	4	8	age	age	NOUN
fnp-5813	4	9	following	follow	VERB
fnp-5813	4	10	an	an	DET
fnp-5813	4	11	accidental	accidental	ADJ
fnp-5813	4	12	death	death	NOUN
fnp-5813	4	13	.	.	PUNCT
fnp-5813	5	1	at	at	ADP
fnp-5813	5	2	the	the	DET
fnp-5813	5	3	tumor	tumor	NOUN
fnp-5813	5	4	sites	site	NOUN
fnp-5813	5	5	,	,	PUNCT
fnp-5813	5	6	we	we	PRON
fnp-5813	5	7	found	find	VERB
fnp-5813	5	8	both	both	DET
fnp-5813	5	9	collagenous	collagenous	ADJ
fnp-5813	5	10	tissue	tissue	NOUN
fnp-5813	5	11	with	with	ADP
fnp-5813	5	12	small	small	ADJ
fnp-5813	5	13	islands	island	NOUN
fnp-5813	5	14	of	of	ADP
fnp-5813	5	15	low	low	ADJ
fnp-5813	5	16	grade	grade	NOUN
fnp-5813	5	17	meningioma	meningioma	NOUN
fnp-5813	5	18	having	have	VERB
fnp-5813	5	19	strong	strong	ADJ
fnp-5813	5	20	nuclear	nuclear	ADJ
fnp-5813	5	21	immunoreactivity	immunoreactivity	NOUN
fnp-5813	5	22	for	for	ADP
fnp-5813	5	23	progesterone	progesterone	NOUN
fnp-5813	5	24	receptor	receptor	NOUN
fnp-5813	5	25	and	and	CCONJ
fnp-5813	5	26	lipomatous	lipomatous	ADJ
fnp-5813	5	27	tissue	tissue	NOUN
fnp-5813	5	28	.	.	PUNCT
fnp-5813	6	1	a	a	DET
fnp-5813	6	2	literature	literature	NOUN
fnp-5813	6	3	review	review	NOUN
fnp-5813	6	4	showed	show	VERB
fnp-5813	6	5	similar	similar	ADJ
fnp-5813	6	6	cases	case	NOUN
fnp-5813	6	7	of	of	ADP
fnp-5813	6	8	radiologic	radiologic	ADJ
fnp-5813	6	9	meningioma	meningioma	NOUN
fnp-5813	6	10	regression	regression	NOUN
fnp-5813	6	11	following	follow	VERB
fnp-5813	6	12	discontinuance	discontinuance	NOUN
fnp-5813	6	13	of	of	ADP
fnp-5813	6	14	progestins	progestin	NOUN
fnp-5813	6	15	.	.	PUNCT
fnp-5813	7	1	our	our	PRON
fnp-5813	7	2	case	case	NOUN
fnp-5813	7	3	is	be	AUX
fnp-5813	7	4	the	the	DET
fnp-5813	7	5	first	first	ADJ
fnp-5813	7	6	one	one	NUM
fnp-5813	7	7	with	with	ADP
fnp-5813	7	8	histopathologic	histopathologic	ADJ
fnp-5813	7	9	characterization	characterization	NOUN
fnp-5813	7	10	of	of	ADP
fnp-5813	7	11	the	the	DET
fnp-5813	7	12	end	end	NOUN
fnp-5813	7	13	point	point	NOUN
fnp-5813	7	14	.	.	PUNCT
fnp-5813	8	1	introduction	introduction	NOUN
fnp-5813	8	2	meningiomas	meningioma	NOUN
fnp-5813	8	3	are	be	AUX
fnp-5813	8	4	twice	twice	ADV
fnp-5813	8	5	as	as	ADV
fnp-5813	8	6	common	common	ADJ
fnp-5813	8	7	in	in	ADP
fnp-5813	8	8	females	female	NOUN
fnp-5813	8	9	as	as	ADP
fnp-5813	8	10	in	in	ADP
fnp-5813	8	11	males	male	NOUN
fnp-5813	8	12	.	.	PUNCT
fnp-5813	9	1	these	these	DET
fnp-5813	9	2	tumors	tumor	NOUN
fnp-5813	9	3	are	be	AUX
fnp-5813	9	4	known	know	VERB
fnp-5813	9	5	to	to	PART
fnp-5813	9	6	express	express	VERB
fnp-5813	9	7	progesterone	progesterone	NOUN
fnp-5813	9	8	receptor	receptor	NOUN
fnp-5813	9	9	and	and	CCONJ
fnp-5813	9	10	to	to	ADP
fnp-5813	9	11	a	a	DET
fnp-5813	9	12	lesser	less	ADJ
fnp-5813	9	13	extent	extent	NOUN
fnp-5813	9	14	estrogen	estrogen	NOUN
fnp-5813	9	15	receptors	receptor	NOUN
fnp-5813	9	16	[	[	X
fnp-5813	9	17	1	1	NUM
fnp-5813	9	18	,	,	PUNCT
fnp-5813	9	19	2	2	NUM
fnp-5813	9	20	]	]	PUNCT
fnp-5813	9	21	.	.	PUNCT
fnp-5813	10	1	numerous	numerous	ADJ
fnp-5813	10	2	case	case	NOUN
fnp-5813	10	3	reports	report	NOUN
fnp-5813	10	4	and	and	CCONJ
fnp-5813	10	5	population	population	NOUN
fnp-5813	10	6	-	-	PUNCT
fnp-5813	10	7	based	base	VERB
fnp-5813	10	8	studies	study	NOUN
fnp-5813	10	9	show	show	VERB
fnp-5813	10	10	increased	increase	VERB
fnp-5813	10	11	risk	risk	NOUN
fnp-5813	10	12	for	for	ADP
fnp-5813	10	13	meningioma	meningioma	NOUN
fnp-5813	10	14	,	,	PUNCT
fnp-5813	10	15	tumor	tumor	NOUN
fnp-5813	10	16	multiplicity	multiplicity	NOUN
fnp-5813	10	17	,	,	PUNCT
fnp-5813	10	18	and	and	CCONJ
fnp-5813	10	19	tumor	tumor	NOUN
fnp-5813	10	20	progression	progression	NOUN
fnp-5813	10	21	in	in	ADP
fnp-5813	10	22	women	woman	NOUN
fnp-5813	10	23	who	who	PRON
fnp-5813	10	24	receive	receive	VERB
fnp-5813	10	25	synthetic	synthetic	ADJ
fnp-5813	10	26	progestins	progestin	NOUN
fnp-5813	10	27	including	include	VERB
fnp-5813	10	28	cyproterone	cyproterone	NOUN
fnp-5813	10	29	acetate	acetate	NOUN
fnp-5813	10	30	,	,	PUNCT
fnp-5813	10	31	megestrol	megestrol	NOUN
fnp-5813	10	32	acetate	acetate	NOUN
fnp-5813	10	33	(	(	PUNCT
fnp-5813	10	34	also	also	ADV
fnp-5813	10	35	called	call	VERB
fnp-5813	10	36	nomegestrol	nomegestrol	NOUN
fnp-5813	10	37	)	)	PUNCT
fnp-5813	10	38	,	,	PUNCT
fnp-5813	10	39	and	and	CCONJ
fnp-5813	10	40	chlormadinone	chlormadinone	NOUN
fnp-5813	10	41	acetate	acetate	NOUN
fnp-5813	11	1	[	[	X
fnp-5813	11	2	3–10	3–10	NOUN
fnp-5813	11	3	]	]	PUNCT
fnp-5813	11	4	.	.	PUNCT
fnp-5813	12	1	progestin	progestin	NOUN
fnp-5813	12	2	-	-	PUNCT
fnp-5813	12	3	associated	associate	VERB
fnp-5813	12	4	meningiomas	meningioma	NOUN
fnp-5813	12	5	are	be	AUX
fnp-5813	12	6	often	often	ADV
fnp-5813	12	7	located	locate	VERB
fnp-5813	12	8	at	at	ADP
fnp-5813	12	9	the	the	DET
fnp-5813	12	10	skull	skull	NOUN
fnp-5813	12	11	base	base	NOUN
fnp-5813	12	12	and	and	CCONJ
fnp-5813	12	13	have	have	VERB
fnp-5813	12	14	higher	high	ADJ
fnp-5813	12	15	frequencies	frequency	NOUN
fnp-5813	12	16	of	of	ADP
fnp-5813	12	17	pik3ca	pik3ca	NOUN
fnp-5813	12	18	and	and	CCONJ
fnp-5813	12	19	traf7	traf7	NOUN
fnp-5813	12	20	mutations	mutation	NOUN
fnp-5813	13	1	[	[	X
fnp-5813	13	2	11	11	NUM
fnp-5813	13	3	]	]	PUNCT
fnp-5813	13	4	.	.	PUNCT
fnp-5813	14	1	some	some	DET
fnp-5813	14	2	tumors	tumor	NOUN
fnp-5813	14	3	decrease	decrease	VERB
fnp-5813	14	4	in	in	ADP
fnp-5813	14	5	size	size	NOUN
fnp-5813	14	6	after	after	ADP
fnp-5813	14	7	drug	drug	NOUN
fnp-5813	14	8	discontinuation	discontinuation	NOUN
fnp-5813	14	9	[	[	X
fnp-5813	14	10	12	12	NUM
fnp-5813	14	11	,	,	PUNCT
fnp-5813	14	12	13	13	NUM
fnp-5813	14	13	]	]	PUNCT
fnp-5813	14	14	,	,	PUNCT
fnp-5813	14	15	although	although	SCONJ
fnp-5813	14	16	administration	administration	NOUN
fnp-5813	14	17	of	of	ADP
fnp-5813	14	18	the	the	DET
fnp-5813	14	19	antiprogesterone	antiprogesterone	NOUN
fnp-5813	14	20	agent	agent	NOUN
fnp-5813	14	21	mifepristone	mifepristone	NOUN
fnp-5813	14	22	has	have	AUX
fnp-5813	14	23	not	not	PART
fnp-5813	14	24	been	be	AUX
fnp-5813	14	25	shown	show	VERB
fnp-5813	14	26	to	to	PART
fnp-5813	14	27	be	be	AUX
fnp-5813	14	28	efficacious	efficacious	ADJ
fnp-5813	14	29	for	for	ADP
fnp-5813	14	30	treatment	treatment	NOUN
fnp-5813	14	31	of	of	ADP
fnp-5813	14	32	progestin	progestin	NOUN
fnp-5813	14	33	-	-	PUNCT
fnp-5813	14	34	induced	induce	VERB
fnp-5813	14	35	meningioma	meningioma	NOUN
fnp-5813	15	1	[	[	X
fnp-5813	15	2	14	14	NUM
fnp-5813	15	3	,	,	PUNCT
fnp-5813	15	4	15	15	NUM
fnp-5813	15	5	]	]	PUNCT
fnp-5813	15	6	.	.	PUNCT
fnp-5813	16	1	here	here	ADV
fnp-5813	16	2	we	we	PRON
fnp-5813	16	3	report	report	VERB
fnp-5813	16	4	the	the	DET
fnp-5813	16	5	autopsy	autopsy	ADJ
fnp-5813	16	6	findings	finding	NOUN
fnp-5813	16	7	in	in	ADP
fnp-5813	16	8	a	a	DET
fnp-5813	16	9	woman	woman	NOUN
fnp-5813	16	10	who	who	PRON
fnp-5813	16	11	developed	develop	VERB
fnp-5813	16	12	multiple	multiple	ADJ
fnp-5813	16	13	intracranial	intracranial	ADJ
fnp-5813	16	14	tumors	tumor	NOUN
fnp-5813	16	15	during	during	ADP
fnp-5813	16	16	long	long	ADJ
fnp-5813	16	17	-	-	PUNCT
fnp-5813	16	18	term	term	NOUN
fnp-5813	16	19	therapy	therapy	NOUN
fnp-5813	16	20	with	with	ADP
fnp-5813	16	21	the	the	DET
fnp-5813	16	22	progesterone	progesterone	NOUN
fnp-5813	16	23	agonist	agonist	NOUN
fnp-5813	16	24	megestrol	megestrol	NOUN
fnp-5813	16	25	acetate	acetate	NOUN
fnp-5813	16	26	.	.	PUNCT
fnp-5813	17	1	the	the	DET
fnp-5813	17	2	tumors	tumor	NOUN
fnp-5813	17	3	,	,	PUNCT
fnp-5813	17	4	presumed	presume	VERB
fnp-5813	17	5	to	to	PART
fnp-5813	17	6	be	be	AUX
fnp-5813	17	7	meningiomas	meningioma	NOUN
fnp-5813	17	8	,	,	PUNCT
fnp-5813	17	9	regressed	regress	VERB
fnp-5813	17	10	almost	almost	ADV
fnp-5813	17	11	entirely	entirely	ADV
fnp-5813	17	12	upon	upon	SCONJ
fnp-5813	17	13	cessation	cessation	NOUN
fnp-5813	17	14	of	of	ADP
fnp-5813	17	15	the	the	DET
fnp-5813	17	16	drug	drug	NOUN
fnp-5813	17	17	.	.	PUNCT
fnp-5813	18	1	clinical	clinical	ADJ
fnp-5813	18	2	summary	summary	NOUN
fnp-5813	18	3	at	at	ADP
fnp-5813	18	4	64	64	NUM
fnp-5813	18	5	years	year	NOUN
fnp-5813	18	6	age	age	NOUN
fnp-5813	18	7	,	,	PUNCT
fnp-5813	18	8	this	this	DET
fnp-5813	18	9	woman	woman	NOUN
fnp-5813	18	10	underwent	undergo	VERB
fnp-5813	18	11	hysterectomy	hysterectomy	NOUN
fnp-5813	18	12	with	with	ADP
fnp-5813	18	13	bilateral	bilateral	ADJ
fnp-5813	18	14	salpingo	salpingo	NOUN
fnp-5813	18	15	-	-	PUNCT
fnp-5813	18	16	oophorectomy	oophorectomy	NOUN
fnp-5813	18	17	for	for	ADP
fnp-5813	18	18	low	low	ADJ
fnp-5813	18	19	grade	grade	NOUN
fnp-5813	18	20	endometrial	endometrial	ADJ
fnp-5813	18	21	stromal	stromal	ADJ
fnp-5813	18	22	sarcoma	sarcoma	NOUN
fnp-5813	18	23	and	and	CCONJ
fnp-5813	18	24	was	be	AUX
fnp-5813	18	25	placed	place	VERB
fnp-5813	18	26	on	on	ADP
fnp-5813	18	27	progesterone	progesterone	NOUN
fnp-5813	18	28	therapy	therapy	NOUN
fnp-5813	18	29	with	with	ADP
fnp-5813	18	30	megestrol	megestrol	NOUN
fnp-5813	18	31	160	160	NUM
fnp-5813	18	32	 	 	SPACE
fnp-5813	18	33	mg	mg	PROPN
fnp-5813	18	34	daily	daily	ADV
fnp-5813	18	35	.	.	PUNCT
fnp-5813	19	1	regular	regular	ADJ
fnp-5813	19	2	imaging	imaging	NOUN
fnp-5813	19	3	follow	follow	NOUN
fnp-5813	19	4	-	-	PUNCT
fnp-5813	19	5	up	up	NOUN
fnp-5813	19	6	in	in	ADP
fnp-5813	19	7	the	the	DET
fnp-5813	19	8	subsequent	subsequent	ADJ
fnp-5813	19	9	decade	decade	NOUN
fnp-5813	19	10	showed	show	VERB
fnp-5813	19	11	no	no	DET
fnp-5813	19	12	evidence	evidence	NOUN
fnp-5813	19	13	of	of	ADP
fnp-5813	19	14	local	local	ADJ
fnp-5813	19	15	recurrence	recurrence	NOUN
fnp-5813	19	16	or	or	CCONJ
fnp-5813	19	17	metastatic	metastatic	ADJ
fnp-5813	19	18	disease	disease	NOUN
fnp-5813	19	19	.	.	PUNCT
fnp-5813	20	1	psoriasis	psoriasis	NOUN
fnp-5813	20	2	had	have	AUX
fnp-5813	20	3	been	be	AUX
fnp-5813	20	4	treated	treat	VERB
fnp-5813	20	5	with	with	ADP
fnp-5813	20	6	oral	oral	ADJ
fnp-5813	20	7	methotrexate	methotrexate	NOUN
fnp-5813	20	8	intermittently	intermittently	ADV
fnp-5813	20	9	from	from	ADP
fnp-5813	20	10	age	age	NOUN
fnp-5813	20	11	62	62	NUM
fnp-5813	20	12	to	to	PART
fnp-5813	20	13	73	73	NUM
fnp-5813	20	14	years	year	NOUN
fnp-5813	20	15	,	,	PUNCT
fnp-5813	20	16	acitretin	acitretin	NOUN
fnp-5813	20	17	,	,	PUNCT
fnp-5813	20	18	a	a	DET
fnp-5813	20	19	retinoid	retinoid	NOUN
fnp-5813	20	20	,	,	PUNCT
fnp-5813	20	21	for	for	ADP
fnp-5813	20	22	1	1	NUM
fnp-5813	20	23	year	year	NOUN
fnp-5813	20	24	at	at	ADP
fnp-5813	20	25	age	age	NOUN
fnp-5813	20	26	74	74	NUM
fnp-5813	20	27	,	,	PUNCT
fnp-5813	20	28	and	and	CCONJ
fnp-5813	20	29	apremilast	apremilast	VERB
fnp-5813	20	30	,	,	PUNCT
fnp-5813	20	31	a	a	DET
fnp-5813	20	32	selective	selective	ADJ
fnp-5813	20	33	inhibitor	inhibitor	NOUN
fnp-5813	20	34	of	of	ADP
fnp-5813	20	35	the	the	DET
fnp-5813	20	36	enzyme	enzyme	NOUN
fnp-5813	20	37	phosphodiesterase	phosphodiesterase	NOUN
fnp-5813	20	38	4	4	NUM
fnp-5813	20	39	 	 	SPACE
fnp-5813	20	40	/	/	SYM
fnp-5813	20	41	 	 	SPACE
fnp-5813	20	42	pde4	pde4	NOUN
fnp-5813	20	43	,	,	PUNCT
fnp-5813	20	44	from	from	ADP
fnp-5813	20	45	age	age	NOUN
fnp-5813	20	46	77	77	NUM
fnp-5813	20	47	to	to	PART
fnp-5813	20	48	83	83	NUM
fnp-5813	20	49	.	.	PUNCT
fnp-5813	21	1	the	the	DET
fnp-5813	21	2	past	past	ADJ
fnp-5813	21	3	medical	medical	ADJ
fnp-5813	21	4	history	history	NOUN
fnp-5813	21	5	of	of	ADP
fnp-5813	21	6	the	the	DET
fnp-5813	21	7	woman	woman	NOUN
fnp-5813	21	8	also	also	ADV
fnp-5813	21	9	included	include	VERB
fnp-5813	21	10	diabetes	diabetes	NOUN
fnp-5813	21	11	mellitus	mellitus	NOUN
fnp-5813	21	12	type	type	NOUN
fnp-5813	21	13	2	2	NUM
fnp-5813	21	14	,	,	PUNCT
fnp-5813	21	15	hypothyroidism	hypothyroidism	NOUN
fnp-5813	21	16	,	,	PUNCT
fnp-5813	21	17	and	and	CCONJ
fnp-5813	21	18	arterial	arterial	ADJ
fnp-5813	21	19	hypertension	hypertension	NOUN
fnp-5813	21	20	for	for	ADP
fnp-5813	21	21	which	which	PRON
fnp-5813	21	22	she	she	PRON
fnp-5813	21	23	was	be	AUX
fnp-5813	21	24	treated	treat	VERB
fnp-5813	21	25	with	with	ADP
fnp-5813	21	26	metformin	metformin	NOUN
fnp-5813	21	27	,	,	PUNCT
fnp-5813	21	28	levothyroxine	levothyroxine	PROPN
fnp-5813	21	29	,	,	PUNCT
fnp-5813	21	30	nifedipine	nifedipine	NOUN
fnp-5813	21	31	,	,	PUNCT
fnp-5813	21	32	and	and	CCONJ
fnp-5813	21	33	hydrochlorothiazide	hydrochlorothiazide	PROPN
fnp-5813	21	34	,	,	PUNCT
fnp-5813	21	35	respectively	respectively	ADV
fnp-5813	21	36	.	.	PUNCT
fnp-5813	22	1	ct	ct	PROPN
fnp-5813	22	2	scans	scan	NOUN
fnp-5813	22	3	of	of	ADP
fnp-5813	22	4	the	the	DET
fnp-5813	22	5	head	head	NOUN
fnp-5813	22	6	had	have	AUX
fnp-5813	22	7	been	be	AUX
fnp-5813	22	8	done	do	VERB
fnp-5813	22	9	at	at	ADP
fnp-5813	22	10	56	56	NUM
fnp-5813	22	11	and	and	CCONJ
fnp-5813	22	12	66	66	NUM
fnp-5813	22	13	years	year	NOUN
fnp-5813	22	14	because	because	SCONJ
fnp-5813	22	15	of	of	ADP
fnp-5813	22	16	headaches	headache	NOUN
fnp-5813	22	17	;	;	PUNCT
fnp-5813	22	18	these	these	PRON
fnp-5813	22	19	showed	show	VERB
fnp-5813	22	20	minor	minor	ADJ
fnp-5813	22	21	ischemic	ischemic	ADJ
fnp-5813	22	22	changes	change	NOUN
fnp-5813	22	23	in	in	ADP
fnp-5813	22	24	cerebral	cerebral	ADJ
fnp-5813	22	25	white	white	ADJ
fnp-5813	22	26	matter	matter	NOUN
fnp-5813	22	27	and	and	CCONJ
fnp-5813	22	28	no	no	DET
fnp-5813	22	29	evidence	evidence	NOUN
fnp-5813	22	30	of	of	ADP
fnp-5813	22	31	intracranial	intracranial	ADJ
fnp-5813	22	32	tumor	tumor	NOUN
fnp-5813	22	33	.	.	PUNCT
fnp-5813	23	1	at	at	ADP
fnp-5813	23	2	age	age	NOUN
fnp-5813	23	3	73	73	NUM
fnp-5813	23	4	years	year	NOUN
fnp-5813	23	5	,	,	PUNCT
fnp-5813	23	6	the	the	DET
fnp-5813	23	7	woman	woman	NOUN
fnp-5813	23	8	presented	present	VERB
fnp-5813	23	9	with	with	ADP
fnp-5813	23	10	labile	labile	ADJ
fnp-5813	23	11	emotions	emotion	NOUN
fnp-5813	23	12	and	and	CCONJ
fnp-5813	23	13	confusion	confusion	NOUN
fnp-5813	23	14	.	.	PUNCT
fnp-5813	24	1	she	she	PRON
fnp-5813	24	2	had	have	VERB
fnp-5813	24	3	a	a	DET
fnp-5813	24	4	mild	mild	ADJ
fnp-5813	24	5	resting	rest	VERB
fnp-5813	24	6	tremor	tremor	NOUN
fnp-5813	24	7	but	but	CCONJ
fnp-5813	24	8	no	no	DET
fnp-5813	24	9	localizing	localize	VERB
fnp-5813	24	10	signs	sign	NOUN
fnp-5813	24	11	.	.	PUNCT
fnp-5813	25	1	a	a	DET
fnp-5813	25	2	ct	ct	PROPN
fnp-5813	25	3	scan	scan	NOUN
fnp-5813	25	4	of	of	ADP
fnp-5813	25	5	the	the	DET
fnp-5813	25	6	head	head	NOUN
fnp-5813	25	7	showed	show	VERB
fnp-5813	25	8	three	three	NUM
fnp-5813	25	9	dura	dura	NOUN
fnp-5813	25	10	-	-	PUNCT
fnp-5813	25	11	based	base	VERB
fnp-5813	25	12	tumors	tumor	NOUN
fnp-5813	25	13	in	in	ADP
fnp-5813	25	14	the	the	DET
fnp-5813	25	15	left	left	ADJ
fnp-5813	25	16	parietal	parietal	ADJ
fnp-5813	25	17	 	 	SPACE
fnp-5813	25	18	/	/	SYM
fnp-5813	25	19	 	 	SPACE
fnp-5813	25	20	posterior	posterior	ADJ
fnp-5813	25	21	falx	falx	ADJ
fnp-5813	25	22	region	region	NOUN
fnp-5813	25	23	(	(	PUNCT
fnp-5813	25	24	2.9	2.9	NUM
fnp-5813	25	25	 	 	SPACE
fnp-5813	25	26	cm	cm	NOUN
fnp-5813	25	27	)	)	PUNCT
fnp-5813	25	28	,	,	PUNCT
fnp-5813	25	29	the	the	DET
fnp-5813	25	30	left	left	ADJ
fnp-5813	25	31	frontal	frontal	ADJ
fnp-5813	25	32	 	 	SPACE
fnp-5813	25	33	/	/	SYM
fnp-5813	25	34	 	 	SPACE
fnp-5813	25	35	anterior	anterior	ADJ
fnp-5813	25	36	falx	falx	PROPN
fnp-5813	25	37	region	region	NOUN
fnp-5813	25	38	(	(	PUNCT
fnp-5813	25	39	2.8	2.8	NUM
fnp-5813	25	40	 	 	SPACE
fnp-5813	25	41	cm	cm	NOUN
fnp-5813	25	42	)	)	PUNCT
fnp-5813	25	43	,	,	PUNCT
fnp-5813	25	44	and	and	CCONJ
fnp-5813	25	45	the	the	DET
fnp-5813	25	46	right	right	ADJ
fnp-5813	25	47	parasellar	parasellar	ADJ
fnp-5813	25	48	region	region	NOUN
fnp-5813	25	49	(	(	PUNCT
fnp-5813	25	50	1.7	1.7	NUM
fnp-5813	25	51	 	 	SPACE
fnp-5813	25	52	cm	cm	NOUN
fnp-5813	25	53	)	)	PUNCT
fnp-5813	25	54	(	(	PUNCT
fnp-5813	25	55	figures	figure	NOUN
fnp-5813	25	56	 	 	SPACE
fnp-5813	25	57	1	1	NUM
fnp-5813	25	58	and	and	CCONJ
fnp-5813	25	59	2	2	NUM
fnp-5813	25	60	)	)	PUNCT
fnp-5813	25	61	.	.	PUNCT
fnp-5813	26	1	measurements	measurement	NOUN
fnp-5813	26	2	presented	present	VERB
fnp-5813	26	3	in	in	ADP
fnp-5813	26	4	figure	figure	NOUN
fnp-5813	26	5	 	 	SPACE
fnp-5813	26	6	2	2	NUM
fnp-5813	26	7	are	be	AUX
fnp-5813	26	8	from	from	ADP
fnp-5813	26	9	the	the	DET
fnp-5813	26	10	ct	ct	PROPN
fnp-5813	26	11	scans	scan	NOUN
fnp-5813	26	12	.	.	PUNCT
fnp-5813	27	1	all	all	DET
fnp-5813	27	2	tumors	tumor	NOUN
fnp-5813	27	3	were	be	AUX
fnp-5813	27	4	isointense	isointense	VERB
fnp-5813	27	5	with	with	ADP
fnp-5813	27	6	gray	gray	ADJ
fnp-5813	27	7	matter	matter	NOUN
fnp-5813	27	8	on	on	ADP
fnp-5813	27	9	unenhanced	unenhanced	ADJ
fnp-5813	27	10	imaging	imaging	NOUN
fnp-5813	27	11	,	,	PUNCT
fnp-5813	27	12	and	and	CCONJ
fnp-5813	27	13	all	all	PRON
fnp-5813	27	14	were	be	AUX
fnp-5813	27	15	bright	bright	ADJ
fnp-5813	27	16	following	follow	VERB
fnp-5813	27	17	contrast	contrast	NOUN
fnp-5813	27	18	enhancement	enhancement	NOUN
fnp-5813	27	19	.	.	PUNCT
fnp-5813	28	1	the	the	DET
fnp-5813	28	2	tumors	tumor	NOUN
fnp-5813	28	3	were	be	AUX
fnp-5813	28	4	thought	think	VERB
fnp-5813	28	5	to	to	PART
fnp-5813	28	6	be	be	AUX
fnp-5813	28	7	meningiomas	meningioma	NOUN
fnp-5813	28	8	.	.	PUNCT
fnp-5813	29	1	a	a	DET
fnp-5813	29	2	single	single	ADJ
fnp-5813	29	3	magnetic	magnetic	ADJ
fnp-5813	29	4	resonance	resonance	NOUN
fnp-5813	29	5	(	(	PUNCT
fnp-5813	29	6	mr	mr	PROPN
fnp-5813	29	7	)	)	PUNCT
fnp-5813	29	8	study	study	NOUN
fnp-5813	29	9	was	be	AUX
fnp-5813	29	10	incomplete	incomplete	ADJ
fnp-5813	29	11	because	because	SCONJ
fnp-5813	29	12	of	of	ADP
fnp-5813	29	13	claustrophobia	claustrophobia	NOUN
fnp-5813	29	14	.	.	PUNCT
fnp-5813	30	1	the	the	DET
fnp-5813	30	2	brain	brain	NOUN
fnp-5813	30	3	tumors	tumor	NOUN
fnp-5813	30	4	were	be	AUX
fnp-5813	30	5	isointense	isointense	VERB
fnp-5813	30	6	on	on	ADP
fnp-5813	30	7	the	the	DET
fnp-5813	30	8	t1	t1	NOUN
fnp-5813	30	9	sequence	sequence	NOUN
fnp-5813	30	10	.	.	PUNCT
fnp-5813	31	1	approximately	approximately	ADV
fnp-5813	31	2	1	1	NUM
fnp-5813	31	3	year	year	NOUN
fnp-5813	31	4	later	later	ADV
fnp-5813	31	5	at	at	ADP
fnp-5813	31	6	74.8	74.8	NUM
fnp-5813	31	7	years	year	NOUN
fnp-5813	31	8	of	of	ADP
fnp-5813	31	9	age	age	NOUN
fnp-5813	31	10	,	,	PUNCT
fnp-5813	31	11	the	the	DET
fnp-5813	31	12	woman	woman	NOUN
fnp-5813	31	13	stopped	stop	VERB
fnp-5813	31	14	eating	eat	VERB
fnp-5813	31	15	and	and	CCONJ
fnp-5813	31	16	was	be	AUX
fnp-5813	31	17	unable	unable	ADJ
fnp-5813	31	18	to	to	PART
fnp-5813	31	19	walk	walk	VERB
fnp-5813	31	20	,	,	PUNCT
fnp-5813	31	21	whereupon	whereupon	ADV
fnp-5813	31	22	she	she	PRON
fnp-5813	31	23	was	be	AUX
fnp-5813	31	24	admitted	admit	VERB
fnp-5813	31	25	to	to	ADP
fnp-5813	31	26	hospital	hospital	NOUN
fnp-5813	31	27	.	.	PUNCT
fnp-5813	32	1	a	a	DET
fnp-5813	32	2	ct	ct	NOUN
fnp-5813	32	3	scan	scan	NOUN
fnp-5813	32	4	at	at	ADP
fnp-5813	32	5	the	the	DET
fnp-5813	32	6	time	time	NOUN
fnp-5813	32	7	of	of	ADP
fnp-5813	32	8	admission	admission	NOUN
fnp-5813	32	9	showed	show	VERB
fnp-5813	32	10	further	further	ADJ
fnp-5813	32	11	enlargement	enlargement	NOUN
fnp-5813	32	12	of	of	ADP
fnp-5813	32	13	two	two	NUM
fnp-5813	32	14	tumors	tumor	NOUN
fnp-5813	32	15	with	with	ADP
fnp-5813	32	16	significant	significant	ADJ
fnp-5813	32	17	local	local	ADJ
fnp-5813	32	18	mass	mass	ADJ
fnp-5813	32	19	effect	effect	NOUN
fnp-5813	32	20	and	and	CCONJ
fnp-5813	32	21	surrounding	surround	VERB
fnp-5813	32	22	vasogenic	vasogenic	ADJ
fnp-5813	32	23	edema	edema	NOUN
fnp-5813	32	24	(	(	PUNCT
fnp-5813	32	25	figure	figure	NOUN
fnp-5813	32	26	 	 	SPACE
fnp-5813	32	27	1	1	NUM
fnp-5813	32	28	)	)	PUNCT
fnp-5813	32	29	.	.	PUNCT
fnp-5813	33	1	the	the	DET
fnp-5813	33	2	woman	woman	NOUN
fnp-5813	33	3	was	be	AUX
fnp-5813	33	4	judged	judge	VERB
fnp-5813	33	5	not	not	PART
fnp-5813	33	6	to	to	PART
fnp-5813	33	7	be	be	AUX
fnp-5813	33	8	a	a	DET
fnp-5813	33	9	candidate	candidate	NOUN
fnp-5813	33	10	for	for	ADP
fnp-5813	33	11	neurosurgical	neurosurgical	ADJ
fnp-5813	33	12	intervention	intervention	NOUN
fnp-5813	33	13	.	.	PUNCT
fnp-5813	34	1	a	a	DET
fnp-5813	34	2	ct	ct	NOUN
fnp-5813	34	3	scan	scan	NOUN
fnp-5813	34	4	two	two	NUM
fnp-5813	34	5	months	month	NOUN
fnp-5813	34	6	after	after	ADP
fnp-5813	34	7	discontinuation	discontinuation	NOUN
fnp-5813	34	8	of	of	ADP
fnp-5813	34	9	megestrol	megestrol	NOUN
fnp-5813	34	10	showed	show	VERB
fnp-5813	34	11	that	that	SCONJ
fnp-5813	34	12	the	the	DET
fnp-5813	34	13	two	two	NUM
fnp-5813	34	14	largest	large	ADJ
fnp-5813	34	15	tumors	tumor	NOUN
fnp-5813	34	16	had	have	AUX
fnp-5813	34	17	decreased	decrease	VERB
fnp-5813	34	18	in	in	ADP
fnp-5813	34	19	size	size	NOUN
fnp-5813	34	20	,	,	PUNCT
fnp-5813	34	21	whereas	whereas	SCONJ
fnp-5813	34	22	a	a	DET
fnp-5813	34	23	new	new	ADJ
fnp-5813	34	24	small	small	ADJ
fnp-5813	34	25	en	en	X
fnp-5813	34	26	plaque	plaque	NOUN
fnp-5813	34	27	tumor	tumor	NOUN
fnp-5813	34	28	had	have	AUX
fnp-5813	34	29	appeared	appear	VERB
fnp-5813	34	30	in	in	ADP
fnp-5813	34	31	the	the	DET
fnp-5813	34	32	lateral	lateral	ADJ
fnp-5813	34	33	part	part	NOUN
fnp-5813	34	34	of	of	ADP
fnp-5813	34	35	the	the	DET
fnp-5813	34	36	left	left	ADJ
fnp-5813	34	37	frontal	frontal	ADJ
fnp-5813	34	38	lobe	lobe	NOUN
fnp-5813	34	39	.	.	PUNCT
fnp-5813	35	1	during	during	ADP
fnp-5813	35	2	a	a	DET
fnp-5813	35	3	one	one	NUM
fnp-5813	35	4	year	year	NOUN
fnp-5813	35	5	hospital	hospital	NOUN
fnp-5813	35	6	stay	stay	VERB
fnp-5813	35	7	without	without	ADP
fnp-5813	35	8	specific	specific	ADJ
fnp-5813	35	9	anti	anti	ADJ
fnp-5813	35	10	-	-	ADJ
fnp-5813	35	11	neoplastic	neoplastic	ADJ
fnp-5813	35	12	therapy	therapy	NOUN
fnp-5813	35	13	,	,	PUNCT
fnp-5813	35	14	the	the	DET
fnp-5813	35	15	neurologic	neurologic	ADJ
fnp-5813	35	16	status	status	NOUN
fnp-5813	35	17	of	of	ADP
fnp-5813	35	18	the	the	DET
fnp-5813	35	19	woman	woman	NOUN
fnp-5813	35	20	gradually	gradually	ADV
fnp-5813	35	21	improved	improve	VERB
fnp-5813	35	22	.	.	PUNCT
fnp-5813	36	1	a	a	DET
fnp-5813	36	2	ct	ct	NOUN
fnp-5813	36	3	scan	scan	NOUN
fnp-5813	36	4	at	at	ADP
fnp-5813	36	5	75.7	75.7	NUM
fnp-5813	36	6	years	year	NOUN
fnp-5813	36	7	age	age	NOUN
fnp-5813	36	8	showed	show	VERB
fnp-5813	36	9	that	that	SCONJ
fnp-5813	36	10	all	all	DET
fnp-5813	36	11	tumors	tumor	NOUN
fnp-5813	36	12	had	have	AUX
fnp-5813	36	13	decreased	decrease	VERB
fnp-5813	36	14	(	(	PUNCT
fnp-5813	36	15	figure	figure	NOUN
fnp-5813	36	16	 	 	SPACE
fnp-5813	36	17	1	1	NUM
fnp-5813	36	18	and	and	CCONJ
fnp-5813	36	19	figure	figure	VERB
fnp-5813	36	20	 	 	SPACE
fnp-5813	36	21	2	2	NUM
fnp-5813	36	22	)	)	PUNCT
fnp-5813	36	23	.	.	PUNCT
fnp-5813	37	1	at	at	ADP
fnp-5813	37	2	age	age	NOUN
fnp-5813	37	3	76	76	NUM
fnp-5813	37	4	years	year	NOUN
fnp-5813	37	5	,	,	PUNCT
fnp-5813	37	6	the	the	DET
fnp-5813	37	7	woman	woman	NOUN
fnp-5813	37	8	returned	return	VERB
fnp-5813	37	9	to	to	ADP
fnp-5813	37	10	independent	independent	ADJ
fnp-5813	37	11	living	living	NOUN
fnp-5813	37	12	and	and	CCONJ
fnp-5813	37	13	regained	regain	VERB
fnp-5813	37	14	her	her	PRON
fnp-5813	37	15	motor	motor	NOUN
fnp-5813	37	16	vehicle	vehicle	NOUN
fnp-5813	37	17	driving	drive	VERB
fnp-5813	37	18	license	license	NOUN
fnp-5813	37	19	.	.	PUNCT
fnp-5813	38	1	at	at	ADP
fnp-5813	38	2	age	age	NOUN
fnp-5813	38	3	77	77	NUM
fnp-5813	38	4	years	year	NOUN
fnp-5813	38	5	her	her	PRON
fnp-5813	38	6	tremor	tremor	NOUN
fnp-5813	38	7	had	have	AUX
fnp-5813	38	8	increased	increase	VERB
fnp-5813	38	9	slightly	slightly	ADV
fnp-5813	38	10	.	.	PUNCT
fnp-5813	39	1	ct	ct	PROPN
fnp-5813	39	2	scans	scan	NOUN
fnp-5813	39	3	at	at	ADP
fnp-5813	39	4	78	78	NUM
fnp-5813	39	5	and	and	CCONJ
fnp-5813	39	6	82	82	NUM
fnp-5813	39	7	years	year	NOUN
fnp-5813	39	8	age	age	NOUN
fnp-5813	39	9	showed	show	VERB
fnp-5813	39	10	mild	mild	ADJ
fnp-5813	39	11	diffuse	diffuse	ADJ
fnp-5813	39	12	cerebral	cerebral	ADJ
fnp-5813	39	13	atrophy	atrophy	NOUN
fnp-5813	39	14	and	and	CCONJ
fnp-5813	39	15	all	all	DET
fnp-5813	39	16	intracranial	intracranial	ADJ
fnp-5813	39	17	tumors	tumor	NOUN
fnp-5813	39	18	had	have	AUX
fnp-5813	39	19	disappeared	disappear	VERB
fnp-5813	39	20	by	by	ADP
fnp-5813	39	21	82	82	NUM
fnp-5813	39	22	years	year	NOUN
fnp-5813	39	23	age	age	NOUN
fnp-5813	39	24	(	(	PUNCT
fnp-5813	39	25	figure	figure	NOUN
fnp-5813	39	26	 	 	SPACE
fnp-5813	39	27	1	1	NUM
fnp-5813	39	28	and	and	CCONJ
fnp-5813	39	29	figure	figure	VERB
fnp-5813	39	30	 	 	SPACE
fnp-5813	39	31	2	2	NUM
fnp-5813	39	32	)	)	PUNCT
fnp-5813	39	33	.	.	PUNCT
fnp-5813	40	1	the	the	DET
fnp-5813	40	2	woman	woman	NOUN
fnp-5813	40	3	died	die	VERB
fnp-5813	40	4	after	after	ADP
fnp-5813	40	5	choking	choke	VERB
fnp-5813	40	6	on	on	ADP
fnp-5813	40	7	food	food	NOUN
fnp-5813	40	8	at	at	ADP
fnp-5813	40	9	83	83	NUM
fnp-5813	40	10	years	year	NOUN
fnp-5813	40	11	.	.	PUNCT
fnp-5813	41	1	figure	figure	NOUN
fnp-5813	41	2	1	1	NUM
fnp-5813	41	3	.	.	PUNCT
fnp-5813	42	1	ct	ct	PROPN
fnp-5813	42	2	scans	scan	NOUN
fnp-5813	42	3	with	with	ADP
fnp-5813	42	4	contrast	contrast	NOUN
fnp-5813	42	5	enhancement	enhancement	NOUN
fnp-5813	42	6	of	of	ADP
fnp-5813	42	7	brain	brain	NOUN
fnp-5813	42	8	showing	show	VERB
fnp-5813	42	9	dura	dura	NOUN
fnp-5813	42	10	-	-	PUNCT
fnp-5813	42	11	based	base	VERB
fnp-5813	42	12	tumors	tumor	NOUN
fnp-5813	42	13	in	in	ADP
fnp-5813	42	14	the	the	DET
fnp-5813	42	15	right	right	ADJ
fnp-5813	42	16	parasellar	parasellar	NOUN
fnp-5813	42	17	,	,	PUNCT
fnp-5813	42	18	left	leave	VERB
fnp-5813	42	19	frontal	frontal	ADJ
fnp-5813	42	20	,	,	PUNCT
fnp-5813	42	21	and	and	CCONJ
fnp-5813	42	22	left	leave	VERB
fnp-5813	42	23	parietal	parietal	ADJ
fnp-5813	42	24	regions	region	NOUN
fnp-5813	42	25	in	in	ADP
fnp-5813	42	26	a	a	DET
fnp-5813	42	27	woman	woman	NOUN
fnp-5813	42	28	at	at	ADP
fnp-5813	42	29	ages	age	NOUN
fnp-5813	42	30	73.5	73.5	NUM
fnp-5813	42	31	and	and	CCONJ
fnp-5813	42	32	74.8	74.8	NUM
fnp-5813	42	33	years	year	NOUN
fnp-5813	42	34	when	when	SCONJ
fnp-5813	42	35	taking	take	VERB
fnp-5813	42	36	megestrol	megestrol	NOUN
fnp-5813	42	37	,	,	PUNCT
fnp-5813	42	38	and	and	CCONJ
fnp-5813	42	39	at	at	ADP
fnp-5813	42	40	ages	age	NOUN
fnp-5813	42	41	75.7	75.7	NUM
fnp-5813	42	42	years	year	NOUN
fnp-5813	42	43	and	and	CCONJ
fnp-5813	42	44	82	82	NUM
fnp-5813	42	45	years	year	NOUN
fnp-5813	42	46	,	,	PUNCT
fnp-5813	42	47	after	after	SCONJ
fnp-5813	42	48	megestrol	megestrol	NOUN
fnp-5813	42	49	had	have	AUX
fnp-5813	42	50	been	be	AUX
fnp-5813	42	51	discontinued	discontinue	VERB
fnp-5813	42	52	.	.	PUNCT
fnp-5813	43	1	figure	figure	NOUN
fnp-5813	43	2	2	2	NUM
fnp-5813	43	3	.	.	NOUN
fnp-5813	43	4	line	line	NOUN
fnp-5813	43	5	graph	graph	NOUN
fnp-5813	43	6	showing	show	VERB
fnp-5813	43	7	change	change	NOUN
fnp-5813	43	8	in	in	ADP
fnp-5813	43	9	meningioma	meningioma	ADJ
fnp-5813	43	10	sizes	size	NOUN
fnp-5813	43	11	on	on	ADP
fnp-5813	43	12	ct	ct	PROPN
fnp-5813	43	13	scans	scan	NOUN
fnp-5813	43	14	over	over	ADP
fnp-5813	43	15	time	time	NOUN
fnp-5813	43	16	.	.	PUNCT
fnp-5813	44	1	tumor	tumor	NOUN
fnp-5813	44	2	size	size	NOUN
fnp-5813	44	3	(	(	PUNCT
fnp-5813	44	4	in	in	ADP
fnp-5813	44	5	cm	cm	NOUN
fnp-5813	44	6	)	)	PUNCT
fnp-5813	44	7	is	be	AUX
fnp-5813	44	8	reported	report	VERB
fnp-5813	44	9	for	for	ADP
fnp-5813	44	10	the	the	DET
fnp-5813	44	11	greatest	great	ADJ
fnp-5813	44	12	dimension	dimension	NOUN
fnp-5813	44	13	only	only	ADV
fnp-5813	44	14	.	.	PUNCT
fnp-5813	45	1	the	the	DET
fnp-5813	45	2	arrow	arrow	NOUN
fnp-5813	45	3	shows	show	VERB
fnp-5813	45	4	the	the	DET
fnp-5813	45	5	time	time	NOUN
fnp-5813	45	6	when	when	SCONJ
fnp-5813	45	7	megestrol	megestrol	NOUN
fnp-5813	45	8	was	be	AUX
fnp-5813	45	9	started	start	VERB
fnp-5813	45	10	and	and	CCONJ
fnp-5813	45	11	the	the	DET
fnp-5813	45	12	vertical	vertical	ADJ
fnp-5813	45	13	line	line	NOUN
fnp-5813	45	14	shows	show	VERB
fnp-5813	45	15	the	the	DET
fnp-5813	45	16	time	time	NOUN
fnp-5813	45	17	when	when	SCONJ
fnp-5813	45	18	megestrol	megestrol	NOUN
fnp-5813	45	19	was	be	AUX
fnp-5813	45	20	discontinued	discontinue	VERB
fnp-5813	45	21	.	.	PUNCT
fnp-5813	46	1	complete	complete	ADJ
fnp-5813	46	2	autopsy	autopsy	NOUN
fnp-5813	46	3	was	be	AUX
fnp-5813	46	4	performed	perform	VERB
fnp-5813	46	5	3	3	NUM
fnp-5813	46	6	days	day	NOUN
fnp-5813	46	7	after	after	ADP
fnp-5813	46	8	death	death	NOUN
fnp-5813	46	9	.	.	PUNCT
fnp-5813	47	1	the	the	DET
fnp-5813	47	2	body	body	NOUN
fnp-5813	47	3	was	be	AUX
fnp-5813	47	4	that	that	PRON
fnp-5813	47	5	of	of	ADP
fnp-5813	47	6	a	a	DET
fnp-5813	47	7	thin	thin	ADJ
fnp-5813	47	8	female	female	NOUN
fnp-5813	47	9	with	with	ADP
fnp-5813	47	10	no	no	DET
fnp-5813	47	11	somatic	somatic	ADJ
fnp-5813	47	12	evidence	evidence	NOUN
fnp-5813	47	13	of	of	ADP
fnp-5813	47	14	malignancy	malignancy	NOUN
fnp-5813	47	15	,	,	PUNCT
fnp-5813	47	16	including	include	VERB
fnp-5813	47	17	in	in	ADP
fnp-5813	47	18	the	the	DET
fnp-5813	47	19	pelvis	pelvi	NOUN
fnp-5813	47	20	at	at	ADP
fnp-5813	47	21	the	the	DET
fnp-5813	47	22	site	site	NOUN
fnp-5813	47	23	of	of	ADP
fnp-5813	47	24	the	the	DET
fnp-5813	47	25	original	original	ADJ
fnp-5813	47	26	endometrial	endometrial	ADJ
fnp-5813	47	27	sarcoma	sarcoma	NOUN
fnp-5813	47	28	.	.	PUNCT
fnp-5813	48	1	pathological	pathological	ADJ
fnp-5813	48	2	findings	finding	NOUN
fnp-5813	48	3	the	the	DET
fnp-5813	48	4	brain	brain	NOUN
fnp-5813	48	5	weight	weight	NOUN
fnp-5813	48	6	was	be	AUX
fnp-5813	48	7	1137	1137	NUM
fnp-5813	48	8	 	 	SPACE
fnp-5813	48	9	g.	g.	NOUN
fnp-5813	48	10	the	the	DET
fnp-5813	48	11	inner	inner	ADJ
fnp-5813	48	12	surface	surface	NOUN
fnp-5813	48	13	of	of	ADP
fnp-5813	48	14	the	the	DET
fnp-5813	48	15	skull	skull	NOUN
fnp-5813	48	16	had	have	VERB
fnp-5813	48	17	extensive	extensive	ADJ
fnp-5813	48	18	lobulated	lobulate	VERB
fnp-5813	48	19	hyperostotic	hyperostotic	ADJ
fnp-5813	48	20	areas	area	NOUN
fnp-5813	48	21	involving	involve	VERB
fnp-5813	48	22	both	both	CCONJ
fnp-5813	48	23	frontal	frontal	ADJ
fnp-5813	48	24	bones	bone	NOUN
fnp-5813	48	25	.	.	PUNCT
fnp-5813	49	1	corresponding	correspond	VERB
fnp-5813	49	2	to	to	ADP
fnp-5813	49	3	the	the	DET
fnp-5813	49	4	sites	site	NOUN
fnp-5813	49	5	of	of	ADP
fnp-5813	49	6	the	the	DET
fnp-5813	49	7	tumors	tumor	NOUN
fnp-5813	49	8	identified	identify	VERB
fnp-5813	49	9	on	on	ADP
fnp-5813	49	10	earlier	early	ADJ
fnp-5813	49	11	ct	ct	NUM
fnp-5813	49	12	scans	scan	NOUN
fnp-5813	49	13	,	,	PUNCT
fnp-5813	49	14	the	the	DET
fnp-5813	49	15	dura	dura	NOUN
fnp-5813	49	16	mater	mater	NOUN
fnp-5813	49	17	along	along	ADP
fnp-5813	49	18	the	the	DET
fnp-5813	49	19	skull	skull	NOUN
fnp-5813	49	20	base	base	NOUN
fnp-5813	49	21	anterior	anterior	ADJ
fnp-5813	49	22	to	to	ADP
fnp-5813	49	23	the	the	DET
fnp-5813	49	24	left	left	ADJ
fnp-5813	49	25	olfactory	olfactory	ADJ
fnp-5813	49	26	groove	groove	NOUN
fnp-5813	49	27	had	have	VERB
fnp-5813	49	28	a	a	DET
fnp-5813	49	29	soft	soft	ADJ
fnp-5813	49	30	,	,	PUNCT
fnp-5813	49	31	yellow	yellow	ADJ
fnp-5813	49	32	lesion	lesion	NOUN
fnp-5813	49	33	(	(	PUNCT
fnp-5813	49	34	approximately	approximately	ADV
fnp-5813	49	35	2	2	NUM
fnp-5813	49	36	 	 	SPACE
fnp-5813	49	37	x	x	NOUN
fnp-5813	49	38	 	 	SPACE
fnp-5813	49	39	1	1	NUM
fnp-5813	49	40	 	 	SPACE
fnp-5813	49	41	x	x	NOUN
fnp-5813	49	42	 	 	SPACE
fnp-5813	49	43	<	<	NOUN
fnp-5813	49	44	 	 	SPACE
fnp-5813	49	45	0.3	0.3	NUM
fnp-5813	49	46	 	 	SPACE
fnp-5813	49	47	cm	cm	NOUN
fnp-5813	49	48	)	)	PUNCT
fnp-5813	49	49	(	(	PUNCT
fnp-5813	49	50	figure	figure	NOUN
fnp-5813	49	51	 	 	SPACE
fnp-5813	49	52	3a	3a	NUM
fnp-5813	49	53	)	)	PUNCT
fnp-5813	49	54	.	.	PUNCT
fnp-5813	50	1	the	the	DET
fnp-5813	50	2	dura	dura	NOUN
fnp-5813	50	3	mater	mater	NOUN
fnp-5813	50	4	in	in	ADP
fnp-5813	50	5	the	the	DET
fnp-5813	50	6	right	right	ADJ
fnp-5813	50	7	parasellar	parasellar	ADJ
fnp-5813	50	8	region	region	NOUN
fnp-5813	50	9	was	be	AUX
fnp-5813	50	10	thickened	thicken	VERB
fnp-5813	50	11	and	and	CCONJ
fnp-5813	50	12	yellow	yellow	ADJ
fnp-5813	50	13	.	.	PUNCT
fnp-5813	51	1	the	the	DET
fnp-5813	51	2	internal	internal	ADJ
fnp-5813	51	3	surface	surface	NOUN
fnp-5813	51	4	of	of	ADP
fnp-5813	51	5	the	the	DET
fnp-5813	51	6	paramedian	paramedian	PROPN
fnp-5813	51	7	left	leave	VERB
fnp-5813	51	8	parietal	parietal	ADJ
fnp-5813	51	9	convexity	convexity	NOUN
fnp-5813	51	10	dura	dura	NOUN
fnp-5813	51	11	was	be	AUX
fnp-5813	51	12	focally	focally	ADV
fnp-5813	51	13	thickened	thicken	VERB
fnp-5813	51	14	(	(	PUNCT
fnp-5813	51	15	approximately	approximately	ADV
fnp-5813	51	16	3	3	NUM
fnp-5813	51	17	 	 	SPACE
fnp-5813	51	18	x	x	ADJ
fnp-5813	51	19	 	 	SPACE
fnp-5813	51	20	2	2	NUM
fnp-5813	51	21	 	 	SPACE
fnp-5813	51	22	x	x	NOUN
fnp-5813	51	23	 	 	SPACE
fnp-5813	51	24	0.5	0.5	NUM
fnp-5813	51	25	 	 	SPACE
fnp-5813	51	26	cm	cm	NOUN
fnp-5813	51	27	)	)	PUNCT
fnp-5813	51	28	with	with	ADP
fnp-5813	51	29	adhesion	adhesion	NOUN
fnp-5813	51	30	to	to	ADP
fnp-5813	51	31	the	the	DET
fnp-5813	51	32	brain	brain	NOUN
fnp-5813	51	33	(	(	PUNCT
fnp-5813	51	34	figure	figure	NOUN
fnp-5813	51	35	 	 	SPACE
fnp-5813	51	36	3b	3b	NUM
fnp-5813	51	37	)	)	PUNCT
fnp-5813	51	38	.	.	PUNCT
fnp-5813	52	1	the	the	DET
fnp-5813	52	2	leptomeninges	leptomeninge	NOUN
fnp-5813	52	3	were	be	AUX
fnp-5813	52	4	unremarkable	unremarkable	ADJ
fnp-5813	52	5	.	.	PUNCT
fnp-5813	53	1	coronal	coronal	ADJ
fnp-5813	53	2	slices	slice	NOUN
fnp-5813	53	3	through	through	ADP
fnp-5813	53	4	the	the	DET
fnp-5813	53	5	cerebral	cerebral	ADJ
fnp-5813	53	6	hemispheres	hemisphere	NOUN
fnp-5813	53	7	demonstrated	demonstrate	VERB
fnp-5813	53	8	minimal	minimal	ADJ
fnp-5813	53	9	focal	focal	ADJ
fnp-5813	53	10	atrophy	atrophy	NOUN
fnp-5813	53	11	in	in	ADP
fnp-5813	53	12	the	the	DET
fnp-5813	53	13	left	left	ADJ
fnp-5813	53	14	frontal	frontal	ADJ
fnp-5813	53	15	lobe	lobe	ADJ
fnp-5813	53	16	tip	tip	NOUN
fnp-5813	53	17	and	and	CCONJ
fnp-5813	53	18	more	more	ADV
fnp-5813	53	19	pronounced	pronounced	ADJ
fnp-5813	53	20	atrophy	atrophy	NOUN
fnp-5813	53	21	with	with	ADP
fnp-5813	53	22	cavitation	cavitation	NOUN
fnp-5813	53	23	of	of	ADP
fnp-5813	53	24	the	the	DET
fnp-5813	53	25	subcortical	subcortical	ADJ
fnp-5813	53	26	white	white	ADJ
fnp-5813	53	27	matter	matter	NOUN
fnp-5813	53	28	in	in	ADP
fnp-5813	53	29	the	the	DET
fnp-5813	53	30	left	left	ADJ
fnp-5813	53	31	medial	medial	ADJ
fnp-5813	53	32	parietal	parietal	ADJ
fnp-5813	53	33	region	region	NOUN
fnp-5813	53	34	.	.	PUNCT
fnp-5813	54	1	figure	figure	VERB
fnp-5813	54	2	3	3	NUM
fnp-5813	54	3	.	.	PUNCT
fnp-5813	54	4	a	a	X
fnp-5813	54	5	)	)	PUNCT
fnp-5813	54	6	photograph	photograph	NOUN
fnp-5813	54	7	showing	show	VERB
fnp-5813	54	8	the	the	DET
fnp-5813	54	9	anterior	anterior	ADJ
fnp-5813	54	10	cranial	cranial	ADJ
fnp-5813	54	11	fossa	fossa	NOUN
fnp-5813	54	12	with	with	ADP
fnp-5813	54	13	left	left	ADJ
fnp-5813	54	14	frontal	frontal	ADJ
fnp-5813	54	15	bone	bone	NOUN
fnp-5813	54	16	hyperostosis	hyperostosis	NOUN
fnp-5813	54	17	and	and	CCONJ
fnp-5813	54	18	yellowish	yellowish	VERB
fnp-5813	54	19	thick	thick	ADJ
fnp-5813	54	20	,	,	PUNCT
fnp-5813	54	21	firm	firm	ADJ
fnp-5813	54	22	tissue	tissue	NOUN
fnp-5813	54	23	(	(	PUNCT
fnp-5813	54	24	arrow	arrow	NOUN
fnp-5813	54	25	)	)	PUNCT
fnp-5813	54	26	reflected	reflect	VERB
fnp-5813	54	27	from	from	ADP
fnp-5813	54	28	the	the	DET
fnp-5813	54	29	anterior	anterior	ADJ
fnp-5813	54	30	falx	falx	ADJ
fnp-5813	54	31	cerebri	cerebri	NOUN
fnp-5813	54	32	at	at	ADP
fnp-5813	54	33	the	the	DET
fnp-5813	54	34	time	time	NOUN
fnp-5813	54	35	of	of	ADP
fnp-5813	54	36	autopsy	autopsy	ADJ
fnp-5813	54	37	.	.	PUNCT
fnp-5813	55	1	b	b	X
fnp-5813	55	2	)	)	PUNCT
fnp-5813	55	3	photograph	photograph	NOUN
fnp-5813	55	4	showing	show	VERB
fnp-5813	55	5	the	the	DET
fnp-5813	55	6	thickened	thicken	VERB
fnp-5813	55	7	dura	dura	NOUN
fnp-5813	55	8	mater	mater	NOUN
fnp-5813	55	9	near	near	ADP
fnp-5813	55	10	the	the	DET
fnp-5813	55	11	superior	superior	ADJ
fnp-5813	55	12	sagittal	sagittal	ADJ
fnp-5813	55	13	sinus	sinus	NOUN
fnp-5813	55	14	in	in	ADP
fnp-5813	55	15	the	the	DET
fnp-5813	55	16	left	left	ADJ
fnp-5813	55	17	parietal	parietal	ADJ
fnp-5813	55	18	region	region	NOUN
fnp-5813	55	19	after	after	ADP
fnp-5813	55	20	formalin	formalin	NOUN
fnp-5813	55	21	fixation	fixation	NOUN
fnp-5813	55	22	.	.	PUNCT
fnp-5813	56	1	c	c	X
fnp-5813	56	2	)	)	PUNCT
fnp-5813	56	3	photomicrograph	photomicrograph	NOUN
fnp-5813	56	4	showing	show	VERB
fnp-5813	56	5	the	the	DET
fnp-5813	56	6	left	left	ADJ
fnp-5813	56	7	parietal	parietal	ADJ
fnp-5813	56	8	dura	dura	NOUN
fnp-5813	56	9	and	and	CCONJ
fnp-5813	56	10	fibrotic	fibrotic	ADJ
fnp-5813	56	11	tumor	tumor	NOUN
fnp-5813	56	12	with	with	ADP
fnp-5813	56	13	lipomatous	lipomatous	ADJ
fnp-5813	56	14	meningioma	meningioma	NOUN
fnp-5813	56	15	(	(	PUNCT
fnp-5813	56	16	arrow	arrow	NOUN
fnp-5813	56	17	)	)	PUNCT
fnp-5813	56	18	.	.	PUNCT
fnp-5813	57	1	hematoxylin	hematoxylin	PROPN
fnp-5813	57	2	&	&	CCONJ
fnp-5813	57	3	eosin	eosin	PROPN
fnp-5813	57	4	stain	stain	NOUN
fnp-5813	57	5	,	,	PUNCT
fnp-5813	57	6	original	original	ADJ
fnp-5813	57	7	magnification	magnification	NOUN
fnp-5813	57	8	12.5x	12.5x	NUM
fnp-5813	57	9	.	.	PUNCT
fnp-5813	58	1	d	d	X
fnp-5813	58	2	)	)	PUNCT
fnp-5813	58	3	photomicrograph	photomicrograph	NOUN
fnp-5813	58	4	showing	show	VERB
fnp-5813	58	5	a	a	DET
fnp-5813	58	6	cluster	cluster	NOUN
fnp-5813	58	7	of	of	ADP
fnp-5813	58	8	meningothelial	meningothelial	ADJ
fnp-5813	58	9	cells	cell	NOUN
fnp-5813	58	10	in	in	ADP
fnp-5813	58	11	the	the	DET
fnp-5813	58	12	left	left	ADJ
fnp-5813	58	13	frontal	frontal	ADJ
fnp-5813	58	14	tumor	tumor	NOUN
fnp-5813	58	15	.	.	PUNCT
fnp-5813	59	1	h&e	h&e	PROPN
fnp-5813	59	2	stain	stain	NOUN
fnp-5813	59	3	,	,	PUNCT
fnp-5813	59	4	original	original	ADJ
fnp-5813	59	5	magnification	magnification	NOUN
fnp-5813	59	6	200x	200x	NUM
fnp-5813	59	7	.	.	PUNCT
fnp-5813	60	1	e	e	X
fnp-5813	60	2	)	)	PUNCT
fnp-5813	60	3	photomicrograph	photomicrograph	NOUN
fnp-5813	60	4	showing	show	VERB
fnp-5813	60	5	the	the	DET
fnp-5813	60	6	residual	residual	ADJ
fnp-5813	60	7	left	leave	VERB
fnp-5813	60	8	parietal	parietal	ADJ
fnp-5813	60	9	tumor	tumor	NOUN
fnp-5813	60	10	with	with	ADP
fnp-5813	60	11	immunoreactivity	immunoreactivity	NOUN
fnp-5813	60	12	for	for	ADP
fnp-5813	60	13	epithelial	epithelial	ADJ
fnp-5813	60	14	membrane	membrane	NOUN
fnp-5813	60	15	antigen	antigen	NOUN
fnp-5813	60	16	(	(	PUNCT
fnp-5813	60	17	ema	ema	PROPN
fnp-5813	60	18	)	)	PUNCT
fnp-5813	60	19	in	in	ADP
fnp-5813	60	20	brown	brown	NOUN
fnp-5813	60	21	with	with	ADP
fnp-5813	60	22	blue	blue	ADJ
fnp-5813	60	23	hematoxylin	hematoxylin	PROPN
fnp-5813	60	24	counterstain	counterstain	NOUN
fnp-5813	60	25	.	.	PUNCT
fnp-5813	61	1	original	original	ADJ
fnp-5813	61	2	magnification	magnification	NOUN
fnp-5813	61	3	100x	100x	NUM
fnp-5813	61	4	.	.	PUNCT
fnp-5813	62	1	f	f	X
fnp-5813	62	2	)	)	PUNCT
fnp-5813	62	3	photomicrograph	photomicrograph	NOUN
fnp-5813	62	4	showing	show	VERB
fnp-5813	62	5	the	the	DET
fnp-5813	62	6	residual	residual	ADJ
fnp-5813	62	7	left	leave	VERB
fnp-5813	62	8	frontal	frontal	ADJ
fnp-5813	62	9	tumor	tumor	NOUN
fnp-5813	62	10	with	with	ADP
fnp-5813	62	11	nuclear	nuclear	ADJ
fnp-5813	62	12	immunoreactivity	immunoreactivity	NOUN
fnp-5813	62	13	for	for	ADP
fnp-5813	62	14	progesterone	progesterone	NOUN
fnp-5813	62	15	receptor	receptor	NOUN
fnp-5813	62	16	(	(	PUNCT
fnp-5813	62	17	pr	pr	NOUN
fnp-5813	62	18	)	)	PUNCT
fnp-5813	62	19	in	in	ADP
fnp-5813	62	20	brown	brown	ADJ
fnp-5813	62	21	.	.	PUNCT
fnp-5813	63	1	original	original	ADJ
fnp-5813	63	2	magnification	magnification	NOUN
fnp-5813	63	3	200x	200x	NUM
fnp-5813	63	4	.	.	PUNCT
fnp-5813	64	1	microscopic	microscopic	ADJ
fnp-5813	64	2	features	feature	NOUN
fnp-5813	64	3	of	of	ADP
fnp-5813	64	4	the	the	DET
fnp-5813	64	5	dura	dura	NOUN
fnp-5813	64	6	mater	mater	NOUN
fnp-5813	64	7	from	from	ADP
fnp-5813	64	8	the	the	DET
fnp-5813	64	9	three	three	NUM
fnp-5813	64	10	identifiable	identifiable	ADJ
fnp-5813	64	11	previous	previous	ADJ
fnp-5813	64	12	tumor	tumor	NOUN
fnp-5813	64	13	sites	site	NOUN
fnp-5813	64	14	were	be	AUX
fnp-5813	64	15	all	all	PRON
fnp-5813	64	16	similar	similar	ADJ
fnp-5813	64	17	showing	show	VERB
fnp-5813	64	18	multiple	multiple	ADJ
fnp-5813	64	19	small	small	ADJ
fnp-5813	64	20	collections	collection	NOUN
fnp-5813	64	21	of	of	ADP
fnp-5813	64	22	meningothelial	meningothelial	ADJ
fnp-5813	64	23	cells	cell	NOUN
fnp-5813	64	24	(	(	PUNCT
fnp-5813	64	25	figure	figure	NOUN
fnp-5813	64	26	 	 	SPACE
fnp-5813	64	27	3d	3d	NUM
fnp-5813	64	28	)	)	PUNCT
fnp-5813	64	29	,	,	PUNCT
fnp-5813	64	30	fibrovascular	fibrovascular	ADJ
fnp-5813	64	31	hyperplasia	hyperplasia	NOUN
fnp-5813	64	32	,	,	PUNCT
fnp-5813	64	33	and	and	CCONJ
fnp-5813	64	34	focal	focal	ADJ
fnp-5813	64	35	lipomatous	lipomatous	ADJ
fnp-5813	64	36	meningioma	meningioma	NOUN
fnp-5813	64	37	(	(	PUNCT
fnp-5813	64	38	figure	figure	NOUN
fnp-5813	64	39	 	 	SPACE
fnp-5813	64	40	3c	3c	NUM
fnp-5813	64	41	)	)	PUNCT
fnp-5813	64	42	.	.	PUNCT
fnp-5813	65	1	the	the	DET
fnp-5813	65	2	latter	latter	ADJ
fnp-5813	65	3	resembled	resemble	VERB
fnp-5813	65	4	adipose	adipose	ADP
fnp-5813	65	5	tissue	tissue	NOUN
fnp-5813	65	6	and	and	CCONJ
fnp-5813	65	7	did	do	AUX
fnp-5813	65	8	not	not	PART
fnp-5813	65	9	include	include	VERB
fnp-5813	65	10	meningothelial	meningothelial	ADJ
fnp-5813	65	11	cells	cell	NOUN
fnp-5813	65	12	with	with	ADP
fnp-5813	65	13	foamy	foamy	ADJ
fnp-5813	65	14	cytoplasm	cytoplasm	NOUN
fnp-5813	65	15	i.e.	i.e.	X
fnp-5813	65	16	lipidized	lipidize	VERB
fnp-5813	65	17	or	or	CCONJ
fnp-5813	65	18	xanthomatous	xanthomatous	ADJ
fnp-5813	65	19	change	change	NOUN
fnp-5813	65	20	[	[	X
fnp-5813	65	21	16	16	NUM
fnp-5813	65	22	,	,	PUNCT
fnp-5813	65	23	17	17	NUM
fnp-5813	65	24	]	]	PUNCT
fnp-5813	65	25	.	.	PUNCT
fnp-5813	66	1	immunostains	immunostain	NOUN
fnp-5813	66	2	for	for	ADP
fnp-5813	66	3	epithelial	epithelial	ADJ
fnp-5813	66	4	membrane	membrane	NOUN
fnp-5813	66	5	antigen	antigen	NOUN
fnp-5813	66	6	(	(	PUNCT
fnp-5813	66	7	ema	ema	PROPN
fnp-5813	66	8	)	)	PUNCT
fnp-5813	66	9	and	and	CCONJ
fnp-5813	66	10	progesterone	progesterone	NOUN
fnp-5813	66	11	receptor	receptor	NOUN
fnp-5813	66	12	(	(	PUNCT
fnp-5813	66	13	pr	pr	NOUN
fnp-5813	66	14	)	)	PUNCT
fnp-5813	66	15	highlighted	highlight	VERB
fnp-5813	66	16	the	the	DET
fnp-5813	66	17	meningothelial	meningothelial	ADJ
fnp-5813	66	18	cell	cell	NOUN
fnp-5813	66	19	aggregates	aggregate	NOUN
fnp-5813	66	20	buried	bury	VERB
fnp-5813	66	21	within	within	ADP
fnp-5813	66	22	the	the	DET
fnp-5813	66	23	collagenous	collagenous	ADJ
fnp-5813	66	24	tissue	tissue	NOUN
fnp-5813	66	25	(	(	PUNCT
fnp-5813	66	26	figures	figure	NOUN
fnp-5813	66	27	 	 	SPACE
fnp-5813	66	28	3e	3e	NOUN
fnp-5813	66	29	and	and	CCONJ
fnp-5813	66	30	3f	3f	NUM
fnp-5813	66	31	)	)	PUNCT
fnp-5813	66	32	.	.	PUNCT
fnp-5813	67	1	nuclei	nucleus	NOUN
fnp-5813	67	2	in	in	ADP
fnp-5813	67	3	the	the	DET
fnp-5813	67	4	lipomatous	lipomatous	ADJ
fnp-5813	67	5	component	component	NOUN
fnp-5813	67	6	were	be	AUX
fnp-5813	67	7	predominantly	predominantly	ADV
fnp-5813	67	8	negative	negative	ADJ
fnp-5813	67	9	for	for	ADP
fnp-5813	67	10	pr	pr	NOUN
fnp-5813	67	11	.	.	PUNCT
fnp-5813	68	1	the	the	DET
fnp-5813	68	2	cells	cell	NOUN
fnp-5813	68	3	were	be	AUX
fnp-5813	68	4	negative	negative	ADJ
fnp-5813	68	5	for	for	ADP
fnp-5813	68	6	cytokeratin	cytokeratin	NOUN
fnp-5813	68	7	(	(	PUNCT
fnp-5813	68	8	ae1ae3	ae1ae3	ADJ
fnp-5813	68	9	)	)	PUNCT
fnp-5813	68	10	,	,	PUNCT
fnp-5813	68	11	estrogen	estrogen	NOUN
fnp-5813	68	12	receptor	receptor	NOUN
fnp-5813	68	13	(	(	PUNCT
fnp-5813	68	14	er	er	INTJ
fnp-5813	68	15	)	)	PUNCT
fnp-5813	68	16	,	,	PUNCT
fnp-5813	68	17	wt1	wt1	VERB
fnp-5813	68	18	,	,	PUNCT
fnp-5813	68	19	and	and	CCONJ
fnp-5813	68	20	cd10	cd10	PROPN
fnp-5813	68	21	although	although	SCONJ
fnp-5813	68	22	fibroblasts	fibroblast	NOUN
fnp-5813	68	23	and	and	CCONJ
fnp-5813	68	24	lipomatous	lipomatous	ADJ
fnp-5813	68	25	cells	cell	NOUN
fnp-5813	68	26	were	be	AUX
fnp-5813	68	27	positive	positive	ADJ
fnp-5813	68	28	for	for	ADP
fnp-5813	68	29	cd10	cd10	PROPN
fnp-5813	68	30	.	.	PUNCT
fnp-5813	69	1	this	this	PRON
fnp-5813	69	2	excludes	exclude	VERB
fnp-5813	69	3	the	the	DET
fnp-5813	69	4	remote	remote	ADJ
fnp-5813	69	5	possibility	possibility	NOUN
fnp-5813	69	6	that	that	SCONJ
fnp-5813	69	7	these	these	DET
fnp-5813	69	8	lesions	lesion	NOUN
fnp-5813	69	9	represented	represent	VERB
fnp-5813	69	10	metastatic	metastatic	ADJ
fnp-5813	69	11	endometrial	endometrial	ADJ
fnp-5813	69	12	stromal	stromal	ADJ
fnp-5813	69	13	sarcoma	sarcoma	NOUN
fnp-5813	69	14	.	.	PUNCT
fnp-5813	70	1	an	an	DET
fnp-5813	70	2	immunostain	immunostain	NOUN
fnp-5813	70	3	for	for	ADP
fnp-5813	70	4	ki67	ki67	PROPN
fnp-5813	70	5	showed	show	VERB
fnp-5813	70	6	no	no	DET
fnp-5813	70	7	cell	cell	NOUN
fnp-5813	70	8	proliferation	proliferation	NOUN
fnp-5813	70	9	in	in	ADP
fnp-5813	70	10	the	the	DET
fnp-5813	70	11	meningothelial	meningothelial	ADJ
fnp-5813	70	12	aggregates	aggregate	NOUN
fnp-5813	70	13	.	.	PUNCT
fnp-5813	71	1	based	base	VERB
fnp-5813	71	2	upon	upon	SCONJ
fnp-5813	71	3	the	the	DET
fnp-5813	71	4	histopathological	histopathological	ADJ
fnp-5813	71	5	features	feature	NOUN
fnp-5813	71	6	,	,	PUNCT
fnp-5813	71	7	we	we	PRON
fnp-5813	71	8	conclude	conclude	VERB
fnp-5813	71	9	that	that	SCONJ
fnp-5813	71	10	these	these	DET
fnp-5813	71	11	lesions	lesion	NOUN
fnp-5813	71	12	represent	represent	VERB
fnp-5813	71	13	regressed	regress	VERB
fnp-5813	71	14	meningiomas	meningioma	NOUN
fnp-5813	71	15	.	.	PUNCT
fnp-5813	72	1	based	base	VERB
fnp-5813	72	2	upon	upon	SCONJ
fnp-5813	72	3	the	the	DET
fnp-5813	72	4	history	history	NOUN
fnp-5813	72	5	of	of	ADP
fnp-5813	72	6	regression	regression	NOUN
fnp-5813	72	7	,	,	PUNCT
fnp-5813	72	8	inflammatory	inflammatory	ADJ
fnp-5813	72	9	pseudotumor	pseudotumor	NOUN
fnp-5813	72	10	was	be	AUX
fnp-5813	72	11	also	also	ADV
fnp-5813	72	12	considered	consider	VERB
fnp-5813	72	13	,	,	PUNCT
fnp-5813	72	14	but	but	CCONJ
fnp-5813	72	15	the	the	DET
fnp-5813	72	16	patient	patient	NOUN
fnp-5813	72	17	had	have	AUX
fnp-5813	72	18	been	be	AUX
fnp-5813	72	19	on	on	ADP
fnp-5813	72	20	no	no	DET
fnp-5813	72	21	anti	anti	ADJ
fnp-5813	72	22	-	-	ADJ
fnp-5813	72	23	inflammatory	inflammatory	ADJ
fnp-5813	72	24	therapy	therapy	NOUN
fnp-5813	72	25	and	and	CCONJ
fnp-5813	72	26	the	the	DET
fnp-5813	72	27	residual	residual	ADJ
fnp-5813	72	28	tissue	tissue	NOUN
fnp-5813	72	29	mass	mass	NOUN
fnp-5813	72	30	showed	show	VERB
fnp-5813	72	31	no	no	DET
fnp-5813	72	32	features	feature	NOUN
fnp-5813	72	33	of	of	ADP
fnp-5813	72	34	inflammation	inflammation	NOUN
fnp-5813	72	35	.	.	PUNCT
fnp-5813	73	1	a	a	DET
fnp-5813	73	2	small	small	ADJ
fnp-5813	73	3	focus	focus	NOUN
fnp-5813	73	4	of	of	ADP
fnp-5813	73	5	extramedullary	extramedullary	ADJ
fnp-5813	73	6	hematopoiesis	hematopoiesis	NOUN
fnp-5813	73	7	was	be	AUX
fnp-5813	73	8	present	present	ADJ
fnp-5813	73	9	in	in	ADP
fnp-5813	73	10	the	the	DET
fnp-5813	73	11	parasellar	parasellar	ADJ
fnp-5813	73	12	region	region	NOUN
fnp-5813	73	13	.	.	PUNCT
fnp-5813	74	1	the	the	DET
fnp-5813	74	2	left	left	ADJ
fnp-5813	74	3	frontal	frontal	ADJ
fnp-5813	74	4	lobe	lobe	VERB
fnp-5813	74	5	tip	tip	NOUN
fnp-5813	74	6	and	and	CCONJ
fnp-5813	74	7	the	the	DET
fnp-5813	74	8	left	left	ADJ
fnp-5813	74	9	medial	medial	ADJ
fnp-5813	74	10	occipital	occipital	ADJ
fnp-5813	74	11	parietal	parietal	ADJ
fnp-5813	74	12	region	region	NOUN
fnp-5813	74	13	at	at	ADP
fnp-5813	74	14	the	the	DET
fnp-5813	74	15	sites	site	NOUN
fnp-5813	74	16	of	of	ADP
fnp-5813	74	17	the	the	DET
fnp-5813	74	18	previous	previous	ADJ
fnp-5813	74	19	tumors	tumor	NOUN
fnp-5813	74	20	were	be	AUX
fnp-5813	74	21	atrophic	atrophic	ADJ
fnp-5813	74	22	.	.	PUNCT
fnp-5813	75	1	in	in	ADP
fnp-5813	75	2	addition	addition	NOUN
fnp-5813	75	3	to	to	ADP
fnp-5813	75	4	the	the	DET
fnp-5813	75	5	intracranial	intracranial	ADJ
fnp-5813	75	6	tumors	tumor	NOUN
fnp-5813	75	7	,	,	PUNCT
fnp-5813	75	8	there	there	PRON
fnp-5813	75	9	was	be	VERB
fnp-5813	75	10	an	an	DET
fnp-5813	75	11	intermediate	intermediate	ADJ
fnp-5813	75	12	level	level	NOUN
fnp-5813	75	13	of	of	ADP
fnp-5813	75	14	alzheimer	alzheimer	PROPN
fnp-5813	75	15	disease	disease	NOUN
fnp-5813	75	16	type	type	NOUN
fnp-5813	75	17	neuropathologic	neuropathologic	ADJ
fnp-5813	75	18	change	change	NOUN
fnp-5813	75	19	(	(	PUNCT
fnp-5813	75	20	nia	nia	ADJ
fnp-5813	75	21	-	-	PUNCT
fnp-5813	75	22	aa	aa	PROPN
fnp-5813	75	23	score	score	NOUN
fnp-5813	75	24	a2	a2	PROPN
fnp-5813	75	25	,	,	PUNCT
fnp-5813	75	26	b2	b2	NOUN
fnp-5813	75	27	,	,	PUNCT
fnp-5813	75	28	c2	c2	PROPN
fnp-5813	75	29	)	)	PUNCT
fnp-5813	76	1	[	[	X
fnp-5813	76	2	18	18	NUM
fnp-5813	76	3	]	]	PUNCT
fnp-5813	76	4	and	and	CCONJ
fnp-5813	76	5	there	there	PRON
fnp-5813	76	6	were	be	VERB
fnp-5813	76	7	extremely	extremely	ADV
fnp-5813	76	8	rare	rare	ADJ
fnp-5813	76	9	cortical	cortical	ADJ
fnp-5813	76	10	lewy	lewy	ADJ
fnp-5813	76	11	bodies	body	NOUN
fnp-5813	76	12	.	.	PUNCT
fnp-5813	77	1	there	there	PRON
fnp-5813	77	2	was	be	VERB
fnp-5813	77	3	no	no	DET
fnp-5813	77	4	evidence	evidence	NOUN
fnp-5813	77	5	for	for	ADP
fnp-5813	77	6	brainstem	brainstem	NOUN
fnp-5813	77	7	neurodegenerative	neurodegenerative	ADJ
fnp-5813	77	8	changes	change	NOUN
fnp-5813	77	9	to	to	PART
fnp-5813	77	10	explain	explain	VERB
fnp-5813	77	11	her	her	PRON
fnp-5813	77	12	tremor	tremor	NOUN
fnp-5813	77	13	or	or	CCONJ
fnp-5813	77	14	swallowing	swallow	VERB
fnp-5813	77	15	difficulty	difficulty	NOUN
fnp-5813	77	16	.	.	PUNCT
fnp-5813	78	1	discussion	discussion	NOUN
fnp-5813	78	2	spontaneous	spontaneous	ADJ
fnp-5813	78	3	regression	regression	NOUN
fnp-5813	78	4	of	of	ADP
fnp-5813	78	5	intracranial	intracranial	ADJ
fnp-5813	78	6	meningiomas	meningioma	NOUN
fnp-5813	78	7	is	be	AUX
fnp-5813	78	8	rare	rare	ADJ
fnp-5813	78	9	and	and	CCONJ
fnp-5813	78	10	the	the	DET
fnp-5813	78	11	histopathology	histopathology	NOUN
fnp-5813	78	12	of	of	ADP
fnp-5813	78	13	regressed	regress	VERB
fnp-5813	78	14	meningiomas	meningioma	NOUN
fnp-5813	78	15	is	be	AUX
fnp-5813	78	16	not	not	PART
fnp-5813	78	17	well	well	ADV
fnp-5813	78	18	documented	document	VERB
fnp-5813	78	19	.	.	PUNCT
fnp-5813	79	1	in	in	ADP
fnp-5813	79	2	this	this	DET
fnp-5813	79	3	case	case	NOUN
fnp-5813	79	4	report	report	NOUN
fnp-5813	79	5	,	,	PUNCT
fnp-5813	79	6	we	we	PRON
fnp-5813	79	7	describe	describe	VERB
fnp-5813	79	8	a	a	DET
fnp-5813	79	9	woman	woman	NOUN
fnp-5813	79	10	with	with	ADP
fnp-5813	79	11	multiple	multiple	ADJ
fnp-5813	79	12	meningiomas	meningioma	NOUN
fnp-5813	79	13	that	that	PRON
fnp-5813	79	14	appeared	appear	VERB
fnp-5813	79	15	after	after	ADP
fnp-5813	79	16	a	a	DET
fnp-5813	79	17	seven	seven	NUM
fnp-5813	79	18	year	year	NOUN
fnp-5813	79	19	period	period	NOUN
fnp-5813	79	20	of	of	ADP
fnp-5813	79	21	treatment	treatment	NOUN
fnp-5813	79	22	with	with	ADP
fnp-5813	79	23	megestrol	megestrol	NOUN
fnp-5813	79	24	,	,	PUNCT
fnp-5813	79	25	a	a	DET
fnp-5813	79	26	synthetic	synthetic	ADJ
fnp-5813	79	27	progesterone	progesterone	NOUN
fnp-5813	79	28	,	,	PUNCT
fnp-5813	79	29	and	and	CCONJ
fnp-5813	79	30	that	that	PRON
fnp-5813	79	31	vanished	vanish	VERB
fnp-5813	79	32	approximately	approximately	ADV
fnp-5813	79	33	three	three	NUM
fnp-5813	79	34	years	year	NOUN
fnp-5813	79	35	after	after	ADP
fnp-5813	79	36	discontinuation	discontinuation	NOUN
fnp-5813	79	37	of	of	ADP
fnp-5813	79	38	the	the	DET
fnp-5813	79	39	drug	drug	NOUN
fnp-5813	79	40	.	.	PUNCT
fnp-5813	80	1	it	it	PRON
fnp-5813	80	2	has	have	AUX
fnp-5813	80	3	been	be	AUX
fnp-5813	80	4	reported	report	VERB
fnp-5813	80	5	that	that	SCONJ
fnp-5813	80	6	meningiomas	meningioma	NOUN
fnp-5813	80	7	rarely	rarely	ADV
fnp-5813	80	8	regress	regress	ADJ
fnp-5813	80	9	following	follow	VERB
fnp-5813	80	10	administration	administration	NOUN
fnp-5813	80	11	of	of	ADP
fnp-5813	80	12	estrogen	estrogen	NOUN
fnp-5813	80	13	antagonists	antagonist	NOUN
fnp-5813	80	14	e.g.	e.g.	ADV
fnp-5813	80	15	mepitiostane	mepitiostane	NOUN
fnp-5813	80	16	[	[	X
fnp-5813	80	17	19	19	NUM
fnp-5813	80	18	]	]	PUNCT
fnp-5813	80	19	,	,	PUNCT
fnp-5813	80	20	post	post	ADJ
fnp-5813	80	21	-	-	ADJ
fnp-5813	80	22	partum	partum	ADJ
fnp-5813	80	23	[	[	X
fnp-5813	80	24	20	20	NUM
fnp-5813	80	25	]	]	PUNCT
fnp-5813	80	26	,	,	PUNCT
fnp-5813	80	27	following	follow	VERB
fnp-5813	80	28	menopause	menopause	NOUN
fnp-5813	80	29	[	[	X
fnp-5813	80	30	21	21	NUM
fnp-5813	80	31	]	]	PUNCT
fnp-5813	80	32	,	,	PUNCT
fnp-5813	80	33	or	or	CCONJ
fnp-5813	80	34	“	"	PUNCT
fnp-5813	80	35	spontaneously	spontaneously	ADV
fnp-5813	80	36	”	"	PUNCT
fnp-5813	80	37	[	[	X
fnp-5813	80	38	22	22	NUM
fnp-5813	80	39	]	]	PUNCT
fnp-5813	80	40	.	.	PUNCT
fnp-5813	81	1	several	several	ADJ
fnp-5813	81	2	case	case	NOUN
fnp-5813	81	3	reports	report	NOUN
fnp-5813	81	4	and	and	CCONJ
fnp-5813	81	5	small	small	ADJ
fnp-5813	81	6	series	series	NOUN
fnp-5813	81	7	show	show	VERB
fnp-5813	81	8	radiologic	radiologic	ADJ
fnp-5813	81	9	regression	regression	NOUN
fnp-5813	81	10	of	of	ADP
fnp-5813	81	11	meningiomas	meningioma	NOUN
fnp-5813	81	12	after	after	ADP
fnp-5813	81	13	cessation	cessation	NOUN
fnp-5813	81	14	of	of	ADP
fnp-5813	81	15	progestin	progestin	NOUN
fnp-5813	81	16	therapies	therapy	NOUN
fnp-5813	81	17	with	with	ADP
fnp-5813	81	18	chlormadinone	chlormadinone	NOUN
fnp-5813	81	19	acetate	acetate	NOUN
fnp-5813	81	20	,	,	PUNCT
fnp-5813	81	21	megestrol	megestrol	NOUN
fnp-5813	81	22	acetate	acetate	NOUN
fnp-5813	81	23	,	,	PUNCT
fnp-5813	81	24	and	and	CCONJ
fnp-5813	81	25	cyproterone	cyproterone	NOUN
fnp-5813	81	26	acetate	acetate	NOUN
fnp-5813	81	27	[	[	X
fnp-5813	81	28	23–29	23–29	NOUN
fnp-5813	81	29	]	]	PUNCT
fnp-5813	81	30	.	.	PUNCT
fnp-5813	82	1	in	in	ADP
fnp-5813	82	2	one	one	NUM
fnp-5813	82	3	series	series	NOUN
fnp-5813	82	4	,	,	PUNCT
fnp-5813	82	5	osseous	osseous	ADJ
fnp-5813	82	6	hypertrophy	hypertrophy	NOUN
fnp-5813	82	7	at	at	ADP
fnp-5813	82	8	the	the	DET
fnp-5813	82	9	sites	site	NOUN
fnp-5813	82	10	of	of	ADP
fnp-5813	82	11	regressed	regress	VERB
fnp-5813	82	12	tumors	tumor	NOUN
fnp-5813	82	13	was	be	AUX
fnp-5813	82	14	documented	document	VERB
fnp-5813	82	15	[	[	X
fnp-5813	82	16	8	8	NUM
fnp-5813	82	17	]	]	PUNCT
fnp-5813	82	18	.	.	PUNCT
fnp-5813	83	1	notably	notably	ADV
fnp-5813	83	2	,	,	PUNCT
fnp-5813	83	3	tumor	tumor	NOUN
fnp-5813	83	4	growth	growth	NOUN
fnp-5813	83	5	and	and	CCONJ
fnp-5813	83	6	regression	regression	NOUN
fnp-5813	83	7	could	could	AUX
fnp-5813	83	8	not	not	PART
fnp-5813	83	9	be	be	AUX
fnp-5813	83	10	attributed	attribute	VERB
fnp-5813	83	11	temporally	temporally	ADV
fnp-5813	83	12	to	to	ADP
fnp-5813	83	13	any	any	DET
fnp-5813	83	14	other	other	ADJ
fnp-5813	83	15	medication	medication	NOUN
fnp-5813	83	16	or	or	CCONJ
fnp-5813	83	17	disease	disease	NOUN
fnp-5813	83	18	process	process	NOUN
fnp-5813	83	19	.	.	PUNCT
fnp-5813	84	1	recent	recent	ADJ
fnp-5813	84	2	reviews	review	NOUN
fnp-5813	84	3	of	of	ADP
fnp-5813	84	4	biological	biological	ADJ
fnp-5813	84	5	therapies	therapy	NOUN
fnp-5813	84	6	used	use	VERB
fnp-5813	84	7	for	for	ADP
fnp-5813	84	8	dermatologic	dermatologic	ADJ
fnp-5813	84	9	diseases	disease	NOUN
fnp-5813	84	10	including	include	VERB
fnp-5813	84	11	psoriasis	psoriasis	NOUN
fnp-5813	84	12	highlighted	highlight	VERB
fnp-5813	84	13	very	very	ADV
fnp-5813	84	14	rare	rare	ADJ
fnp-5813	84	15	cases	case	NOUN
fnp-5813	84	16	in	in	ADP
fnp-5813	84	17	which	which	PRON
fnp-5813	84	18	meningiomas	meningioma	NOUN
fnp-5813	84	19	were	be	AUX
fnp-5813	84	20	diagnosed	diagnose	VERB
fnp-5813	84	21	in	in	ADP
fnp-5813	84	22	patients	patient	NOUN
fnp-5813	84	23	receiving	receive	VERB
fnp-5813	84	24	methotrexate	methotrexate	NOUN
fnp-5813	84	25	,	,	PUNCT
fnp-5813	84	26	secukinumab	secukinumab	NOUN
fnp-5813	84	27	or	or	CCONJ
fnp-5813	84	28	etanercept	etanercept	NOUN
fnp-5813	84	29	.	.	PUNCT
fnp-5813	85	1	the	the	DET
fnp-5813	85	2	authors	author	NOUN
fnp-5813	85	3	concluded	conclude	VERB
fnp-5813	85	4	that	that	SCONJ
fnp-5813	85	5	these	these	DET
fnp-5813	85	6	drugs	drug	NOUN
fnp-5813	85	7	did	do	AUX
fnp-5813	85	8	not	not	PART
fnp-5813	85	9	appear	appear	VERB
fnp-5813	85	10	to	to	PART
fnp-5813	85	11	cause	cause	VERB
fnp-5813	85	12	,	,	PUNCT
fnp-5813	85	13	exacerbate	exacerbate	VERB
fnp-5813	85	14	,	,	PUNCT
fnp-5813	85	15	or	or	CCONJ
fnp-5813	85	16	shrink	shrink	VERB
fnp-5813	85	17	the	the	DET
fnp-5813	85	18	tumors	tumor	NOUN
fnp-5813	86	1	[	[	X
fnp-5813	86	2	30	30	NUM
fnp-5813	86	3	,	,	PUNCT
fnp-5813	86	4	31	31	NUM
fnp-5813	86	5	]	]	PUNCT
fnp-5813	86	6	.	.	PUNCT
fnp-5813	87	1	one	one	NUM
fnp-5813	87	2	woman	woman	NOUN
fnp-5813	87	3	was	be	AUX
fnp-5813	87	4	prescribed	prescribe	VERB
fnp-5813	87	5	apremilast	apremilast	ADJ
fnp-5813	87	6	,	,	PUNCT
fnp-5813	87	7	an	an	DET
fnp-5813	87	8	inhibitor	inhibitor	NOUN
fnp-5813	87	9	of	of	ADP
fnp-5813	87	10	phosphodiesterase	phosphodiesterase	NOUN
fnp-5813	87	11	4	4	NUM
fnp-5813	87	12	(	(	PUNCT
fnp-5813	87	13	pde4	pde4	NOUN
fnp-5813	87	14	)	)	PUNCT
fnp-5813	87	15	,	,	PUNCT
fnp-5813	87	16	for	for	ADP
fnp-5813	87	17	her	her	PRON
fnp-5813	87	18	psoriasis	psoriasis	NOUN
fnp-5813	87	19	during	during	ADP
fnp-5813	87	20	the	the	DET
fnp-5813	87	21	period	period	NOUN
fnp-5813	87	22	of	of	ADP
fnp-5813	87	23	meningioma	meningioma	ADJ
fnp-5813	87	24	regression	regression	NOUN
fnp-5813	87	25	[	[	X
fnp-5813	87	26	32	32	NUM
fnp-5813	87	27	]	]	PUNCT
fnp-5813	87	28	.	.	PUNCT
fnp-5813	88	1	although	although	SCONJ
fnp-5813	88	2	pde4	pde4	NOUN
fnp-5813	88	3	is	be	AUX
fnp-5813	88	4	reported	report	VERB
fnp-5813	88	5	to	to	PART
fnp-5813	88	6	be	be	AUX
fnp-5813	88	7	expressed	express	VERB
fnp-5813	88	8	in	in	ADP
fnp-5813	88	9	some	some	DET
fnp-5813	88	10	meningiomas	meningioma	NOUN
fnp-5813	88	11	,	,	PUNCT
fnp-5813	88	12	there	there	PRON
fnp-5813	88	13	is	be	VERB
fnp-5813	88	14	no	no	DET
fnp-5813	88	15	evidence	evidence	NOUN
fnp-5813	88	16	that	that	SCONJ
fnp-5813	88	17	pde4	pde4	NOUN
fnp-5813	88	18	inhibition	inhibition	NOUN
fnp-5813	88	19	can	can	AUX
fnp-5813	88	20	treat	treat	VERB
fnp-5813	88	21	meningiomas	meningioma	NOUN
fnp-5813	88	22	[	[	X
fnp-5813	88	23	33	33	NUM
fnp-5813	88	24	]	]	PUNCT
fnp-5813	88	25	.	.	PUNCT
fnp-5813	89	1	in	in	ADP
fnp-5813	89	2	our	our	PRON
fnp-5813	89	3	case	case	NOUN
fnp-5813	89	4	,	,	PUNCT
fnp-5813	89	5	the	the	DET
fnp-5813	89	6	residual	residual	ADJ
fnp-5813	89	7	meningothelial	meningothelial	ADJ
fnp-5813	89	8	cells	cell	NOUN
fnp-5813	89	9	were	be	AUX
fnp-5813	89	10	strongly	strongly	ADV
fnp-5813	89	11	immunoreactive	immunoreactive	ADJ
fnp-5813	89	12	for	for	ADP
fnp-5813	89	13	progesterone	progesterone	NOUN
fnp-5813	89	14	receptor	receptor	NOUN
fnp-5813	89	15	(	(	PUNCT
fnp-5813	89	16	pr	pr	NOUN
fnp-5813	89	17	)	)	PUNCT
fnp-5813	89	18	,	,	PUNCT
fnp-5813	89	19	as	as	SCONJ
fnp-5813	89	20	is	be	AUX
fnp-5813	89	21	often	often	ADV
fnp-5813	89	22	reported	report	VERB
fnp-5813	89	23	for	for	ADP
fnp-5813	89	24	meningioma	meningioma	NOUN
fnp-5813	89	25	[	[	X
fnp-5813	89	26	1	1	NUM
fnp-5813	89	27	]	]	PUNCT
fnp-5813	89	28	.	.	PUNCT
fnp-5813	90	1	in	in	ADP
fnp-5813	90	2	cell	cell	NOUN
fnp-5813	90	3	culture	culture	NOUN
fnp-5813	90	4	,	,	PUNCT
fnp-5813	90	5	the	the	DET
fnp-5813	90	6	presence	presence	NOUN
fnp-5813	90	7	of	of	ADP
fnp-5813	90	8	pr	pr	NOUN
fnp-5813	90	9	determines	determine	VERB
fnp-5813	90	10	the	the	DET
fnp-5813	90	11	responsiveness	responsiveness	NOUN
fnp-5813	90	12	of	of	ADP
fnp-5813	90	13	meningothelial	meningothelial	ADJ
fnp-5813	90	14	cells	cell	NOUN
fnp-5813	90	15	to	to	PART
fnp-5813	90	16	progesterone	progesterone	VERB
fnp-5813	90	17	[	[	X
fnp-5813	90	18	34	34	NUM
fnp-5813	90	19	]	]	PUNCT
fnp-5813	90	20	.	.	PUNCT
fnp-5813	91	1	other	other	ADJ
fnp-5813	91	2	experiments	experiment	NOUN
fnp-5813	91	3	showed	show	VERB
fnp-5813	91	4	that	that	SCONJ
fnp-5813	91	5	progesterone	progesterone	NOUN
fnp-5813	91	6	in	in	ADP
fnp-5813	91	7	the	the	DET
fnp-5813	91	8	culture	culture	NOUN
fnp-5813	91	9	medium	medium	NOUN
fnp-5813	91	10	does	do	AUX
fnp-5813	91	11	not	not	PART
fnp-5813	91	12	have	have	VERB
fnp-5813	91	13	direct	direct	ADJ
fnp-5813	91	14	mitogenic	mitogenic	ADJ
fnp-5813	91	15	effects	effect	NOUN
fnp-5813	91	16	but	but	CCONJ
fnp-5813	91	17	increases	increase	VERB
fnp-5813	91	18	the	the	DET
fnp-5813	91	19	sensitivity	sensitivity	NOUN
fnp-5813	91	20	of	of	ADP
fnp-5813	91	21	meningioma	meningioma	NOUN
fnp-5813	91	22	cells	cell	NOUN
fnp-5813	91	23	to	to	ADP
fnp-5813	91	24	other	other	ADJ
fnp-5813	91	25	mitogenic	mitogenic	ADJ
fnp-5813	91	26	stimuli	stimulus	NOUN
fnp-5813	91	27	[	[	X
fnp-5813	91	28	35	35	NUM
fnp-5813	91	29	]	]	PUNCT
fnp-5813	91	30	.	.	PUNCT
fnp-5813	92	1	specific	specific	ADJ
fnp-5813	92	2	molecular	molecular	ADJ
fnp-5813	92	3	effects	effect	NOUN
fnp-5813	92	4	of	of	ADP
fnp-5813	92	5	the	the	DET
fnp-5813	92	6	synthetic	synthetic	ADJ
fnp-5813	92	7	progesterone	progesterone	NOUN
fnp-5813	92	8	agonist	agonist	NOUN
fnp-5813	92	9	megestrol	megestrol	NOUN
fnp-5813	92	10	have	have	AUX
fnp-5813	92	11	not	not	PART
fnp-5813	92	12	been	be	AUX
fnp-5813	92	13	studied	study	VERB
fnp-5813	92	14	in	in	ADP
fnp-5813	92	15	detail	detail	NOUN
fnp-5813	92	16	in	in	ADP
fnp-5813	92	17	meningioma	meningioma	ADJ
fnp-5813	92	18	cells	cell	NOUN
fnp-5813	92	19	.	.	PUNCT
fnp-5813	93	1	seemingly	seemingly	ADV
fnp-5813	93	2	paradoxically	paradoxically	ADV
fnp-5813	93	3	,	,	PUNCT
fnp-5813	93	4	megestrol	megestrol	NOUN
fnp-5813	93	5	inhibits	inhibit	VERB
fnp-5813	93	6	proliferation	proliferation	NOUN
fnp-5813	93	7	of	of	ADP
fnp-5813	93	8	cultured	cultured	ADJ
fnp-5813	93	9	breast	breast	NOUN
fnp-5813	93	10	cells	cell	NOUN
fnp-5813	93	11	that	that	PRON
fnp-5813	93	12	express	express	VERB
fnp-5813	93	13	pr	pr	NOUN
fnp-5813	93	14	[	[	X
fnp-5813	93	15	36	36	NUM
fnp-5813	93	16	]	]	PUNCT
fnp-5813	93	17	.	.	PUNCT
fnp-5813	94	1	meningiomas	meningioma	NOUN
fnp-5813	94	2	however	however	ADV
fnp-5813	94	3	differentially	differentially	ADV
fnp-5813	94	4	express	express	VERB
fnp-5813	94	5	several	several	ADJ
fnp-5813	94	6	distinct	distinct	ADJ
fnp-5813	94	7	steroid	steroid	NOUN
fnp-5813	94	8	receptor	receptor	NOUN
fnp-5813	94	9	coactivators	coactivator	NOUN
fnp-5813	95	1	[	[	X
fnp-5813	95	2	37	37	NUM
fnp-5813	95	3	]	]	PUNCT
fnp-5813	95	4	,	,	PUNCT
fnp-5813	95	5	which	which	PRON
fnp-5813	95	6	might	might	AUX
fnp-5813	95	7	explain	explain	VERB
fnp-5813	95	8	why	why	SCONJ
fnp-5813	95	9	their	their	PRON
fnp-5813	95	10	response	response	NOUN
fnp-5813	95	11	to	to	ADP
fnp-5813	95	12	sex	sex	NOUN
fnp-5813	95	13	hormones	hormone	NOUN
fnp-5813	95	14	is	be	AUX
fnp-5813	95	15	variable	variable	ADJ
fnp-5813	95	16	and	and	CCONJ
fnp-5813	95	17	unpredictable	unpredictable	ADJ
fnp-5813	95	18	[	[	X
fnp-5813	95	19	38	38	NUM
fnp-5813	95	20	]	]	PUNCT
fnp-5813	95	21	.	.	PUNCT
fnp-5813	96	1	the	the	DET
fnp-5813	96	2	present	present	ADJ
fnp-5813	96	3	report	report	NOUN
fnp-5813	96	4	is	be	AUX
fnp-5813	96	5	the	the	DET
fnp-5813	96	6	first	first	ADJ
fnp-5813	96	7	one	one	NUM
fnp-5813	96	8	to	to	PART
fnp-5813	96	9	show	show	VERB
fnp-5813	96	10	the	the	DET
fnp-5813	96	11	histopathologic	histopathologic	ADJ
fnp-5813	96	12	endpoint	endpoint	NOUN
fnp-5813	96	13	associated	associate	VERB
fnp-5813	96	14	with	with	ADP
fnp-5813	96	15	meningioma	meningioma	NOUN
fnp-5813	96	16	regression	regression	NOUN
fnp-5813	96	17	.	.	PUNCT
fnp-5813	97	1	small	small	ADJ
fnp-5813	97	2	clusters	cluster	NOUN
fnp-5813	97	3	of	of	ADP
fnp-5813	97	4	residual	residual	ADJ
fnp-5813	97	5	meningothelial	meningothelial	ADJ
fnp-5813	97	6	tumor	tumor	NOUN
fnp-5813	97	7	cells	cell	NOUN
fnp-5813	97	8	were	be	AUX
fnp-5813	97	9	present	present	ADJ
fnp-5813	97	10	in	in	ADP
fnp-5813	97	11	a	a	DET
fnp-5813	97	12	background	background	NOUN
fnp-5813	97	13	of	of	ADP
fnp-5813	97	14	lipomatous	lipomatous	ADJ
fnp-5813	97	15	tissue	tissue	NOUN
fnp-5813	97	16	.	.	PUNCT
fnp-5813	98	1	the	the	DET
fnp-5813	98	2	lipomatous	lipomatous	ADJ
fnp-5813	98	3	variant	variant	NOUN
fnp-5813	98	4	of	of	ADP
fnp-5813	98	5	meningioma	meningioma	NOUN
fnp-5813	98	6	is	be	AUX
fnp-5813	98	7	a	a	DET
fnp-5813	98	8	rare	rare	ADJ
fnp-5813	98	9	but	but	CCONJ
fnp-5813	98	10	well	well	ADV
fnp-5813	98	11	-	-	PUNCT
fnp-5813	98	12	recognized	recognize	VERB
fnp-5813	98	13	entity	entity	NOUN
fnp-5813	98	14	[	[	X
fnp-5813	98	15	16	16	NUM
fnp-5813	98	16	]	]	PUNCT
fnp-5813	98	17	.	.	PUNCT
fnp-5813	99	1	it	it	PRON
fnp-5813	99	2	should	should	AUX
fnp-5813	99	3	be	be	AUX
fnp-5813	99	4	noted	note	VERB
fnp-5813	99	5	that	that	SCONJ
fnp-5813	99	6	the	the	DET
fnp-5813	99	7	tumors	tumor	NOUN
fnp-5813	99	8	,	,	PUNCT
fnp-5813	99	9	at	at	ADP
fnp-5813	99	10	their	their	PRON
fnp-5813	99	11	apex	apex	NOUN
fnp-5813	99	12	,	,	PUNCT
fnp-5813	99	13	had	have	VERB
fnp-5813	99	14	specific	specific	ADJ
fnp-5813	99	15	imaging	imaging	NOUN
fnp-5813	99	16	characteristics	characteristic	NOUN
fnp-5813	99	17	with	with	ADP
fnp-5813	99	18	isointensegray	isointensegray	ADJ
fnp-5813	99	19	matter	matter	NOUN
fnp-5813	99	20	on	on	ADP
fnp-5813	99	21	ct	ct	PROPN
fnp-5813	99	22	and	and	CCONJ
fnp-5813	99	23	mr	mr	PROPN
fnp-5813	99	24	suggestive	suggestive	ADJ
fnp-5813	99	25	of	of	ADP
fnp-5813	99	26	more	more	ADJ
fnp-5813	99	27	common	common	ADJ
fnp-5813	99	28	forms	form	NOUN
fnp-5813	99	29	of	of	ADP
fnp-5813	99	30	meningioma	meningioma	NOUN
fnp-5813	99	31	,	,	PUNCT
fnp-5813	99	32	in	in	ADP
fnp-5813	99	33	contrast	contrast	NOUN
fnp-5813	99	34	to	to	ADP
fnp-5813	99	35	the	the	DET
fnp-5813	99	36	features	feature	NOUN
fnp-5813	99	37	of	of	ADP
fnp-5813	99	38	lipomatous	lipomatous	ADJ
fnp-5813	99	39	meningioma	meningioma	NOUN
fnp-5813	99	40	which	which	PRON
fnp-5813	99	41	are	be	AUX
fnp-5813	99	42	hypointense	hypointense	NOUN
fnp-5813	99	43	on	on	ADP
fnp-5813	99	44	ct	ct	PROPN
fnp-5813	99	45	scans	scan	NOUN
fnp-5813	99	46	and	and	CCONJ
fnp-5813	99	47	hyperintense	hyperintense	NOUN
fnp-5813	99	48	on	on	ADP
fnp-5813	99	49	t1	t1	PROPN
fnp-5813	99	50	-	-	PUNCT
fnp-5813	99	51	weighted	weight	VERB
fnp-5813	99	52	mr	mr	PROPN
fnp-5813	99	53	[	[	X
fnp-5813	99	54	39	39	NUM
fnp-5813	99	55	]	]	PUNCT
fnp-5813	99	56	.	.	PUNCT
fnp-5813	100	1	whether	whether	SCONJ
fnp-5813	100	2	conversion	conversion	NOUN
fnp-5813	100	3	of	of	ADP
fnp-5813	100	4	meningioma	meningioma	NOUN
fnp-5813	100	5	to	to	ADP
fnp-5813	100	6	lipomatous	lipomatous	ADJ
fnp-5813	100	7	meningioma	meningioma	NOUN
fnp-5813	100	8	[	[	X
fnp-5813	100	9	16	16	NUM
fnp-5813	100	10	]	]	PUNCT
fnp-5813	100	11	necessarily	necessarily	ADV
fnp-5813	100	12	accompanies	accompany	VERB
fnp-5813	100	13	regression	regression	NOUN
fnp-5813	100	14	is	be	AUX
fnp-5813	100	15	unknown	unknown	ADJ
fnp-5813	100	16	.	.	PUNCT
fnp-5813	101	1	some	some	DET
fnp-5813	101	2	authors	author	NOUN
fnp-5813	101	3	have	have	AUX
fnp-5813	101	4	argued	argue	VERB
fnp-5813	101	5	about	about	ADP
fnp-5813	101	6	the	the	DET
fnp-5813	101	7	nature	nature	NOUN
fnp-5813	101	8	of	of	ADP
fnp-5813	101	9	this	this	PRON
fnp-5813	101	10	is	be	AUX
fnp-5813	101	11	phenomenon	phenomenon	NOUN
fnp-5813	101	12	which	which	PRON
fnp-5813	101	13	may	may	AUX
fnp-5813	101	14	be	be	AUX
fnp-5813	101	15	regressive	regressive	ADJ
fnp-5813	101	16	or	or	CCONJ
fnp-5813	101	17	metaplastic	metaplastic	ADJ
fnp-5813	101	18	[	[	X
fnp-5813	101	19	16	16	NUM
fnp-5813	101	20	,	,	PUNCT
fnp-5813	101	21	39	39	NUM
fnp-5813	101	22	,	,	PUNCT
fnp-5813	101	23	40	40	NUM
fnp-5813	101	24	]	]	PUNCT
fnp-5813	101	25	.	.	PUNCT
fnp-5813	102	1	conflicts	conflict	NOUN
fnp-5813	102	2	of	of	ADP
fnp-5813	102	3	interest	interest	NOUN
fnp-5813	102	4	statement	statement	NOUN
fnp-5813	102	5	the	the	DET
fnp-5813	102	6	authors	author	NOUN
fnp-5813	102	7	have	have	VERB
fnp-5813	102	8	no	no	DET
fnp-5813	102	9	conflicts	conflict	NOUN
fnp-5813	102	10	of	of	ADP
fnp-5813	102	11	interest	interest	NOUN
fnp-5813	102	12	to	to	PART
fnp-5813	102	13	report	report	VERB
fnp-5813	102	14	.	.	PUNCT
fnp-5813	103	1	funding	funding	NOUN
fnp-5813	103	2	statement	statement	NOUN
fnp-5813	103	3	the	the	DET
fnp-5813	103	4	authors	author	NOUN
fnp-5813	103	5	acknowledge	acknowledge	VERB
fnp-5813	103	6	that	that	SCONJ
fnp-5813	103	7	they	they	PRON
fnp-5813	103	8	received	receive	VERB
fnp-5813	103	9	no	no	DET
fnp-5813	103	10	funding	funding	NOUN
fnp-5813	103	11	in	in	ADP
fnp-5813	103	12	support	support	NOUN
fnp-5813	103	13	for	for	ADP
fnp-5813	103	14	this	this	DET
fnp-5813	103	15	work	work	NOUN
fnp-5813	103	16	.	.	PUNCT
fnp-5813	104	1	informed	inform	VERB
fnp-5813	104	2	consent	consent	NOUN
fnp-5813	104	3	permission	permission	NOUN
fnp-5813	104	4	to	to	PART
fnp-5813	104	5	publish	publish	VERB
fnp-5813	104	6	this	this	DET
fnp-5813	104	7	report	report	NOUN
fnp-5813	104	8	was	be	AUX
fnp-5813	104	9	explicitly	explicitly	ADV
fnp-5813	104	10	granted	grant	VERB
fnp-5813	104	11	by	by	ADP
fnp-5813	104	12	the	the	DET
fnp-5813	104	13	next	next	ADJ
fnp-5813	104	14	of	of	ADP
fnp-5813	104	15	kin	kin	PROPN
fnp-5813	104	16	.	.	PUNCT
fnp-5813	105	1	the	the	DET
fnp-5813	105	2	university	university	PROPN
fnp-5813	105	3	of	of	ADP
fnp-5813	105	4	manitoba	manitoba	PROPN
fnp-5813	105	5	research	research	PROPN
fnp-5813	105	6	ethics	ethic	NOUN
fnp-5813	105	7	and	and	CCONJ
fnp-5813	105	8	compliance	compliance	NOUN
fnp-5813	105	9	committee	committee	NOUN
fnp-5813	105	10	approved	approve	VERB
fnp-5813	105	11	the	the	DET
fnp-5813	105	12	case	case	NOUN
fnp-5813	105	13	report	report	NOUN
fnp-5813	105	14	(	(	PUNCT
fnp-5813	105	15	reference	reference	NOUN
fnp-5813	105	16	#	#	NOUN
fnp-5813	105	17	hs25528	hs25528	NOUN
fnp-5813	105	18	)	)	PUNCT
fnp-5813	105	19	.	.	PUNCT
fnp-5813	106	1	references	reference	NOUN
fnp-5813	106	2	1	1	NUM
fnp-5813	106	3	.	.	PUNCT
fnp-5813	107	1	maiuri	maiuri	PROPN
fnp-5813	107	2	f	f	PROPN
fnp-5813	107	3	,	,	PUNCT
fnp-5813	107	4	mariniello	mariniello	PROPN
fnp-5813	107	5	g	g	PROPN
fnp-5813	107	6	,	,	PUNCT
fnp-5813	107	7	de	de	X
fnp-5813	107	8	divitiis	divitiis	NOUN
fnp-5813	107	9	o	o	NOUN
fnp-5813	107	10	,	,	PUNCT
fnp-5813	107	11	et	et	PROPN
fnp-5813	107	12	al	al	PROPN
fnp-5813	107	13	.	.	PROPN
fnp-5813	107	14	(	(	PUNCT
fnp-5813	107	15	2021	2021	NUM
fnp-5813	107	16	)	)	PUNCT
fnp-5813	107	17	progesterone	progesterone	NOUN
fnp-5813	107	18	receptor	receptor	NOUN
fnp-5813	107	19	expression	expression	NOUN
fnp-5813	107	20	in	in	ADP
fnp-5813	107	21	meningiomas	meningioma	NOUN
fnp-5813	107	22	:	:	PUNCT
fnp-5813	107	23	pathological	pathological	ADJ
fnp-5813	107	24	and	and	CCONJ
fnp-5813	107	25	prognostic	prognostic	ADJ
fnp-5813	107	26	implications	implication	NOUN
fnp-5813	107	27	.	.	PUNCT
fnp-5813	108	1	frontiers	frontier	NOUN
fnp-5813	108	2	in	in	ADP
fnp-5813	108	3	oncology	oncology	NOUN
fnp-5813	108	4	11	11	NUM
fnp-5813	108	5	:	:	PUNCT
fnp-5813	108	6	611218	611218	NUM
fnp-5813	108	7	.	.	PUNCT
fnp-5813	109	1	https://doi.org/10.3389/fonc.2021.611218	https://doi.org/10.3389/fonc.2021.611218	PROPN
fnp-5813	109	2	2	2	NUM
fnp-5813	109	3	.	.	PUNCT
fnp-5813	109	4	telugu	telugu	PROPN
fnp-5813	109	5	rb	rb	PROPN
fnp-5813	109	6	,	,	PUNCT
fnp-5813	109	7	chowhan	chowhan	PROPN
fnp-5813	109	8	ak	ak	PROPN
fnp-5813	109	9	,	,	PUNCT
fnp-5813	109	10	rukmangadha	rukmangadha	NOUN
fnp-5813	109	11	n	n	CCONJ
fnp-5813	109	12	,	,	PUNCT
fnp-5813	109	13	et	et	PROPN
fnp-5813	109	14	al	al	PROPN
fnp-5813	109	15	.	.	PROPN
fnp-5813	110	1	(	(	PUNCT
fnp-5813	110	2	2020	2020	NUM
fnp-5813	110	3	)	)	PUNCT
fnp-5813	110	4	estrogen	estrogen	NOUN
fnp-5813	110	5	and	and	CCONJ
fnp-5813	110	6	progesterone	progesterone	NOUN
fnp-5813	110	7	receptor	receptor	NOUN
fnp-5813	110	8	in	in	ADP
fnp-5813	110	9	meningiomas	meningioma	NOUN
fnp-5813	110	10	:	:	PUNCT
fnp-5813	110	11	an	an	DET
fnp-5813	110	12	immunohistochemical	immunohistochemical	ADJ
fnp-5813	110	13	analysis	analysis	NOUN
fnp-5813	110	14	.	.	PUNCT
fnp-5813	111	1	j	j	PROPN
fnp-5813	111	2	cancer	cancer	NOUN
fnp-5813	111	3	res	re	NOUN
fnp-5813	111	4	ther	ther	ADV
fnp-5813	111	5	16(6	16(6	NUM
fnp-5813	111	6	):	):	PUNCT
fnp-5813	111	7	1482	1482	NUM
fnp-5813	111	8	-	-	SYM
fnp-5813	111	9	1487	1487	NUM
fnp-5813	111	10	.	.	PUNCT
fnp-5813	112	1	https://doi.org/10.4103/jcrt.jcrt_1075_16	https://doi.org/10.4103/jcrt.jcrt_1075_16	PROPN
fnp-5813	112	2	3	3	X
fnp-5813	112	3	.	.	PUNCT
fnp-5813	113	1	harland	harland	PROPN
fnp-5813	113	2	ta	ta	PROPN
fnp-5813	113	3	,	,	PUNCT
fnp-5813	113	4	freeman	freeman	PROPN
fnp-5813	113	5	jl	jl	PROPN
fnp-5813	113	6	,	,	PUNCT
fnp-5813	113	7	davern	davern	NOUN
fnp-5813	113	8	m	m	PROPN
fnp-5813	113	9	,	,	PUNCT
fnp-5813	113	10	et	et	PROPN
fnp-5813	113	11	al	al	PROPN
fnp-5813	113	12	.	.	PUNCT
fnp-5813	114	1	(	(	PUNCT
fnp-5813	114	2	2018	2018	NUM
fnp-5813	114	3	)	)	PUNCT
fnp-5813	114	4	progesterone	progesterone	NOUN
fnp-5813	114	5	-	-	PUNCT
fnp-5813	114	6	only	only	ADV
fnp-5813	114	7	contraception	contraception	NOUN
fnp-5813	114	8	is	be	AUX
fnp-5813	114	9	associated	associate	VERB
fnp-5813	114	10	with	with	ADP
fnp-5813	114	11	a	a	DET
fnp-5813	114	12	shorter	short	ADJ
fnp-5813	114	13	progression	progression	NOUN
fnp-5813	114	14	-	-	PUNCT
fnp-5813	114	15	free	free	ADJ
fnp-5813	114	16	survival	survival	NOUN
fnp-5813	114	17	in	in	ADP
fnp-5813	114	18	premenopausal	premenopausal	ADJ
fnp-5813	114	19	women	woman	NOUN
fnp-5813	114	20	with	with	ADP
fnp-5813	114	21	who	who	PRON
fnp-5813	114	22	grade	grade	VERB
fnp-5813	114	23	i	i	PRON
fnp-5813	114	24	meningioma	meningioma	VERB
fnp-5813	114	25	.	.	PUNCT
fnp-5813	115	1	j	j	PROPN
fnp-5813	115	2	neurooncol	neurooncol	PROPN
fnp-5813	115	3	136(2	136(2	NUM
fnp-5813	115	4	):	):	PUNCT
fnp-5813	115	5	327	327	NUM
fnp-5813	115	6	-	-	SYM
fnp-5813	115	7	333	333	NUM
fnp-5813	115	8	.	.	PUNCT
fnp-5813	116	1	https://doi.org/10.1007/s11060-017-2656-9	https://doi.org/10.1007/s11060-017-2656-9	NUM
fnp-5813	116	2	4	4	NUM
fnp-5813	116	3	.	.	PUNCT
fnp-5813	116	4	graillon	graillon	PROPN
fnp-5813	116	5	t	t	PROPN
fnp-5813	116	6	,	,	PUNCT
fnp-5813	116	7	boissonneau	boissonneau	PROPN
fnp-5813	116	8	s	s	PART
fnp-5813	116	9	,	,	PUNCT
fnp-5813	116	10	appay	appay	VERB
fnp-5813	116	11	r	r	NOUN
fnp-5813	116	12	,	,	PUNCT
fnp-5813	116	13	et	et	PROPN
fnp-5813	116	14	al	al	PROPN
fnp-5813	116	15	.	.	PROPN
fnp-5813	117	1	(	(	PUNCT
fnp-5813	117	2	2021	2021	NUM
fnp-5813	117	3	)	)	PUNCT
fnp-5813	117	4	meningiomas	meningioma	NOUN
fnp-5813	117	5	in	in	ADP
fnp-5813	117	6	patients	patient	NOUN
fnp-5813	117	7	with	with	ADP
fnp-5813	117	8	long	long	ADJ
fnp-5813	117	9	-	-	PUNCT
fnp-5813	117	10	term	term	NOUN
fnp-5813	117	11	exposition	exposition	NOUN
fnp-5813	117	12	to	to	ADP
fnp-5813	117	13	progestins	progestin	NOUN
fnp-5813	117	14	:	:	PUNCT
fnp-5813	117	15	characteristics	characteristic	NOUN
fnp-5813	117	16	and	and	CCONJ
fnp-5813	117	17	outcome	outcome	NOUN
fnp-5813	117	18	.	.	PUNCT
fnp-5813	118	1	neuro	neuro	PROPN
fnp-5813	118	2	-	-	PUNCT
fnp-5813	118	3	chirurgie	chirurgie	PROPN
fnp-5813	118	4	67(6	67(6	PROPN
fnp-5813	118	5	):	):	PUNCT
fnp-5813	118	6	556	556	NUM
fnp-5813	118	7	-	-	SYM
fnp-5813	118	8	563	563	NUM
fnp-5813	118	9	.	.	PUNCT
fnp-5813	119	1	https://doi.org/10.1016/j.neuchi.2021.04.018	https://doi.org/10.1016/j.neuchi.2021.04.018	PROPN
fnp-5813	119	2	5	5	NUM
fnp-5813	119	3	.	.	PUNCT
fnp-5813	119	4	hoisnard	hoisnard	PROPN
fnp-5813	119	5	l	l	PROPN
fnp-5813	119	6	,	,	PUNCT
fnp-5813	119	7	laanani	laanani	PROPN
fnp-5813	119	8	m	m	PROPN
fnp-5813	119	9	,	,	PUNCT
fnp-5813	119	10	passeri	passeri	PROPN
fnp-5813	119	11	t	t	PROPN
fnp-5813	119	12	,	,	PUNCT
fnp-5813	119	13	et	et	PROPN
fnp-5813	119	14	al	al	PROPN
fnp-5813	119	15	.	.	PROPN
fnp-5813	120	1	(	(	PUNCT
fnp-5813	120	2	2022	2022	NUM
fnp-5813	120	3	)	)	PUNCT
fnp-5813	120	4	risk	risk	NOUN
fnp-5813	120	5	of	of	ADP
fnp-5813	120	6	intracranial	intracranial	ADJ
fnp-5813	120	7	meningioma	meningioma	NOUN
fnp-5813	120	8	with	with	ADP
fnp-5813	120	9	three	three	NUM
fnp-5813	120	10	potent	potent	ADJ
fnp-5813	120	11	progestogens	progestogen	NOUN
fnp-5813	120	12	:	:	PUNCT
fnp-5813	120	13	a	a	DET
fnp-5813	120	14	population	population	NOUN
fnp-5813	120	15	-	-	PUNCT
fnp-5813	120	16	based	base	VERB
fnp-5813	120	17	case	case	NOUN
fnp-5813	120	18	-	-	PUNCT
fnp-5813	120	19	control	control	NOUN
fnp-5813	120	20	study	study	NOUN
fnp-5813	120	21	.	.	PUNCT
fnp-5813	121	1	eur	eur	PROPN
fnp-5813	121	2	j	j	PROPN
fnp-5813	121	3	neurol	neurol	PROPN
fnp-5813	121	4	in	in	ADP
fnp-5813	121	5	press	press	NOUN
fnp-5813	121	6	.	.	PUNCT
fnp-5813	122	1	https://doi.org/10.1111/ene.15423	https://doi.org/10.1111/ene.15423	PROPN
fnp-5813	122	2	6	6	NUM
fnp-5813	122	3	.	.	PUNCT
fnp-5813	122	4	samarut	samarut	PROPN
fnp-5813	122	5	e	e	NOUN
fnp-5813	122	6	,	,	PUNCT
fnp-5813	122	7	lugat	lugat	ADJ
fnp-5813	122	8	a	a	PRON
fnp-5813	122	9	,	,	PUNCT
fnp-5813	122	10	amelot	amelot	NOUN
fnp-5813	122	11	a	a	PRON
fnp-5813	122	12	,	,	PUNCT
fnp-5813	122	13	et	et	PROPN
fnp-5813	122	14	al	al	PROPN
fnp-5813	122	15	.	.	PROPN
fnp-5813	123	1	(	(	PUNCT
fnp-5813	123	2	2021	2021	NUM
fnp-5813	123	3	)	)	PUNCT
fnp-5813	123	4	meningiomas	meningioma	NOUN
fnp-5813	123	5	and	and	CCONJ
fnp-5813	123	6	cyproterone	cyproterone	NOUN
fnp-5813	123	7	acetate	acetate	NOUN
fnp-5813	123	8	:	:	PUNCT
fnp-5813	123	9	a	a	DET
fnp-5813	123	10	retrospective	retrospective	ADJ
fnp-5813	123	11	,	,	PUNCT
fnp-5813	123	12	monocentric	monocentric	ADJ
fnp-5813	123	13	cohort	cohort	NOUN
fnp-5813	123	14	of	of	ADP
fnp-5813	123	15	388	388	NUM
fnp-5813	123	16	patients	patient	NOUN
fnp-5813	123	17	treated	treat	VERB
fnp-5813	123	18	by	by	ADP
fnp-5813	123	19	surgery	surgery	NOUN
fnp-5813	123	20	or	or	CCONJ
fnp-5813	123	21	radiotherapy	radiotherapy	NOUN
fnp-5813	123	22	for	for	ADP
fnp-5813	123	23	intracranial	intracranial	ADJ
fnp-5813	123	24	meningioma	meningioma	NOUN
fnp-5813	123	25	.	.	PUNCT
fnp-5813	124	1	j	j	PROPN
fnp-5813	124	2	neurooncol	neurooncol	PROPN
fnp-5813	124	3	152(1	152(1	NUM
fnp-5813	124	4	):	):	PUNCT
fnp-5813	124	5	115	115	NUM
fnp-5813	124	6	-	-	SYM
fnp-5813	124	7	123	123	NUM
fnp-5813	124	8	.	.	PUNCT
fnp-5813	125	1	https://doi.org/10.1007/s11060-020-03683-6	https://doi.org/10.1007/s11060-020-03683-6	PROPN
fnp-5813	125	2	7	7	NUM
fnp-5813	125	3	.	.	PUNCT
fnp-5813	126	1	nguyen	nguyen	PROPN
fnp-5813	126	2	p	p	X
fnp-5813	126	3	,	,	PUNCT
fnp-5813	126	4	roland	roland	PROPN
fnp-5813	126	5	n	n	CCONJ
fnp-5813	126	6	,	,	PUNCT
fnp-5813	126	7	neumann	neumann	PROPN
fnp-5813	126	8	a	a	PROPN
fnp-5813	126	9	,	,	PUNCT
fnp-5813	126	10	et	et	PROPN
fnp-5813	126	11	al	al	PROPN
fnp-5813	126	12	.	.	PROPN
fnp-5813	127	1	(	(	PUNCT
fnp-5813	127	2	2024	2024	NUM
fnp-5813	127	3	)	)	PUNCT
fnp-5813	127	4	prolonged	prolonged	ADJ
fnp-5813	127	5	use	use	NOUN
fnp-5813	127	6	of	of	ADP
fnp-5813	127	7	nomegestrol	nomegestrol	NOUN
fnp-5813	127	8	acetate	acetate	NOUN
fnp-5813	127	9	and	and	CCONJ
fnp-5813	127	10	risk	risk	NOUN
fnp-5813	127	11	of	of	ADP
fnp-5813	127	12	intracranial	intracranial	ADJ
fnp-5813	127	13	meningioma	meningioma	NOUN
fnp-5813	127	14	:	:	PUNCT
fnp-5813	127	15	a	a	DET
fnp-5813	127	16	population	population	NOUN
fnp-5813	127	17	-	-	PUNCT
fnp-5813	127	18	based	base	VERB
fnp-5813	127	19	cohort	cohort	NOUN
fnp-5813	127	20	study	study	NOUN
fnp-5813	127	21	.	.	PUNCT
fnp-5813	128	1	lancet	lancet	PROPN
fnp-5813	128	2	reg	reg	PROPN
fnp-5813	128	3	health	health	PROPN
fnp-5813	128	4	eur	eur	PROPN
fnp-5813	128	5	42	42	NUM
fnp-5813	128	6	:	:	SYM
fnp-5813	128	7	100928	100928	NUM
fnp-5813	128	8	.	.	PUNCT
fnp-5813	129	1	https://doi.org/10.1016/j.lanepe.2024.100928	https://doi.org/10.1016/j.lanepe.2024.100928	PROPN
fnp-5813	129	2	8	8	NUM
fnp-5813	129	3	.	.	PUNCT
fnp-5813	130	1	florea	florea	PROPN
fnp-5813	130	2	sm	sm	PROPN
fnp-5813	130	3	,	,	PUNCT
fnp-5813	130	4	passeri	passeri	PROPN
fnp-5813	130	5	t	t	PROPN
fnp-5813	130	6	,	,	PUNCT
fnp-5813	130	7	abbritti	abbritti	PROPN
fnp-5813	130	8	r	r	PROPN
fnp-5813	130	9	,	,	PUNCT
fnp-5813	130	10	et	et	PROPN
fnp-5813	130	11	al	al	PROPN
fnp-5813	130	12	.	.	PROPN
fnp-5813	130	13	(	(	PUNCT
fnp-5813	130	14	2023	2023	NUM
fnp-5813	130	15	)	)	PUNCT
fnp-5813	130	16	opposed	oppose	VERB
fnp-5813	130	17	evolution	evolution	NOUN
fnp-5813	130	18	of	of	ADP
fnp-5813	130	19	the	the	DET
fnp-5813	130	20	osseous	osseous	ADJ
fnp-5813	130	21	and	and	CCONJ
fnp-5813	130	22	soft	soft	ADJ
fnp-5813	130	23	parts	part	NOUN
fnp-5813	130	24	of	of	ADP
fnp-5813	130	25	progestin	progestin	NOUN
fnp-5813	130	26	-	-	PUNCT
fnp-5813	130	27	associated	associate	VERB
fnp-5813	130	28	osteomeningioma	osteomeningioma	NOUN
fnp-5813	130	29	after	after	ADP
fnp-5813	130	30	progestin	progestin	NOUN
fnp-5813	130	31	intake	intake	NOUN
fnp-5813	130	32	discontinuation	discontinuation	NOUN
fnp-5813	130	33	.	.	PUNCT
fnp-5813	131	1	journal	journal	NOUN
fnp-5813	131	2	of	of	ADP
fnp-5813	131	3	neurosurgery	neurosurgery	PROPN
fnp-5813	131	4	139(4	139(4	NUM
fnp-5813	131	5	):	):	PUNCT
fnp-5813	131	6	944	944	NUM
fnp-5813	131	7	-	-	SYM
fnp-5813	131	8	952	952	NUM
fnp-5813	131	9	.	.	PUNCT
fnp-5813	132	1	https://doi.org/10.3171/2022.12.jns222006	https://doi.org/10.3171/2022.12.jns222006	PROPN
fnp-5813	132	2	9	9	NUM
fnp-5813	132	3	.	.	PUNCT
fnp-5813	132	4	roland	roland	PROPN
fnp-5813	132	5	n	n	PROPN
fnp-5813	132	6	,	,	PUNCT
fnp-5813	132	7	neumann	neumann	PROPN
fnp-5813	132	8	a	a	PRON
fnp-5813	132	9	,	,	PUNCT
fnp-5813	132	10	hoisnard	hoisnard	NOUN
fnp-5813	132	11	l	l	PROPN
fnp-5813	132	12	,	,	PUNCT
fnp-5813	132	13	et	et	PROPN
fnp-5813	132	14	al	al	PROPN
fnp-5813	132	15	.	.	PROPN
fnp-5813	133	1	(	(	PUNCT
fnp-5813	133	2	2024	2024	NUM
fnp-5813	133	3	)	)	PUNCT
fnp-5813	133	4	use	use	NOUN
fnp-5813	133	5	of	of	ADP
fnp-5813	133	6	progestogens	progestogen	NOUN
fnp-5813	133	7	and	and	CCONJ
fnp-5813	133	8	the	the	DET
fnp-5813	133	9	risk	risk	NOUN
fnp-5813	133	10	of	of	ADP
fnp-5813	133	11	intracranial	intracranial	ADJ
fnp-5813	133	12	meningioma	meningioma	NOUN
fnp-5813	133	13	:	:	PUNCT
fnp-5813	133	14	national	national	ADJ
fnp-5813	133	15	case	case	NOUN
fnp-5813	133	16	-	-	PUNCT
fnp-5813	133	17	control	control	NOUN
fnp-5813	133	18	study	study	NOUN
fnp-5813	133	19	.	.	PUNCT
fnp-5813	134	1	bmj	bmj	PROPN
fnp-5813	134	2	(	(	PUNCT
fnp-5813	134	3	clinical	clinical	ADJ
fnp-5813	134	4	research	research	NOUN
fnp-5813	134	5	ed	ed	NOUN
fnp-5813	134	6	)	)	PUNCT
fnp-5813	134	7	384	384	NUM
fnp-5813	134	8	:	:	PUNCT
fnp-5813	134	9	e078078	e078078	PROPN
fnp-5813	134	10	.	.	PUNCT
fnp-5813	134	11	https://doi.org/10.1136/bmj-2023-078078	https://doi.org/10.1136/bmj-2023-078078	PROPN
fnp-5813	134	12	10	10	NUM
fnp-5813	134	13	.	.	PUNCT
fnp-5813	135	1	raj	raj	PROPN
fnp-5813	135	2	r	r	PROPN
fnp-5813	135	3	,	,	PUNCT
fnp-5813	135	4	korja	korja	NOUN
fnp-5813	135	5	m	m	NOUN
fnp-5813	135	6	,	,	PUNCT
fnp-5813	135	7	koroknay	koroknay	ADJ
fnp-5813	135	8	-	-	PUNCT
fnp-5813	135	9	pál	pál	PROPN
fnp-5813	135	10	p	p	NOUN
fnp-5813	135	11	,	,	PUNCT
fnp-5813	135	12	niemelä	niemelä	NOUN
fnp-5813	135	13	m	m	PROPN
fnp-5813	135	14	(	(	PUNCT
fnp-5813	135	15	2018	2018	NUM
fnp-5813	135	16	)	)	PUNCT
fnp-5813	135	17	multiple	multiple	ADJ
fnp-5813	135	18	meningiomas	meningioma	NOUN
fnp-5813	135	19	in	in	ADP
fnp-5813	135	20	two	two	NUM
fnp-5813	135	21	male	male	NOUN
fnp-5813	135	22	-	-	PUNCT
fnp-5813	135	23	to	to	ADP
fnp-5813	135	24	-	-	PUNCT
fnp-5813	135	25	female	female	ADJ
fnp-5813	135	26	transsexual	transsexual	ADJ
fnp-5813	135	27	patients	patient	NOUN
fnp-5813	135	28	with	with	ADP
fnp-5813	135	29	hormone	hormone	NOUN
fnp-5813	135	30	replacement	replacement	NOUN
fnp-5813	135	31	therapy	therapy	NOUN
fnp-5813	135	32	:	:	PUNCT
fnp-5813	135	33	a	a	DET
fnp-5813	135	34	report	report	NOUN
fnp-5813	135	35	of	of	ADP
fnp-5813	135	36	two	two	NUM
fnp-5813	135	37	cases	case	NOUN
fnp-5813	135	38	and	and	CCONJ
fnp-5813	135	39	a	a	DET
fnp-5813	135	40	brief	brief	ADJ
fnp-5813	135	41	literature	literature	NOUN
fnp-5813	135	42	review	review	PROPN
fnp-5813	135	43	.	.	PUNCT
fnp-5813	136	1	surg	surg	PROPN
fnp-5813	136	2	neurol	neurol	PROPN
fnp-5813	136	3	int	int	PROPN
fnp-5813	136	4	9	9	NUM
fnp-5813	136	5	:	:	SYM
fnp-5813	136	6	109	109	NUM
fnp-5813	136	7	.	.	PUNCT
fnp-5813	137	1	https://doi.org/10.4103/sni.sni_22_18	https://doi.org/10.4103/sni.sni_22_18	PROPN
fnp-5813	137	2	11	11	NUM
fnp-5813	137	3	.	.	PUNCT
fnp-5813	138	1	peyre	peyre	PROPN
fnp-5813	138	2	m	m	PROPN
fnp-5813	138	3	,	,	PUNCT
fnp-5813	138	4	gaillard	gaillard	PROPN
fnp-5813	138	5	s	s	PROPN
fnp-5813	138	6	,	,	PUNCT
fnp-5813	138	7	de	de	X
fnp-5813	138	8	marcellus	marcellus	PROPN
fnp-5813	138	9	c	c	X
fnp-5813	138	10	,	,	PUNCT
fnp-5813	138	11	et	et	PROPN
fnp-5813	138	12	al	al	PROPN
fnp-5813	138	13	.	.	PUNCT
fnp-5813	139	1	(	(	PUNCT
fnp-5813	139	2	2018	2018	NUM
fnp-5813	139	3	)	)	PUNCT
fnp-5813	139	4	progestin	progestin	NOUN
fnp-5813	139	5	-	-	PUNCT
fnp-5813	139	6	associated	associate	VERB
fnp-5813	139	7	shift	shift	NOUN
fnp-5813	139	8	of	of	ADP
fnp-5813	139	9	meningioma	meningioma	ADJ
fnp-5813	139	10	mutational	mutational	ADJ
fnp-5813	139	11	landscape	landscape	NOUN
fnp-5813	139	12	.	.	PUNCT
fnp-5813	140	1	ann	ann	PROPN
fnp-5813	140	2	oncol	oncol	PROPN
fnp-5813	140	3	29(3	29(3	NUM
fnp-5813	140	4	):	):	PUNCT
fnp-5813	140	5	681	681	NUM
fnp-5813	140	6	-	-	SYM
fnp-5813	140	7	686	686	NUM
fnp-5813	140	8	.	.	PUNCT
fnp-5813	141	1	https://doi.org/10.1093/annonc/mdx763	https://doi.org/10.1093/annonc/mdx763	ADJ
fnp-5813	141	2	12	12	NUM
fnp-5813	141	3	.	.	PUNCT
fnp-5813	142	1	samoyeau	samoyeau	PROPN
fnp-5813	142	2	t	t	PROPN
fnp-5813	142	3	,	,	PUNCT
fnp-5813	142	4	provost	provost	NOUN
fnp-5813	142	5	c	c	NOUN
fnp-5813	142	6	,	,	PUNCT
fnp-5813	142	7	roux	roux	VERB
fnp-5813	142	8	a	a	PRON
fnp-5813	142	9	,	,	PUNCT
fnp-5813	142	10	et	et	PROPN
fnp-5813	142	11	al	al	PROPN
fnp-5813	142	12	.	.	PROPN
fnp-5813	143	1	(	(	PUNCT
fnp-5813	143	2	2022	2022	NUM
fnp-5813	143	3	)	)	PUNCT
fnp-5813	143	4	meningioma	meningioma	NOUN
fnp-5813	143	5	in	in	ADP
fnp-5813	143	6	patients	patient	NOUN
fnp-5813	143	7	exposed	expose	VERB
fnp-5813	143	8	to	to	ADP
fnp-5813	143	9	progestin	progestin	NOUN
fnp-5813	143	10	drugs	drug	NOUN
fnp-5813	143	11	:	:	PUNCT
fnp-5813	143	12	results	result	VERB
fnp-5813	143	13	from	from	ADP
fnp-5813	143	14	a	a	DET
fnp-5813	143	15	real	real	ADJ
fnp-5813	143	16	-	-	PUNCT
fnp-5813	143	17	life	life	NOUN
fnp-5813	143	18	screening	screening	NOUN
fnp-5813	143	19	program	program	NOUN
fnp-5813	143	20	.	.	PUNCT
fnp-5813	144	1	j	j	PROPN
fnp-5813	144	2	neurooncol	neurooncol	PROPN
fnp-5813	144	3	160(1	160(1	NUM
fnp-5813	144	4	):	):	PUNCT
fnp-5813	144	5	127	127	NUM
fnp-5813	144	6	-	-	SYM
fnp-5813	144	7	136	136	NUM
fnp-5813	144	8	.	.	PUNCT
fnp-5813	145	1	https://doi.org/10.1007/s11060-022-04124-2	https://doi.org/10.1007/s11060-022-04124-2	NOUN
fnp-5813	145	2	13	13	NUM
fnp-5813	145	3	.	.	PUNCT
fnp-5813	146	1	passeri	passeri	PROPN
fnp-5813	146	2	t	t	PROPN
fnp-5813	146	3	,	,	PUNCT
fnp-5813	146	4	giammattei	giammattei	NOUN
fnp-5813	146	5	l	l	NOUN
fnp-5813	146	6	,	,	PUNCT
fnp-5813	146	7	le	le	PROPN
fnp-5813	146	8	van	van	PROPN
fnp-5813	146	9	t	t	PROPN
fnp-5813	146	10	,	,	PUNCT
fnp-5813	146	11	et	et	PROPN
fnp-5813	146	12	al	al	PROPN
fnp-5813	146	13	.	.	PROPN
fnp-5813	147	1	(	(	PUNCT
fnp-5813	147	2	2022	2022	NUM
fnp-5813	147	3	)	)	PUNCT
fnp-5813	147	4	atypical	atypical	ADJ
fnp-5813	147	5	evolution	evolution	NOUN
fnp-5813	147	6	of	of	ADP
fnp-5813	147	7	meningiomatosis	meningiomatosis	NOUN
fnp-5813	147	8	after	after	ADP
fnp-5813	147	9	discontinuation	discontinuation	NOUN
fnp-5813	147	10	of	of	ADP
fnp-5813	147	11	cyproterone	cyproterone	NOUN
fnp-5813	147	12	acetate	acetate	NOUN
fnp-5813	147	13	:	:	PUNCT
fnp-5813	147	14	clinical	clinical	ADJ
fnp-5813	147	15	cases	case	NOUN
fnp-5813	147	16	and	and	CCONJ
fnp-5813	147	17	histomolecular	histomolecular	ADJ
fnp-5813	147	18	characterization	characterization	NOUN
fnp-5813	147	19	.	.	PUNCT
fnp-5813	148	1	acta	acta	PROPN
fnp-5813	148	2	neurochir	neurochir	PROPN
fnp-5813	148	3	(	(	PUNCT
fnp-5813	148	4	wien	wien	PROPN
fnp-5813	148	5	)	)	PUNCT
fnp-5813	148	6	164(1	164(1	NUM
fnp-5813	148	7	):	):	PUNCT
fnp-5813	148	8	255	255	NUM
fnp-5813	148	9	-	-	SYM
fnp-5813	148	10	263	263	NUM
fnp-5813	148	11	.	.	PUNCT
fnp-5813	149	1	https://doi.org/10.1007/s00701-021-05005-9	https://doi.org/10.1007/s00701-021-05005-9	NUM
fnp-5813	149	2	14	14	NUM
fnp-5813	149	3	.	.	PUNCT
fnp-5813	150	1	abijaoude	abijaoude	PROPN
fnp-5813	150	2	s	s	NOUN
fnp-5813	150	3	,	,	PUNCT
fnp-5813	150	4	marijon	marijon	NOUN
fnp-5813	150	5	p	p	NOUN
fnp-5813	150	6	,	,	PUNCT
fnp-5813	150	7	roblot	roblot	NOUN
fnp-5813	150	8	p	p	NOUN
fnp-5813	150	9	,	,	PUNCT
fnp-5813	150	10	et	et	PROPN
fnp-5813	150	11	al	al	PROPN
fnp-5813	150	12	.	.	PROPN
fnp-5813	150	13	(	(	PUNCT
fnp-5813	150	14	2021	2021	NUM
fnp-5813	150	15	)	)	PUNCT
fnp-5813	150	16	sustained	sustain	VERB
fnp-5813	150	17	growth	growth	NOUN
fnp-5813	150	18	of	of	ADP
fnp-5813	150	19	intraosseous	intraosseous	ADJ
fnp-5813	150	20	hormone	hormone	NOUN
fnp-5813	150	21	-	-	PUNCT
fnp-5813	150	22	associated	associate	VERB
fnp-5813	150	23	meningiomas	meningioma	NOUN
fnp-5813	150	24	after	after	ADP
fnp-5813	150	25	cessation	cessation	NOUN
fnp-5813	150	26	of	of	ADP
fnp-5813	150	27	progestin	progestin	NOUN
fnp-5813	150	28	therapy	therapy	NOUN
fnp-5813	150	29	.	.	PUNCT
fnp-5813	151	1	acta	acta	PROPN
fnp-5813	151	2	neurochir	neurochir	PROPN
fnp-5813	151	3	163(6	163(6	NUM
fnp-5813	151	4	):	):	PUNCT
fnp-5813	151	5	1705	1705	NUM
fnp-5813	151	6	-	-	SYM
fnp-5813	151	7	1710	1710	NUM
fnp-5813	151	8	.	.	PUNCT
fnp-5813	152	1	https://doi.org/10.1007/s00701-021-04781-8	https://doi.org/10.1007/s00701-021-04781-8	PROPN
fnp-5813	152	2	15	15	NUM
fnp-5813	152	3	.	.	PUNCT
fnp-5813	153	1	ji	ji	PROPN
fnp-5813	153	2	y	y	PROPN
fnp-5813	153	3	,	,	PUNCT
fnp-5813	153	4	rankin	rankin	PROPN
fnp-5813	153	5	c	c	PROPN
fnp-5813	153	6	,	,	PUNCT
fnp-5813	153	7	grunberg	grunberg	VERB
fnp-5813	153	8	s	s	PART
fnp-5813	153	9	,	,	PUNCT
fnp-5813	153	10	et	et	PROPN
fnp-5813	153	11	al	al	PROPN
fnp-5813	153	12	.	.	PROPN
fnp-5813	154	1	(	(	PUNCT
fnp-5813	154	2	2015	2015	NUM
fnp-5813	154	3	)	)	PUNCT
fnp-5813	154	4	double	double	ADJ
fnp-5813	154	5	-	-	PUNCT
fnp-5813	154	6	blind	blind	ADJ
fnp-5813	154	7	phase	phase	NOUN
fnp-5813	154	8	iii	iii	NUM
fnp-5813	154	9	randomized	randomized	ADJ
fnp-5813	154	10	trial	trial	NOUN
fnp-5813	154	11	of	of	ADP
fnp-5813	154	12	the	the	DET
fnp-5813	154	13	antiprogestin	antiprogestin	ADJ
fnp-5813	154	14	agent	agent	NOUN
fnp-5813	154	15	mifepristone	mifepristone	NOUN
fnp-5813	154	16	in	in	ADP
fnp-5813	154	17	the	the	DET
fnp-5813	154	18	treatment	treatment	NOUN
fnp-5813	154	19	of	of	ADP
fnp-5813	154	20	unresectable	unresectable	ADJ
fnp-5813	154	21	meningioma	meningioma	NOUN
fnp-5813	154	22	:	:	PUNCT
fnp-5813	154	23	swog	swog	NOUN
fnp-5813	154	24	s9005	s9005	PROPN
fnp-5813	154	25	.	.	PUNCT
fnp-5813	155	1	j	j	PROPN
fnp-5813	155	2	clin	clin	PROPN
fnp-5813	155	3	oncol	oncol	PROPN
fnp-5813	155	4	33(34	33(34	PROPN
fnp-5813	155	5	):	):	PUNCT
fnp-5813	155	6	4093	4093	NUM
fnp-5813	155	7	-	-	SYM
fnp-5813	155	8	4098	4098	NUM
fnp-5813	155	9	.	.	PUNCT
fnp-5813	156	1	https://doi.org/10.1200/jco.2015.61.6490	https://doi.org/10.1200/jco.2015.61.6490	PROPN
fnp-5813	156	2	16	16	NUM
fnp-5813	156	3	.	.	PUNCT
fnp-5813	157	1	roncaroli	roncaroli	PROPN
fnp-5813	157	2	f	f	PROPN
fnp-5813	157	3	,	,	PUNCT
fnp-5813	157	4	scheithauer	scheithauer	NOUN
fnp-5813	157	5	bw	bw	NOUN
fnp-5813	157	6	,	,	PUNCT
fnp-5813	157	7	laeng	laeng	PROPN
fnp-5813	157	8	rh	rh	PROPN
fnp-5813	157	9	,	,	PUNCT
fnp-5813	157	10	cenacchi	cenacchi	PROPN
fnp-5813	157	11	g	g	PROPN
fnp-5813	157	12	,	,	PUNCT
fnp-5813	157	13	abell	abell	NOUN
fnp-5813	157	14	-	-	PUNCT
fnp-5813	157	15	aleff	aleff	NOUN
fnp-5813	157	16	p	p	NOUN
fnp-5813	157	17	,	,	PUNCT
fnp-5813	157	18	moschopulos	moschopulo	NOUN
fnp-5813	157	19	m	m	PROPN
fnp-5813	157	20	(	(	PUNCT
fnp-5813	157	21	2001	2001	NUM
fnp-5813	157	22	)	)	PUNCT
fnp-5813	157	23	lipomatous	lipomatous	ADJ
fnp-5813	157	24	meningioma	meningioma	NOUN
fnp-5813	157	25	:	:	PUNCT
fnp-5813	157	26	a	a	DET
fnp-5813	157	27	clinicopathologic	clinicopathologic	ADJ
fnp-5813	157	28	study	study	NOUN
fnp-5813	157	29	of	of	ADP
fnp-5813	157	30	18	18	NUM
fnp-5813	157	31	cases	case	NOUN
fnp-5813	157	32	with	with	ADP
fnp-5813	157	33	special	special	ADJ
fnp-5813	157	34	reference	reference	NOUN
fnp-5813	157	35	to	to	ADP
fnp-5813	157	36	the	the	DET
fnp-5813	157	37	issue	issue	NOUN
fnp-5813	157	38	of	of	ADP
fnp-5813	157	39	metaplasia	metaplasia	PROPN
fnp-5813	157	40	.	.	PUNCT
fnp-5813	157	41	am	be	AUX
fnp-5813	157	42	j	j	PROPN
fnp-5813	157	43	surg	surg	NOUN
fnp-5813	157	44	pathol	pathol	VERB
fnp-5813	157	45	25(6	25(6	NUM
fnp-5813	157	46	):	):	PUNCT
fnp-5813	157	47	769	769	NUM
fnp-5813	157	48	-	-	SYM
fnp-5813	157	49	775	775	NUM
fnp-5813	157	50	.	.	PUNCT
fnp-5813	158	1	https://doi.org/10.1097/00000478-200106000-00008	https://doi.org/10.1097/00000478-200106000-00008	NUM
fnp-5813	158	2	17	17	NUM
fnp-5813	158	3	.	.	PUNCT
fnp-5813	159	1	wong	wong	PROPN
fnp-5813	159	2	yp	yp	PROPN
fnp-5813	159	3	,	,	PUNCT
fnp-5813	159	4	tan	tan	PROPN
fnp-5813	159	5	gc	gc	PROPN
fnp-5813	159	6	,	,	PUNCT
fnp-5813	159	7	kumar	kumar	PROPN
fnp-5813	159	8	r	r	PROPN
fnp-5813	159	9	(	(	PUNCT
fnp-5813	159	10	2018	2018	NUM
fnp-5813	159	11	)	)	PUNCT
fnp-5813	159	12	xanthomatous	xanthomatous	ADJ
fnp-5813	159	13	meningioma	meningioma	NOUN
fnp-5813	159	14	:	:	PUNCT
fnp-5813	159	15	a	a	DET
fnp-5813	159	16	metaplastic	metaplastic	ADJ
fnp-5813	159	17	or	or	CCONJ
fnp-5813	159	18	degenerative	degenerative	ADJ
fnp-5813	159	19	phenomenon	phenomenon	NOUN
fnp-5813	159	20	?	?	PUNCT
fnp-5813	160	1	neuropathology	neuropathology	NOUN
fnp-5813	160	2	:	:	PUNCT
fnp-5813	160	3	official	official	ADJ
fnp-5813	160	4	journal	journal	NOUN
fnp-5813	160	5	of	of	ADP
fnp-5813	160	6	the	the	DET
fnp-5813	160	7	japanese	japanese	ADJ
fnp-5813	160	8	society	society	NOUN
fnp-5813	160	9	of	of	ADP
fnp-5813	160	10	neuropathology	neuropathology	NOUN
fnp-5813	160	11	38(6	38(6	NOUN
fnp-5813	160	12	):	):	PUNCT
fnp-5813	160	13	619	619	NUM
fnp-5813	160	14	-	-	SYM
fnp-5813	160	15	623	623	NUM
fnp-5813	160	16	.	.	PUNCT
fnp-5813	161	1	https://doi.org/10.1111/neup.12511	https://doi.org/10.1111/neup.12511	PROPN
fnp-5813	161	2	18	18	NUM
fnp-5813	161	3	.	.	PUNCT
fnp-5813	162	1	montine	montine	PROPN
fnp-5813	162	2	tj	tj	PROPN
fnp-5813	162	3	,	,	PUNCT
fnp-5813	162	4	phelps	phelps	PROPN
fnp-5813	162	5	ch	ch	PROPN
fnp-5813	162	6	,	,	PUNCT
fnp-5813	162	7	beach	beach	PROPN
fnp-5813	162	8	tg	tg	PROPN
fnp-5813	162	9	,	,	PUNCT
fnp-5813	162	10	et	et	PROPN
fnp-5813	162	11	al	al	PROPN
fnp-5813	162	12	.	.	PROPN
fnp-5813	162	13	(	(	PUNCT
fnp-5813	162	14	2012	2012	NUM
fnp-5813	162	15	)	)	PUNCT
fnp-5813	162	16	national	national	PROPN
fnp-5813	162	17	institute	institute	NOUN
fnp-5813	162	18	on	on	ADP
fnp-5813	162	19	aging	age	VERB
fnp-5813	162	20	-	-	PUNCT
fnp-5813	162	21	alzheimer	alzheimer	NOUN
fnp-5813	162	22	's	's	PART
fnp-5813	162	23	association	association	NOUN
fnp-5813	162	24	guidelines	guideline	NOUN
fnp-5813	162	25	for	for	ADP
fnp-5813	162	26	the	the	DET
fnp-5813	162	27	neuropathologic	neuropathologic	ADJ
fnp-5813	162	28	assessment	assessment	NOUN
fnp-5813	162	29	of	of	ADP
fnp-5813	162	30	alzheimer	alzheimer	PROPN
fnp-5813	162	31	's	's	PART
fnp-5813	162	32	disease	disease	NOUN
fnp-5813	162	33	:	:	PUNCT
fnp-5813	162	34	a	a	DET
fnp-5813	162	35	practical	practical	ADJ
fnp-5813	162	36	approach	approach	NOUN
fnp-5813	162	37	.	.	PUNCT
fnp-5813	163	1	acta	acta	PROPN
fnp-5813	163	2	neuropathol	neuropathol	PROPN
fnp-5813	163	3	123(1	123(1	NUM
fnp-5813	163	4	):	):	PUNCT
fnp-5813	163	5	1	1	NUM
fnp-5813	163	6	-	-	SYM
fnp-5813	163	7	11	11	NUM
fnp-5813	163	8	.	.	PUNCT
fnp-5813	164	1	https://doi.org/10.1007/s00401-011-0910-3	https://doi.org/10.1007/s00401-011-0910-3	NUM
fnp-5813	164	2	19	19	NUM
fnp-5813	164	3	.	.	PUNCT
fnp-5813	165	1	oura	oura	PROPN
fnp-5813	165	2	s	s	PROPN
fnp-5813	165	3	,	,	PUNCT
fnp-5813	165	4	sakurai	sakurai	PROPN
fnp-5813	165	5	t	t	PROPN
fnp-5813	165	6	,	,	PUNCT
fnp-5813	165	7	yoshimura	yoshimura	VERB
fnp-5813	165	8	g	g	NOUN
fnp-5813	165	9	,	,	PUNCT
fnp-5813	165	10	et	et	PROPN
fnp-5813	165	11	al	al	PROPN
fnp-5813	165	12	.	.	PUNCT
fnp-5813	166	1	(	(	PUNCT
fnp-5813	166	2	2000	2000	NUM
fnp-5813	166	3	)	)	PUNCT
fnp-5813	166	4	regression	regression	NOUN
fnp-5813	166	5	of	of	ADP
fnp-5813	166	6	a	a	DET
fnp-5813	166	7	presumed	presume	VERB
fnp-5813	166	8	meningioma	meningioma	NOUN
fnp-5813	166	9	with	with	ADP
fnp-5813	166	10	the	the	DET
fnp-5813	166	11	antiestrogen	antiestrogen	ADJ
fnp-5813	166	12	agent	agent	NOUN
fnp-5813	166	13	mepitiostane	mepitiostane	NOUN
fnp-5813	166	14	.	.	PUNCT
fnp-5813	167	1	case	case	NOUN
fnp-5813	167	2	report	report	NOUN
fnp-5813	167	3	.	.	PUNCT
fnp-5813	168	1	journal	journal	NOUN
fnp-5813	168	2	of	of	ADP
fnp-5813	168	3	neurosurgery	neurosurgery	NOUN
fnp-5813	168	4	93(1	93(1	NUM
fnp-5813	168	5	):	):	PUNCT
fnp-5813	168	6	132	132	NUM
fnp-5813	168	7	-	-	SYM
fnp-5813	168	8	135	135	NUM
fnp-5813	168	9	.	.	PUNCT
fnp-5813	169	1	https://doi.org/10.3171/jns.2000.93.1.0132	https://doi.org/10.3171/jns.2000.93.1.0132	NOUN
fnp-5813	169	2	20	20	NUM
fnp-5813	169	3	.	.	PUNCT
fnp-5813	170	1	chakravarthy	chakravarthy	ADJ
fnp-5813	170	2	v	v	PROPN
fnp-5813	170	3	,	,	PUNCT
fnp-5813	170	4	kaplan	kaplan	PROPN
fnp-5813	170	5	b	b	PROPN
fnp-5813	170	6	,	,	PUNCT
fnp-5813	170	7	gospodarev	gospodarev	VERB
fnp-5813	170	8	v	v	NOUN
fnp-5813	170	9	,	,	PUNCT
fnp-5813	170	10	myers	myers	PROPN
fnp-5813	170	11	h	h	PROPN
fnp-5813	170	12	,	,	PUNCT
fnp-5813	170	13	de	de	PROPN
fnp-5813	171	1	los	los	PROPN
fnp-5813	171	2	reyes	reyes	PROPN
fnp-5813	171	3	k	k	PROPN
fnp-5813	171	4	,	,	PUNCT
fnp-5813	171	5	achiriloaie	achiriloaie	PROPN
fnp-5813	171	6	a	a	DET
fnp-5813	171	7	(	(	PUNCT
fnp-5813	171	8	2018	2018	NUM
fnp-5813	171	9	)	)	PUNCT
fnp-5813	171	10	houdini	houdini	NOUN
fnp-5813	171	11	tumor	tumor	NOUN
fnp-5813	171	12	:	:	PUNCT
fnp-5813	171	13	case	case	NOUN
fnp-5813	171	14	report	report	NOUN
fnp-5813	171	15	and	and	CCONJ
fnp-5813	171	16	literature	literature	NOUN
fnp-5813	171	17	review	review	NOUN
fnp-5813	171	18	of	of	ADP
fnp-5813	171	19	pregnancy	pregnancy	NOUN
fnp-5813	171	20	-	-	PUNCT
fnp-5813	171	21	associated	associate	VERB
fnp-5813	171	22	meningioma	meningioma	NOUN
fnp-5813	171	23	.	.	PUNCT
fnp-5813	172	1	world	world	NOUN
fnp-5813	172	2	neurosurgery	neurosurgery	NOUN
fnp-5813	172	3	114	114	NUM
fnp-5813	172	4	:	:	PUNCT
fnp-5813	172	5	e1261	e1261	NOUN
fnp-5813	172	6	-	-	PUNCT
fnp-5813	172	7	e1265	e1265	NOUN
fnp-5813	172	8	.	.	PUNCT
fnp-5813	173	1	https://doi.org/10.1016/j.wneu.2018.03.187	https://doi.org/10.1016/j.wneu.2018.03.187	PROPN
fnp-5813	173	2	21	21	NUM
fnp-5813	173	3	.	.	PUNCT
fnp-5813	174	1	takada	takada	PROPN
fnp-5813	174	2	m	m	PROPN
fnp-5813	174	3	,	,	PUNCT
fnp-5813	174	4	yanaka	yanaka	ADV
fnp-5813	174	5	k	k	PROPN
fnp-5813	174	6	,	,	PUNCT
fnp-5813	174	7	nakamura	nakamura	PROPN
fnp-5813	174	8	k	k	PROPN
fnp-5813	174	9	,	,	PUNCT
fnp-5813	174	10	akimoto	akimoto	PROPN
fnp-5813	174	11	k	k	PROPN
fnp-5813	174	12	,	,	PUNCT
fnp-5813	174	13	takeda	takeda	PROPN
fnp-5813	174	14	h	h	PROPN
fnp-5813	174	15	,	,	PUNCT
fnp-5813	174	16	ishikawa	ishikawa	PROPN
fnp-5813	174	17	e	e	PROPN
fnp-5813	174	18	(	(	PUNCT
fnp-5813	174	19	2022	2022	NUM
fnp-5813	174	20	)	)	PUNCT
fnp-5813	174	21	spontaneous	spontaneous	ADJ
fnp-5813	174	22	regression	regression	NOUN
fnp-5813	174	23	of	of	ADP
fnp-5813	174	24	a	a	DET
fnp-5813	174	25	posterior	posterior	ADJ
fnp-5813	174	26	fossa	fossa	ADJ
fnp-5813	174	27	meningioma	meningioma	NOUN
fnp-5813	174	28	:	:	PUNCT
fnp-5813	174	29	a	a	DET
fnp-5813	174	30	case	case	NOUN
fnp-5813	174	31	report	report	NOUN
fnp-5813	174	32	.	.	PUNCT
fnp-5813	175	1	surg	surg	PROPN
fnp-5813	175	2	neurol	neurol	PROPN
fnp-5813	175	3	int	int	PROPN
fnp-5813	175	4	13	13	NUM
fnp-5813	175	5	:	:	SYM
fnp-5813	175	6	334	334	NUM
fnp-5813	175	7	.	.	PUNCT
fnp-5813	176	1	https://doi.org/10.25259/sni_429_2022	https://doi.org/10.25259/sni_429_2022	NOUN
fnp-5813	176	2	22	22	NUM
fnp-5813	176	3	.	.	PUNCT
fnp-5813	177	1	hirota	hirota	PROPN
fnp-5813	177	2	k	k	PROPN
fnp-5813	177	3	,	,	PUNCT
fnp-5813	177	4	fujita	fujita	PROPN
fnp-5813	177	5	t	t	PROPN
fnp-5813	177	6	,	,	PUNCT
fnp-5813	177	7	akagawa	akagawa	PROPN
fnp-5813	177	8	h	h	PROPN
fnp-5813	177	9	,	,	PUNCT
fnp-5813	177	10	onda	onda	PROPN
fnp-5813	177	11	h	h	NOUN
fnp-5813	177	12	,	,	PUNCT
fnp-5813	177	13	kasuya	kasuya	NOUN
fnp-5813	177	14	h	h	PROPN
fnp-5813	177	15	(	(	PUNCT
fnp-5813	177	16	2014	2014	NUM
fnp-5813	177	17	)	)	PUNCT
fnp-5813	177	18	spontaneous	spontaneous	ADJ
fnp-5813	177	19	regression	regression	NOUN
fnp-5813	177	20	together	together	ADV
fnp-5813	177	21	with	with	ADP
fnp-5813	177	22	increased	increase	VERB
fnp-5813	177	23	calcification	calcification	NOUN
fnp-5813	177	24	of	of	ADP
fnp-5813	177	25	incidental	incidental	ADJ
fnp-5813	177	26	meningioma	meningioma	NOUN
fnp-5813	177	27	.	.	PUNCT
fnp-5813	178	1	surg	surg	NOUN
fnp-5813	178	2	neurol	neurol	PROPN
fnp-5813	178	3	int	int	PROPN
fnp-5813	178	4	5	5	NUM
fnp-5813	178	5	:	:	SYM
fnp-5813	178	6	73	73	NUM
fnp-5813	178	7	.	.	PUNCT
fnp-5813	179	1	https://doi.org/10.4103/2152-7806.132957	https://doi.org/10.4103/2152-7806.132957	NOUN
fnp-5813	179	2	23	23	NUM
fnp-5813	179	3	.	.	PUNCT
fnp-5813	180	1	shimizu	shimizu	PROPN
fnp-5813	180	2	j	j	PROPN
fnp-5813	180	3	,	,	PUNCT
fnp-5813	180	4	matsumoto	matsumoto	PROPN
fnp-5813	180	5	m	m	PROPN
fnp-5813	180	6	,	,	PUNCT
fnp-5813	180	7	yamazaki	yamazaki	PROPN
fnp-5813	180	8	e	e	PROPN
fnp-5813	180	9	,	,	PUNCT
fnp-5813	180	10	yasue	yasue	NOUN
fnp-5813	180	11	m	m	PROPN
fnp-5813	180	12	(	(	PUNCT
fnp-5813	180	13	2008	2008	NUM
fnp-5813	180	14	)	)	PUNCT
fnp-5813	180	15	spontaneous	spontaneous	ADJ
fnp-5813	180	16	regression	regression	NOUN
fnp-5813	180	17	of	of	ADP
fnp-5813	180	18	an	an	DET
fnp-5813	180	19	asymptomatic	asymptomatic	ADJ
fnp-5813	180	20	meningioma	meningioma	NOUN
fnp-5813	180	21	associated	associate	VERB
fnp-5813	180	22	with	with	ADP
fnp-5813	180	23	discontinuation	discontinuation	NOUN
fnp-5813	180	24	of	of	ADP
fnp-5813	180	25	progesterone	progesterone	NOUN
fnp-5813	180	26	agonist	agonist	NOUN
fnp-5813	180	27	administration	administration	NOUN
fnp-5813	180	28	.	.	PUNCT
fnp-5813	181	1	neurol	neurol	PROPN
fnp-5813	181	2	med	me	VERB
fnp-5813	181	3	chir	chir	PROPN
fnp-5813	181	4	48(5	48(5	NUM
fnp-5813	181	5	):	):	PUNCT
fnp-5813	181	6	227	227	NUM
fnp-5813	181	7	-	-	SYM
fnp-5813	181	8	230	230	NUM
fnp-5813	181	9	.	.	PUNCT
fnp-5813	182	1	https://doi.org/10.2176/nmc.48.227	https://doi.org/10.2176/nmc.48.227	PROPN
fnp-5813	182	2	24	24	NUM
fnp-5813	182	3	.	.	PUNCT
fnp-5813	183	1	vadivelu	vadivelu	PROPN
fnp-5813	183	2	s	s	PROPN
fnp-5813	183	3	,	,	PUNCT
fnp-5813	183	4	sharer	sharer	PROPN
fnp-5813	183	5	l	l	PROPN
fnp-5813	183	6	,	,	PUNCT
fnp-5813	183	7	schulder	schulder	NOUN
fnp-5813	183	8	m	m	PROPN
fnp-5813	183	9	(	(	PUNCT
fnp-5813	183	10	2010	2010	NUM
fnp-5813	183	11	)	)	PUNCT
fnp-5813	183	12	regression	regression	NOUN
fnp-5813	183	13	of	of	ADP
fnp-5813	183	14	multiple	multiple	ADJ
fnp-5813	183	15	intracranial	intracranial	ADJ
fnp-5813	183	16	meningiomas	meningioma	NOUN
fnp-5813	183	17	after	after	ADP
fnp-5813	183	18	cessation	cessation	NOUN
fnp-5813	183	19	of	of	ADP
fnp-5813	183	20	long	long	ADJ
fnp-5813	183	21	-	-	PUNCT
fnp-5813	183	22	term	term	NOUN
fnp-5813	183	23	progesterone	progesterone	NOUN
fnp-5813	183	24	agonist	agonist	NOUN
fnp-5813	183	25	therapy	therapy	NOUN
fnp-5813	183	26	.	.	PUNCT
fnp-5813	184	1	j	j	PROPN
fnp-5813	184	2	neurosurg	neurosurg	PROPN
fnp-5813	184	3	112(5	112(5	NUM
fnp-5813	184	4	):	):	PUNCT
fnp-5813	184	5	920	920	NUM
fnp-5813	184	6	-	-	SYM
fnp-5813	184	7	924	924	NUM
fnp-5813	184	8	.	.	PUNCT
fnp-5813	185	1	https://doi.org/10.3171/2009.8.jns09201	https://doi.org/10.3171/2009.8.jns09201	PROPN
fnp-5813	185	2	25	25	NUM
fnp-5813	185	3	.	.	PUNCT
fnp-5813	186	1	bernat	bernat	PROPN
fnp-5813	186	2	al	al	PROPN
fnp-5813	186	3	,	,	PUNCT
fnp-5813	186	4	oyama	oyama	PROPN
fnp-5813	186	5	k	k	PROPN
fnp-5813	186	6	,	,	PUNCT
fnp-5813	186	7	hamdi	hamdi	PROPN
fnp-5813	186	8	s	s	PROPN
fnp-5813	186	9	,	,	PUNCT
fnp-5813	186	10	et	et	PROPN
fnp-5813	186	11	al	al	PROPN
fnp-5813	186	12	.	.	PROPN
fnp-5813	186	13	(	(	PUNCT
fnp-5813	186	14	2015	2015	NUM
fnp-5813	186	15	)	)	PUNCT
fnp-5813	186	16	growth	growth	NOUN
fnp-5813	186	17	stabilization	stabilization	NOUN
fnp-5813	186	18	and	and	CCONJ
fnp-5813	186	19	regression	regression	NOUN
fnp-5813	186	20	of	of	ADP
fnp-5813	186	21	meningiomas	meningioma	NOUN
fnp-5813	186	22	after	after	ADP
fnp-5813	186	23	discontinuation	discontinuation	NOUN
fnp-5813	186	24	of	of	ADP
fnp-5813	186	25	cyproterone	cyproterone	NOUN
fnp-5813	186	26	acetate	acetate	NOUN
fnp-5813	186	27	:	:	PUNCT
fnp-5813	186	28	a	a	DET
fnp-5813	186	29	case	case	NOUN
fnp-5813	186	30	series	series	NOUN
fnp-5813	186	31	of	of	ADP
fnp-5813	186	32	12	12	NUM
fnp-5813	186	33	patients	patient	NOUN
fnp-5813	186	34	.	.	PUNCT
fnp-5813	187	1	acta	acta	PROPN
fnp-5813	187	2	neurochir	neurochir	PROPN
fnp-5813	187	3	157(10	157(10	NUM
fnp-5813	187	4	):	):	PUNCT
fnp-5813	187	5	1741	1741	NUM
fnp-5813	187	6	-	-	SYM
fnp-5813	187	7	1746	1746	NUM
fnp-5813	187	8	.	.	PUNCT
fnp-5813	188	1	https://doi.org/10.1007/s00701-015-2532-3	https://doi.org/10.1007/s00701-015-2532-3	NUM
fnp-5813	188	2	26	26	NUM
fnp-5813	188	3	.	.	PUNCT
fnp-5813	189	1	goncalves	goncalve	NOUN
fnp-5813	189	2	am	be	AUX
fnp-5813	189	3	,	,	PUNCT
fnp-5813	189	4	page	page	NOUN
fnp-5813	189	5	p	p	X
fnp-5813	189	6	,	,	PUNCT
fnp-5813	189	7	domigo	domigo	ADJ
fnp-5813	189	8	v	v	NOUN
fnp-5813	189	9	,	,	PUNCT
fnp-5813	189	10	meder	meder	PROPN
fnp-5813	189	11	jf	jf	PROPN
fnp-5813	189	12	,	,	PUNCT
fnp-5813	189	13	oppenheim	oppenheim	PROPN
fnp-5813	189	14	c	c	PROPN
fnp-5813	189	15	(	(	PUNCT
fnp-5813	189	16	2010	2010	NUM
fnp-5813	189	17	)	)	PUNCT
fnp-5813	189	18	abrupt	abrupt	ADJ
fnp-5813	189	19	regression	regression	NOUN
fnp-5813	189	20	of	of	ADP
fnp-5813	189	21	a	a	DET
fnp-5813	189	22	meningioma	meningioma	NOUN
fnp-5813	189	23	after	after	ADP
fnp-5813	189	24	discontinuation	discontinuation	NOUN
fnp-5813	189	25	of	of	ADP
fnp-5813	189	26	cyproterone	cyproterone	NOUN
fnp-5813	189	27	treatment	treatment	NOUN
fnp-5813	189	28	.	.	PUNCT
fnp-5813	190	1	ajnr	ajnr	PROPN
fnp-5813	190	2	american	american	PROPN
fnp-5813	190	3	journal	journal	PROPN
fnp-5813	190	4	of	of	ADP
fnp-5813	190	5	neuroradiology	neuroradiology	NOUN
fnp-5813	190	6	31(8	31(8	NUM
fnp-5813	190	7	):	):	PUNCT
fnp-5813	190	8	1504	1504	NUM
fnp-5813	190	9	-	-	SYM
fnp-5813	190	10	1505	1505	NUM
fnp-5813	190	11	.	.	PUNCT
fnp-5813	191	1	https://doi.org/10.3174/ajnr.a1978	https://doi.org/10.3174/ajnr.a1978	PROPN
fnp-5813	192	1	27	27	NUM
fnp-5813	192	2	.	.	PUNCT
fnp-5813	193	1	cebula	cebula	NOUN
fnp-5813	193	2	h	h	PROPN
fnp-5813	193	3	,	,	PUNCT
fnp-5813	193	4	pham	pham	PROPN
fnp-5813	193	5	tq	tq	PROPN
fnp-5813	193	6	,	,	PUNCT
fnp-5813	193	7	boyer	boyer	PROPN
fnp-5813	193	8	p	p	PROPN
fnp-5813	193	9	,	,	PUNCT
fnp-5813	193	10	froelich	froelich	PROPN
fnp-5813	193	11	s	s	X
fnp-5813	193	12	(	(	PUNCT
fnp-5813	193	13	2010	2010	NUM
fnp-5813	193	14	)	)	PUNCT
fnp-5813	193	15	regression	regression	NOUN
fnp-5813	193	16	of	of	ADP
fnp-5813	193	17	meningiomas	meningioma	NOUN
fnp-5813	193	18	after	after	ADP
fnp-5813	193	19	discontinuation	discontinuation	NOUN
fnp-5813	193	20	of	of	ADP
fnp-5813	193	21	cyproterone	cyproterone	NOUN
fnp-5813	193	22	acetate	acetate	NOUN
fnp-5813	193	23	in	in	ADP
fnp-5813	193	24	a	a	DET
fnp-5813	193	25	transsexual	transsexual	ADJ
fnp-5813	193	26	patient	patient	NOUN
fnp-5813	193	27	.	.	PUNCT
fnp-5813	194	1	acta	acta	PROPN
fnp-5813	194	2	neurochir	neurochir	PROPN
fnp-5813	194	3	152(11	152(11	NUM
fnp-5813	194	4	):	):	PUNCT
fnp-5813	194	5	1955	1955	NUM
fnp-5813	194	6	-	-	SYM
fnp-5813	194	7	1956	1956	NUM
fnp-5813	194	8	.	.	PUNCT
fnp-5813	195	1	https://doi.org/10.1007/s00701-010-0787-2	https://doi.org/10.1007/s00701-010-0787-2	NUM
fnp-5813	195	2	28	28	NUM
fnp-5813	195	3	.	.	PUNCT
fnp-5813	196	1	voormolen	voormolen	PROPN
fnp-5813	196	2	ehj	ehj	PROPN
fnp-5813	196	3	,	,	PUNCT
fnp-5813	196	4	champagne	champagne	PROPN
fnp-5813	196	5	po	po	PROPN
fnp-5813	196	6	,	,	PUNCT
fnp-5813	196	7	roca	roca	PROPN
fnp-5813	196	8	e	e	PROPN
fnp-5813	196	9	,	,	PUNCT
fnp-5813	196	10	et	et	PROPN
fnp-5813	196	11	al	al	PROPN
fnp-5813	196	12	.	.	PROPN
fnp-5813	196	13	(	(	PUNCT
fnp-5813	196	14	2021	2021	NUM
fnp-5813	196	15	)	)	PUNCT
fnp-5813	196	16	intracranial	intracranial	ADJ
fnp-5813	196	17	meningiomas	meningioma	NOUN
fnp-5813	196	18	decrease	decrease	NOUN
fnp-5813	196	19	in	in	ADP
fnp-5813	196	20	volume	volume	NOUN
fnp-5813	196	21	on	on	ADP
fnp-5813	196	22	magnetic	magnetic	ADJ
fnp-5813	196	23	resonance	resonance	NOUN
fnp-5813	196	24	imaging	imaging	NOUN
fnp-5813	196	25	after	after	ADP
fnp-5813	196	26	discontinuing	discontinue	VERB
fnp-5813	196	27	progestin	progestin	NOUN
fnp-5813	196	28	.	.	PUNCT
fnp-5813	197	1	neurosurgery	neurosurgery	NOUN
fnp-5813	197	2	89(2	89(2	NUM
fnp-5813	197	3	):	):	PUNCT
fnp-5813	197	4	308	308	NUM
fnp-5813	197	5	-	-	SYM
fnp-5813	197	6	314	314	NUM
fnp-5813	197	7	.	.	PUNCT
fnp-5813	198	1	https://doi.org/10.1093/neuros/nyab175	https://doi.org/10.1093/neuros/nyab175	PROPN
fnp-5813	199	1	29	29	NUM
fnp-5813	199	2	.	.	PUNCT
fnp-5813	200	1	bernat	bernat	PROPN
fnp-5813	200	2	al	al	PROPN
fnp-5813	200	3	,	,	PUNCT
fnp-5813	200	4	bonnin	bonnin	PROPN
fnp-5813	200	5	s	s	PART
fnp-5813	200	6	,	,	PUNCT
fnp-5813	200	7	labidi	labidi	PROPN
fnp-5813	200	8	m	m	PROPN
fnp-5813	200	9	,	,	PUNCT
fnp-5813	200	10	et	et	PROPN
fnp-5813	200	11	al	al	PROPN
fnp-5813	200	12	.	.	PUNCT
fnp-5813	201	1	(	(	PUNCT
fnp-5813	201	2	2018	2018	NUM
fnp-5813	201	3	)	)	PUNCT
fnp-5813	201	4	regression	regression	NOUN
fnp-5813	201	5	of	of	ADP
fnp-5813	201	6	giant	giant	ADJ
fnp-5813	201	7	olfactory	olfactory	NOUN
fnp-5813	201	8	groove	groove	VERB
fnp-5813	201	9	meningioma	meningioma	NOUN
fnp-5813	201	10	and	and	CCONJ
fnp-5813	201	11	complete	complete	ADJ
fnp-5813	201	12	visual	visual	ADJ
fnp-5813	201	13	acuity	acuity	NOUN
fnp-5813	201	14	recovery	recovery	NOUN
fnp-5813	201	15	after	after	ADP
fnp-5813	201	16	discontinuation	discontinuation	NOUN
fnp-5813	201	17	of	of	ADP
fnp-5813	201	18	cyproterone	cyproterone	NOUN
fnp-5813	201	19	acetate	acetate	NOUN
fnp-5813	201	20	.	.	PUNCT
fnp-5813	202	1	j	j	PROPN
fnp-5813	202	2	ophthalmic	ophthalmic	ADJ
fnp-5813	202	3	vis	vis	X
fnp-5813	202	4	res	re	NOUN
fnp-5813	202	5	13(3	13(3	NUM
fnp-5813	202	6	):	):	PUNCT
fnp-5813	202	7	355	355	NUM
fnp-5813	202	8	-	-	SYM
fnp-5813	202	9	358	358	NUM
fnp-5813	202	10	.	.	PUNCT
fnp-5813	203	1	https://doi.org/10.4103/jovr.jovr_21_17	https://doi.org/10.4103/jovr.jovr_21_17	PROPN
fnp-5813	203	2	30	30	NUM
fnp-5813	203	3	.	.	PUNCT
fnp-5813	203	4	mastorino	mastorino	PROPN
fnp-5813	203	5	l	l	NOUN
fnp-5813	203	6	,	,	PUNCT
fnp-5813	203	7	dapavo	dapavo	VERB
fnp-5813	203	8	p	p	NOUN
fnp-5813	203	9	,	,	PUNCT
fnp-5813	203	10	avallone	avallone	NOUN
fnp-5813	203	11	g	g	PROPN
fnp-5813	203	12	,	,	PUNCT
fnp-5813	203	13	et	et	PROPN
fnp-5813	203	14	al	al	PROPN
fnp-5813	203	15	.	.	PROPN
fnp-5813	204	1	(	(	PUNCT
fnp-5813	204	2	2022	2022	NUM
fnp-5813	204	3	)	)	PUNCT
fnp-5813	204	4	biologic	biologic	NOUN
fnp-5813	204	5	treatment	treatment	NOUN
fnp-5813	204	6	for	for	ADP
fnp-5813	204	7	psoriasis	psoriasis	NOUN
fnp-5813	204	8	in	in	ADP
fnp-5813	204	9	cancer	cancer	NOUN
fnp-5813	204	10	patients	patient	NOUN
fnp-5813	204	11	:	:	PUNCT
fnp-5813	204	12	should	should	AUX
fnp-5813	204	13	they	they	PRON
fnp-5813	204	14	still	still	ADV
fnp-5813	204	15	be	be	AUX
fnp-5813	204	16	considered	consider	VERB
fnp-5813	204	17	forbidden	forbidden	ADJ
fnp-5813	204	18	?	?	PUNCT
fnp-5813	205	1	j	j	PROPN
fnp-5813	205	2	dermatolog	dermatolog	PROPN
fnp-5813	205	3	treat	treat	VERB
fnp-5813	205	4	33(5	33(5	NUM
fnp-5813	205	5	):	):	PUNCT
fnp-5813	205	6	2495	2495	NUM
fnp-5813	205	7	-	-	SYM
fnp-5813	205	8	2502	2502	NUM
fnp-5813	205	9	.	.	PUNCT
fnp-5813	206	1	https://doi.org/10.1080/09546634.2021.1970706	https://doi.org/10.1080/09546634.2021.1970706	PROPN
fnp-5813	207	1	31	31	NUM
fnp-5813	207	2	.	.	PUNCT
fnp-5813	208	1	finnegan	finnegan	PROPN
fnp-5813	208	2	p	p	PROPN
fnp-5813	208	3	,	,	PUNCT
fnp-5813	208	4	ahmad	ahmad	PROPN
fnp-5813	208	5	k	k	PROPN
fnp-5813	208	6	,	,	PUNCT
fnp-5813	208	7	sadlier	sadlier	PROPN
fnp-5813	208	8	m	m	PROPN
fnp-5813	208	9	,	,	PUNCT
fnp-5813	208	10	lynch	lynch	PROPN
fnp-5813	208	11	m	m	PROPN
fnp-5813	208	12	(	(	PUNCT
fnp-5813	208	13	2023	2023	NUM
fnp-5813	208	14	)	)	PUNCT
fnp-5813	208	15	a	a	DET
fnp-5813	208	16	retrospective	retrospective	ADJ
fnp-5813	208	17	review	review	NOUN
fnp-5813	208	18	of	of	ADP
fnp-5813	208	19	the	the	DET
fnp-5813	208	20	management	management	NOUN
fnp-5813	208	21	of	of	ADP
fnp-5813	208	22	patients	patient	NOUN
fnp-5813	208	23	following	follow	VERB
fnp-5813	208	24	a	a	DET
fnp-5813	208	25	malignancy	malignancy	NOUN
fnp-5813	208	26	diagnosis	diagnosis	NOUN
fnp-5813	208	27	on	on	ADP
fnp-5813	208	28	biologic	biologic	NOUN
fnp-5813	208	29	therapies	therapy	NOUN
fnp-5813	208	30	for	for	ADP
fnp-5813	208	31	the	the	DET
fnp-5813	208	32	treatment	treatment	NOUN
fnp-5813	208	33	of	of	ADP
fnp-5813	208	34	dermatological	dermatological	ADJ
fnp-5813	208	35	disorders	disorder	NOUN
fnp-5813	208	36	.	.	PUNCT
fnp-5813	209	1	jaad	jaad	NOUN
fnp-5813	209	2	case	case	NOUN
fnp-5813	209	3	rep	rep	PROPN
fnp-5813	209	4	39	39	NUM
fnp-5813	209	5	:	:	PUNCT
fnp-5813	209	6	81	81	NUM
fnp-5813	209	7	-	-	SYM
fnp-5813	209	8	87	87	NUM
fnp-5813	209	9	.	.	PUNCT
fnp-5813	210	1	https://doi.org/10.1016/j.jdcr.2023.07.007	https://doi.org/10.1016/j.jdcr.2023.07.007	NOUN
fnp-5813	210	2	32	32	NUM
fnp-5813	210	3	.	.	PUNCT
fnp-5813	211	1	schick	schick	PROPN
fnp-5813	211	2	ma	ma	PROPN
fnp-5813	211	3	,	,	PUNCT
fnp-5813	211	4	schlegel	schlegel	PROPN
fnp-5813	211	5	n	n	PROPN
fnp-5813	211	6	(	(	PUNCT
fnp-5813	211	7	2022	2022	NUM
fnp-5813	211	8	)	)	PUNCT
fnp-5813	211	9	clinical	clinical	ADJ
fnp-5813	211	10	implication	implication	NOUN
fnp-5813	211	11	of	of	ADP
fnp-5813	211	12	phosphodiesterase-4	phosphodiesterase-4	NOUN
fnp-5813	211	13	-	-	PUNCT
fnp-5813	211	14	inhibition	inhibition	NOUN
fnp-5813	211	15	.	.	PUNCT
fnp-5813	212	1	international	international	ADJ
fnp-5813	212	2	journal	journal	NOUN
fnp-5813	212	3	of	of	ADP
fnp-5813	212	4	molecular	molecular	ADJ
fnp-5813	212	5	sciences	science	NOUN
fnp-5813	212	6	23(3	23(3	NUM
fnp-5813	212	7	):	):	PUNCT
fnp-5813	212	8	1209	1209	NUM
fnp-5813	212	9	.	.	PUNCT
fnp-5813	213	1	https://doi.org/10.3390/ijms23031209	https://doi.org/10.3390/ijms23031209	NOUN
fnp-5813	213	2	33	33	NUM
fnp-5813	213	3	.	.	PUNCT
fnp-5813	214	1	goldhoff	goldhoff	PROPN
fnp-5813	214	2	p	p	PROPN
fnp-5813	214	3	,	,	PUNCT
fnp-5813	214	4	warrington	warrington	PROPN
fnp-5813	214	5	nm	nm	PROPN
fnp-5813	214	6	,	,	PUNCT
fnp-5813	214	7	limbrick	limbrick	PROPN
fnp-5813	214	8	dd	dd	PROPN
fnp-5813	214	9	,	,	PUNCT
fnp-5813	214	10	jr	jr	PROPN
fnp-5813	214	11	.	.	PROPN
fnp-5813	214	12	,	,	PUNCT
fnp-5813	214	13	et	et	PROPN
fnp-5813	214	14	al	al	PROPN
fnp-5813	214	15	.	.	PUNCT
fnp-5813	214	16	(	(	PUNCT
fnp-5813	214	17	2008	2008	NUM
fnp-5813	214	18	)	)	PUNCT
fnp-5813	214	19	targeted	target	VERB
fnp-5813	214	20	inhibition	inhibition	NOUN
fnp-5813	214	21	of	of	ADP
fnp-5813	214	22	cyclic	cyclic	ADJ
fnp-5813	214	23	amp	amp	NOUN
fnp-5813	214	24	phosphodiesterase-4	phosphodiesterase-4	PROPN
fnp-5813	214	25	promotes	promote	VERB
fnp-5813	214	26	brain	brain	NOUN
fnp-5813	214	27	tumor	tumor	NOUN
fnp-5813	214	28	regression	regression	NOUN
fnp-5813	214	29	.	.	PUNCT
fnp-5813	215	1	clin	clin	PROPN
fnp-5813	215	2	cancer	cancer	NOUN
fnp-5813	215	3	res	re	NOUN
fnp-5813	215	4	14(23	14(23	NOUN
fnp-5813	215	5	):	):	PUNCT
fnp-5813	215	6	7717	7717	NUM
fnp-5813	215	7	-	-	SYM
fnp-5813	215	8	7725	7725	NUM
fnp-5813	215	9	.	.	PUNCT
fnp-5813	216	1	https://doi.org/10.1158/1078-0432.ccr-08-0827	https://doi.org/10.1158/1078-0432.ccr-08-0827	X
fnp-5813	217	1	34	34	NUM
fnp-5813	217	2	.	.	PUNCT
fnp-5813	218	1	carroll	carroll	PROPN
fnp-5813	218	2	rs	rs	PROPN
fnp-5813	218	3	,	,	PUNCT
fnp-5813	218	4	zhang	zhang	PROPN
fnp-5813	218	5	j	j	PROPN
fnp-5813	218	6	,	,	PUNCT
fnp-5813	218	7	dashner	dashner	X
fnp-5813	218	8	k	k	PROPN
fnp-5813	218	9	,	,	PUNCT
fnp-5813	218	10	black	black	ADJ
fnp-5813	218	11	pm	pm	NOUN
fnp-5813	218	12	(	(	PUNCT
fnp-5813	218	13	1995	1995	NUM
fnp-5813	218	14	)	)	PUNCT
fnp-5813	218	15	progesterone	progesterone	NOUN
fnp-5813	218	16	and	and	CCONJ
fnp-5813	218	17	glucocorticoid	glucocorticoid	ADJ
fnp-5813	218	18	receptor	receptor	NOUN
fnp-5813	218	19	activation	activation	NOUN
fnp-5813	218	20	in	in	ADP
fnp-5813	218	21	meningiomas	meningioma	NOUN
fnp-5813	218	22	.	.	PUNCT
fnp-5813	219	1	neurosurgery	neurosurgery	NOUN
fnp-5813	219	2	37(1	37(1	NUM
fnp-5813	219	3	):	):	PUNCT
fnp-5813	219	4	92	92	NUM
fnp-5813	219	5	-	-	SYM
fnp-5813	219	6	97	97	NUM
fnp-5813	219	7	.	.	PUNCT
fnp-5813	220	1	https://doi.org/10.1227/00006123-199507000-00014	https://doi.org/10.1227/00006123-199507000-00014	X
fnp-5813	220	2	35	35	NUM
fnp-5813	220	3	.	.	PUNCT
fnp-5813	220	4	koper	koper	PROPN
fnp-5813	220	5	jw	jw	PROPN
fnp-5813	220	6	,	,	PUNCT
fnp-5813	220	7	lamberts	lamberts	PROPN
fnp-5813	220	8	sw	sw	PROPN
fnp-5813	220	9	(	(	PUNCT
fnp-5813	220	10	1994	1994	NUM
fnp-5813	220	11	)	)	PUNCT
fnp-5813	220	12	meningiomas	meningioma	NOUN
fnp-5813	220	13	,	,	PUNCT
fnp-5813	220	14	epidermal	epidermal	ADJ
fnp-5813	220	15	growth	growth	NOUN
fnp-5813	220	16	factor	factor	NOUN
fnp-5813	220	17	and	and	CCONJ
fnp-5813	220	18	progesterone	progesterone	NOUN
fnp-5813	220	19	.	.	PUNCT
fnp-5813	221	1	hum	hum	PROPN
fnp-5813	221	2	reprod	reprod	PROPN
fnp-5813	221	3	9	9	NUM
fnp-5813	221	4	suppl	suppl	ADJ
fnp-5813	221	5	1	1	NUM
fnp-5813	221	6	:	:	SYM
fnp-5813	221	7	190	190	NUM
fnp-5813	221	8	-	-	SYM
fnp-5813	221	9	194	194	NUM
fnp-5813	221	10	.	.	PUNCT
fnp-5813	222	1	https://doi.org/10.1093/humrep/9.suppl_1.190	https://doi.org/10.1093/humrep/9.suppl_1.190	PROPN
fnp-5813	222	2	36	36	NUM
fnp-5813	222	3	.	.	PUNCT
fnp-5813	223	1	botella	botella	PROPN
fnp-5813	223	2	j	j	PROPN
fnp-5813	223	3	,	,	PUNCT
fnp-5813	223	4	duranti	duranti	PROPN
fnp-5813	223	5	e	e	PROPN
fnp-5813	223	6	,	,	PUNCT
fnp-5813	223	7	duc	duc	PROPN
fnp-5813	223	8	i	i	PROPN
fnp-5813	223	9	,	,	PUNCT
fnp-5813	223	10	cognet	cognet	PROPN
fnp-5813	223	11	am	be	AUX
fnp-5813	223	12	,	,	PUNCT
fnp-5813	223	13	delansorne	delansorne	ADJ
fnp-5813	223	14	r	r	NOUN
fnp-5813	223	15	,	,	PUNCT
fnp-5813	223	16	paris	paris	PROPN
fnp-5813	223	17	j	j	PROPN
fnp-5813	223	18	(	(	PUNCT
fnp-5813	223	19	1994	1994	NUM
fnp-5813	223	20	)	)	PUNCT
fnp-5813	223	21	inhibition	inhibition	NOUN
fnp-5813	223	22	by	by	ADP
fnp-5813	223	23	nomegestrol	nomegestrol	NOUN
fnp-5813	223	24	acetate	acetate	NOUN
fnp-5813	223	25	and	and	CCONJ
fnp-5813	223	26	other	other	ADJ
fnp-5813	223	27	synthetic	synthetic	ADJ
fnp-5813	223	28	progestins	progestin	NOUN
fnp-5813	223	29	on	on	ADP
fnp-5813	223	30	proliferation	proliferation	NOUN
fnp-5813	223	31	and	and	CCONJ
fnp-5813	223	32	progesterone	progesterone	NOUN
fnp-5813	223	33	receptor	receptor	NOUN
fnp-5813	223	34	content	content	NOUN
fnp-5813	223	35	of	of	ADP
fnp-5813	223	36	t47	t47	PROPN
fnp-5813	223	37	-	-	PUNCT
fnp-5813	223	38	d	d	PROPN
fnp-5813	223	39	human	human	ADJ
fnp-5813	223	40	breast	breast	NOUN
fnp-5813	223	41	cancer	cancer	NOUN
fnp-5813	223	42	cells	cell	NOUN
fnp-5813	223	43	.	.	PUNCT
fnp-5813	224	1	j	j	PROPN
fnp-5813	224	2	steroid	steroid	PROPN
fnp-5813	224	3	biochem	biochem	PROPN
fnp-5813	224	4	mol	mol	ADP
fnp-5813	224	5	biol	biol	PROPN
fnp-5813	224	6	50(1	50(1	PROPN
fnp-5813	224	7	-	-	PUNCT
fnp-5813	224	8	2	2	NUM
fnp-5813	224	9	):	):	PUNCT
fnp-5813	224	10	41	41	NUM
fnp-5813	224	11	-	-	SYM
fnp-5813	224	12	47	47	NUM
fnp-5813	224	13	.	.	PUNCT
fnp-5813	225	1	https://doi.org/10.1016/0960-0760(94)90170-8	https://doi.org/10.1016/0960-0760(94)90170-8	NOUN
fnp-5813	225	2	37	37	NUM
fnp-5813	225	3	.	.	PUNCT
fnp-5813	226	1	carroll	carroll	NOUN
fnp-5813	226	2	rs	rs	PROPN
fnp-5813	226	3	,	,	PUNCT
fnp-5813	226	4	brown	brown	PROPN
fnp-5813	226	5	m	m	PROPN
fnp-5813	226	6	,	,	PUNCT
fnp-5813	226	7	zhang	zhang	PROPN
fnp-5813	226	8	j	j	PROPN
fnp-5813	226	9	,	,	PUNCT
fnp-5813	226	10	direnzo	direnzo	PROPN
fnp-5813	226	11	j	j	PROPN
fnp-5813	226	12	,	,	PUNCT
fnp-5813	226	13	font	font	VERB
fnp-5813	226	14	de	de	PROPN
fnp-5813	226	15	mora	mora	PROPN
fnp-5813	226	16	j	j	PROPN
fnp-5813	226	17	,	,	PUNCT
fnp-5813	226	18	black	black	ADJ
fnp-5813	226	19	pm	pm	NOUN
fnp-5813	226	20	(	(	PUNCT
fnp-5813	226	21	2000	2000	NUM
fnp-5813	226	22	)	)	PUNCT
fnp-5813	226	23	expression	expression	NOUN
fnp-5813	226	24	of	of	ADP
fnp-5813	226	25	a	a	DET
fnp-5813	226	26	subset	subset	NOUN
fnp-5813	226	27	of	of	ADP
fnp-5813	226	28	steroid	steroid	NOUN
fnp-5813	226	29	receptor	receptor	NOUN
fnp-5813	226	30	cofactors	cofactor	NOUN
fnp-5813	226	31	is	be	AUX
fnp-5813	226	32	associated	associate	VERB
fnp-5813	226	33	with	with	ADP
fnp-5813	226	34	progesterone	progesterone	NOUN
fnp-5813	226	35	receptor	receptor	NOUN
fnp-5813	226	36	expression	expression	NOUN
fnp-5813	226	37	in	in	ADP
fnp-5813	226	38	meningiomas	meningiomas	PROPN
fnp-5813	226	39	.	.	PUNCT
fnp-5813	227	1	clin	clin	PROPN
fnp-5813	227	2	cancer	cancer	NOUN
fnp-5813	227	3	res	res	PROPN
fnp-5813	227	4	6(9	6(9	PROPN
fnp-5813	227	5	):	):	PUNCT
fnp-5813	227	6	3570	3570	NUM
fnp-5813	227	7	-	-	SYM
fnp-5813	227	8	3575	3575	NUM
fnp-5813	227	9	.	.	PUNCT
fnp-5813	228	1	pmid	pmid	NOUN
fnp-5813	228	2	:	:	PUNCT
fnp-5813	228	3	10999746	10999746	NUM
fnp-5813	228	4	38	38	NUM
fnp-5813	228	5	.	.	PUNCT
fnp-5813	229	1	agopiantz	agopiantz	PROPN
fnp-5813	229	2	m	m	PROPN
fnp-5813	229	3	,	,	PUNCT
fnp-5813	229	4	carnot	carnot	NOUN
fnp-5813	229	5	m	m	PROPN
fnp-5813	229	6	,	,	PUNCT
fnp-5813	229	7	denis	denis	PROPN
fnp-5813	229	8	c	c	PROPN
fnp-5813	229	9	,	,	PUNCT
fnp-5813	229	10	martin	martin	PROPN
fnp-5813	229	11	e	e	PROPN
fnp-5813	229	12	,	,	PUNCT
fnp-5813	229	13	gauchotte	gauchotte	PROPN
fnp-5813	229	14	g	g	PROPN
fnp-5813	229	15	(	(	PUNCT
fnp-5813	229	16	2023	2023	NUM
fnp-5813	229	17	)	)	PUNCT
fnp-5813	229	18	hormone	hormone	NOUN
fnp-5813	229	19	receptor	receptor	NOUN
fnp-5813	229	20	expression	expression	NOUN
fnp-5813	229	21	in	in	ADP
fnp-5813	229	22	meningiomas	meningioma	NOUN
fnp-5813	229	23	:	:	PUNCT
fnp-5813	229	24	a	a	DET
fnp-5813	229	25	systematic	systematic	ADJ
fnp-5813	229	26	review	review	NOUN
fnp-5813	229	27	.	.	PUNCT
fnp-5813	230	1	cancers	cancer	NOUN
fnp-5813	230	2	15(3	15(3	VERB
fnp-5813	230	3	):	):	PUNCT
fnp-5813	230	4	980	980	NUM
fnp-5813	230	5	.	.	PUNCT
fnp-5813	230	6	https://doi.org/10.3390/cancers15030980	https://doi.org/10.3390/cancers15030980	PROPN
fnp-5813	230	7	39	39	NUM
fnp-5813	230	8	.	.	PUNCT
fnp-5813	231	1	lapolla	lapolla	PROPN
fnp-5813	231	2	p	p	PROPN
fnp-5813	231	3	,	,	PUNCT
fnp-5813	231	4	familiari	familiari	PROPN
fnp-5813	231	5	p	p	PROPN
fnp-5813	231	6	,	,	PUNCT
fnp-5813	231	7	zancana	zancana	PROPN
fnp-5813	231	8	g	g	NOUN
fnp-5813	231	9	,	,	PUNCT
fnp-5813	231	10	et	et	PROPN
fnp-5813	231	11	al	al	PROPN
fnp-5813	231	12	.	.	PROPN
fnp-5813	231	13	(	(	PUNCT
fnp-5813	231	14	2021	2021	NUM
fnp-5813	231	15	)	)	PUNCT
fnp-5813	231	16	lipomatous	lipomatous	ADJ
fnp-5813	231	17	meningioma	meningioma	NOUN
fnp-5813	231	18	:	:	PUNCT
fnp-5813	231	19	clinical	clinical	ADJ
fnp-5813	231	20	-	-	PUNCT
fnp-5813	231	21	pathological	pathological	ADJ
fnp-5813	231	22	findings	finding	NOUN
fnp-5813	231	23	,	,	PUNCT
fnp-5813	231	24	imaging	imaging	NOUN
fnp-5813	231	25	characterisation	characterisation	NOUN
fnp-5813	231	26	and	and	CCONJ
fnp-5813	231	27	correlations	correlation	NOUN
fnp-5813	231	28	of	of	ADP
fnp-5813	231	29	a	a	DET
fnp-5813	231	30	rare	rare	ADJ
fnp-5813	231	31	type	type	NOUN
fnp-5813	231	32	of	of	ADP
fnp-5813	231	33	meningioma	meningioma	NOUN
fnp-5813	231	34	.	.	PUNCT
fnp-5813	232	1	in	in	ADP
fnp-5813	232	2	vivo	vivo	NOUN
fnp-5813	232	3	35(6	35(6	NUM
fnp-5813	232	4	):	):	PUNCT
fnp-5813	232	5	3031	3031	NUM
fnp-5813	232	6	-	-	SYM
fnp-5813	232	7	3037	3037	NUM
fnp-5813	232	8	.	.	PUNCT
fnp-5813	233	1	https://doi.org/10.21873/invivo.12598	https://doi.org/10.21873/invivo.12598	NOUN
fnp-5813	233	2	40	40	NUM
fnp-5813	233	3	.	.	PUNCT
fnp-5813	234	1	bolat	bolat	PROPN
fnp-5813	234	2	f	f	PROPN
fnp-5813	234	3	,	,	PUNCT
fnp-5813	234	4	kayaselcuk	kayaselcuk	PROPN
fnp-5813	234	5	f	f	X
fnp-5813	234	6	,	,	PUNCT
fnp-5813	234	7	aydin	aydin	VERB
fnp-5813	234	8	mv	mv	PROPN
fnp-5813	234	9	,	,	PUNCT
fnp-5813	234	10	erdogan	erdogan	ADJ
fnp-5813	234	11	b	b	X
fnp-5813	234	12	,	,	PUNCT
fnp-5813	234	13	ulusan	ulusan	PROPN
fnp-5813	234	14	s	s	PROPN
fnp-5813	234	15	,	,	PUNCT
fnp-5813	234	16	zorludemir	zorludemir	PROPN
fnp-5813	234	17	s	s	X
fnp-5813	234	18	(	(	PUNCT
fnp-5813	234	19	2003	2003	NUM
fnp-5813	234	20	)	)	PUNCT
fnp-5813	234	21	lipidized	lipidize	VERB
fnp-5813	234	22	or	or	CCONJ
fnp-5813	234	23	lipomatous	lipomatous	ADJ
fnp-5813	234	24	meningioma	meningioma	NOUN
fnp-5813	234	25	,	,	PUNCT
fnp-5813	234	26	which	which	PRON
fnp-5813	234	27	is	be	AUX
fnp-5813	234	28	more	more	ADV
fnp-5813	234	29	appropriate	appropriate	ADJ
fnp-5813	234	30	?	?	PUNCT
fnp-5813	235	1	a	a	DET
fnp-5813	235	2	case	case	NOUN
fnp-5813	235	3	report	report	NOUN
fnp-5813	235	4	.	.	PUNCT
fnp-5813	236	1	neurol	neurol	NOUN
fnp-5813	236	2	res	re	VERB
fnp-5813	236	3	25(7	25(7	NUM
fnp-5813	236	4	):	):	PUNCT
fnp-5813	236	5	764	764	NUM
fnp-5813	236	6	-	-	PUNCT
fnp-5813	236	7	766	766	NUM
fnp-5813	236	8	.	.	PUNCT
fnp-5813	237	1	https://doi.org/10.1179/016164103101202147	https://doi.org/10.1179/016164103101202147	ADP
fnp-5813	237	2	copyright	copyright	NOUN
fnp-5813	237	3	:	:	PUNCT
fnp-5813	238	1	©	©	PROPN
fnp-5813	238	2	2024	2024	NUM
fnp-5813	238	3	the	the	DET
fnp-5813	238	4	author(s	author(s	NOUN
fnp-5813	238	5	)	)	PUNCT
fnp-5813	238	6	.	.	PUNCT
fnp-5813	239	1	this	this	PRON
fnp-5813	239	2	is	be	AUX
fnp-5813	239	3	an	an	DET
fnp-5813	239	4	open	open	ADJ
fnp-5813	239	5	access	access	NOUN
fnp-5813	239	6	article	article	NOUN
fnp-5813	239	7	distributed	distribute	VERB
fnp-5813	239	8	under	under	ADP
fnp-5813	239	9	the	the	DET
fnp-5813	239	10	terms	term	NOUN
fnp-5813	239	11	of	of	ADP
fnp-5813	239	12	the	the	DET
fnp-5813	239	13	creative	creative	ADJ
fnp-5813	239	14	commons	common	NOUN
fnp-5813	239	15	attribution	attribution	NOUN
fnp-5813	239	16	4.0	4.0	NUM
fnp-5813	239	17	international	international	ADJ
fnp-5813	239	18	license	license	NOUN
fnp-5813	239	19	(	(	PUNCT
fnp-5813	239	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-5813	239	21	)	)	PUNCT
fnp-5813	239	22	,	,	PUNCT
fnp-5813	239	23	which	which	PRON
fnp-5813	239	24	permits	permit	VERB
fnp-5813	239	25	unrestricted	unrestricted	ADJ
fnp-5813	239	26	use	use	NOUN
fnp-5813	239	27	,	,	PUNCT
fnp-5813	239	28	distribution	distribution	NOUN
fnp-5813	239	29	,	,	PUNCT
fnp-5813	239	30	and	and	CCONJ
fnp-5813	239	31	reproduction	reproduction	NOUN
fnp-5813	239	32	in	in	ADP
fnp-5813	239	33	any	any	DET
fnp-5813	239	34	medium	medium	NOUN
fnp-5813	239	35	,	,	PUNCT
fnp-5813	239	36	provided	provide	VERB
fnp-5813	239	37	the	the	DET
fnp-5813	239	38	original	original	ADJ
fnp-5813	239	39	author	author	NOUN
fnp-5813	239	40	and	and	CCONJ
fnp-5813	239	41	source	source	NOUN
fnp-5813	239	42	are	be	AUX
fnp-5813	239	43	credited	credit	VERB
fnp-5813	239	44	,	,	PUNCT
fnp-5813	239	45	a	a	DET
fnp-5813	239	46	link	link	NOUN
fnp-5813	239	47	to	to	ADP
fnp-5813	239	48	the	the	DET
fnp-5813	239	49	creative	creative	ADJ
fnp-5813	239	50	commons	common	NOUN
fnp-5813	239	51	license	license	NOUN
fnp-5813	239	52	is	be	AUX
fnp-5813	239	53	provided	provide	VERB
fnp-5813	239	54	,	,	PUNCT
fnp-5813	239	55	and	and	CCONJ
fnp-5813	239	56	any	any	DET
fnp-5813	239	57	changes	change	NOUN
fnp-5813	239	58	are	be	AUX
fnp-5813	239	59	indicated	indicate	VERB
fnp-5813	239	60	.	.	PUNCT
fnp-5813	240	1	the	the	DET
fnp-5813	240	2	creative	creative	ADJ
fnp-5813	240	3	commons	common	NOUN
fnp-5813	240	4	public	public	ADJ
fnp-5813	240	5	domain	domain	NOUN
fnp-5813	240	6	dedication	dedication	NOUN
fnp-5813	240	7	waiver	waiver	NOUN
fnp-5813	240	8	(	(	PUNCT
fnp-5813	240	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-5813	240	10	)	)	PUNCT
fnp-5813	240	11	applies	apply	VERB
fnp-5813	240	12	to	to	ADP
fnp-5813	240	13	the	the	DET
fnp-5813	240	14	data	datum	NOUN
fnp-5813	240	15	made	make	VERB
fnp-5813	240	16	available	available	ADJ
fnp-5813	240	17	in	in	ADP
fnp-5813	240	18	this	this	DET
fnp-5813	240	19	article	article	NOUN
fnp-5813	240	20	,	,	PUNCT
fnp-5813	240	21	unless	unless	SCONJ
fnp-5813	240	22	otherwise	otherwise	ADV
fnp-5813	240	23	stated	state	VERB
fnp-5813	240	24	.	.	PUNCT